
<html lang="en"     class="pb-page"  data-request-id="b3a057be-0a4a-4f44-8677-ef1726585864"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01665;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development" /></meta><meta name="dc.Creator" content="Angelo  Aguilar" /></meta><meta name="dc.Creator" content="Jianfeng  Lu" /></meta><meta name="dc.Creator" content="Liu  Liu" /></meta><meta name="dc.Creator" content="Ding  Du" /></meta><meta name="dc.Creator" content="Denzil  Bernard" /></meta><meta name="dc.Creator" content="Donna  McEachern" /></meta><meta name="dc.Creator" content="Sally  Przybranowski" /></meta><meta name="dc.Creator" content="Xiaoqin  Li" /></meta><meta name="dc.Creator" content="Ruijuan  Luo" /></meta><meta name="dc.Creator" content="Bo  Wen" /></meta><meta name="dc.Creator" content="Duxin  Sun" /></meta><meta name="dc.Creator" content="Hengbang  Wang" /></meta><meta name="dc.Creator" content="Jianfeng  Wen" /></meta><meta name="dc.Creator" content="Guangfeng  Wang" /></meta><meta name="dc.Creator" content="Yifan  Zhai" /></meta><meta name="dc.Creator" content="Ming  Guo" /></meta><meta name="dc.Creator" content="Dajun  Yang" /></meta><meta name="dc.Creator" content="Shaomeng  Wang" /></meta><meta name="dc.Description" content="We previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors. In this paper we describe an extensive structu..." /></meta><meta name="Description" content="We previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors. In this paper we describe an extensive structu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 24, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01665" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01665" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01665" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01665" /></link>
        
    
    

<title>Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01665" /></meta><meta property="og:title" content="Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0031.jpeg" /></meta><meta property="og:description" content="We previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors. In this paper we describe an extensive structure–activity relationship study of this class of MDM2 inhibitors, which led to the discovery of 60 (AA-115/APG-115). Compound 60 has a very high affinity to MDM2 (Ki &lt; 1 nM), potent cellular activity, and an excellent oral pharmacokinetic profile. Compound 60 is capable of achieving complete and long-lasting tumor regression in vivo and is currently in phase I clinical trials for cancer treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01665"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01665">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01665&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01665&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01665&amp;href=/doi/10.1021/acs.jmedchem.6b01665" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2819-2839</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01468" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00326" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Aguilar">Angelo Aguilar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianfeng++Lu">Jianfeng Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liu++Liu">Liu Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ding++Du">Ding Du</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4615-5433" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denzil++Bernard">Denzil Bernard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna++McEachern">Donna McEachern</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sally++Przybranowski">Sally Przybranowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoqin++Li">Xiaoqin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruijuan++Luo">Ruijuan Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Wen">Bo Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duxin++Sun">Duxin Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hengbang++Wang">Hengbang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianfeng++Wen">Jianfeng Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangfeng++Wang">Guangfeng Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yifan++Zhai">Yifan Zhai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Guo">Ming Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dajun++Yang">Dajun Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>±</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaomeng++Wang">Shaomeng Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8782-6950" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">University of Michigan Comprehensive Cancer Center, and Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Jiangsu Ascentage Biomed Development Inc., China Medical City, Taizhou, Jiangsu 225300, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">#</span> <span class="aff-text">Suzhou Ascentage Pharma Inc., Suzhou, Jiangsu 215123, China</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">±</span> <span class="aff-text">Department of Experimental Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, China</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8fdce7eee0e2eae1e8cffae2e6ece7a1eaebfa"><span class="__cf_email__" data-cfemail="86d5eee7e9ebe3e8e1c6f3ebefe5eea8e3e2f3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01665&amp;href=/doi/10.1021%2Facs.jmedchem.6b01665" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2819–2839</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 24, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 November 2016</li><li><span class="item_label"><b>Published</b> online</span>24 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01665" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01665</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01665"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4263</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">75</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01665" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Aguilar&quot;},{&quot;first_name&quot;:&quot;Jianfeng&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Liu&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Ding&quot;,&quot;last_name&quot;:&quot;Du&quot;},{&quot;first_name&quot;:&quot;Denzil&quot;,&quot;last_name&quot;:&quot;Bernard&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;McEachern&quot;},{&quot;first_name&quot;:&quot;Sally&quot;,&quot;last_name&quot;:&quot;Przybranowski&quot;},{&quot;first_name&quot;:&quot;Xiaoqin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Ruijuan&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Duxin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Hengbang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jianfeng&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Guangfeng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yifan&quot;,&quot;last_name&quot;:&quot;Zhai&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Dajun&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Shaomeng&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2819-2839&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01665&quot;},&quot;abstract&quot;:&quot;We previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors. In this paper we describe an extensive structure–activity relationship study of this class of MDM2 inhibitors, which led to the discovery of 60 (AA-115/APG-115). Compound 60 has a very high affinity to MDM2 (Ki &lt; 1 nM), potent cellular activity, and an excellent oral pharmacokinetic profile. Compound 60 is capable of achieving complete and long-lasting tumor regression in vivo and is currently in phase I clinical trials for cancer treatment.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01665&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01665" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01665&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01665" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01665&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01665" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01665&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01665&amp;href=/doi/10.1021/acs.jmedchem.6b01665" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01665" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01665" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01665%26sid%3Dliteratum%253Aachs%26pmid%3D28339198%26genre%3Darticle%26aulast%3DAguilar%26date%3D2017%26atitle%3DDiscovery%2Bof%2B4-%2528%25283%25E2%2580%25B2R%252C4%25E2%2580%25B2S%252C5%25E2%2580%25B2R%2529-6%25E2%2580%25B3-Chloro-4%25E2%2580%25B2-%25283-chloro-2-fluorophenyl%2529-1%25E2%2580%25B2-ethyl-2%25E2%2580%25B3-oxodispiro%255Bcyclohexane-1%252C2%25E2%2580%25B2-pyrrolidine-3%25E2%2580%25B2%252C3%25E2%2580%25B3-indoline%255D-5%25E2%2580%25B2-carboxamido%2529bicyclo%255B2.2.2%255Doctane-1-carboxylic%2BAcid%2B%2528AA-115%252FAPG-115%2529%253A%2BA%2BPotent%2Band%2BOrally%2BActive%2BMurine%2BDouble%2BMinute%2B2%2B%2528MDM2%2529%2BInhibitor%2Bin%2BClinical%2BDevelopment%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2819%26epage%3D2839%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors. In this paper we describe an extensive structure–activity relationship study of this class of MDM2 inhibitors, which led to the discovery of <b>60</b> (AA-115/APG-115). Compound <b>60</b> has a very high affinity to MDM2 (<i>K</i><sub>i</sub> < 1 nM), potent cellular activity, and an excellent oral pharmacokinetic profile. Compound <b>60</b> is capable of achieving complete and long-lasting tumor regression in vivo and is currently in phase I clinical trials for cancer treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The tumor suppressor function of p53 is compromised in essentially all human cancers. In about half of human cancers, <i>TP53</i>, the gene encoding p53 protein, is mutated or deleted, and this inactivates the tumor suppressor function of p53.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the remaining 50%, p53 retains its wild-type status but its function is effectively inhibited by the murine double minute 2 (MDM2) protein through a direct protein–protein interaction.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8">(2-8)</a> Through direct binding, the MDM2 protein blocks the transactivation domain of p53, transports p53 from the nucleus to the cytoplasm, and ubiquitinates p53 for proteasomal degradation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Small-molecule inhibitors designed to block the MDM2–p53 interaction (hereafter called MDM2 inhibitors) can liberate the tumor suppressor function of p53<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> and may have a promising therapeutic potential for cancer treatment. Intense research efforts have resulted in advancement of several potent, selective, non-peptide MDM2 inhibitors (<b>1</b>–<b>5</b>),<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19 ref20">(14-20)</a> shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, into clinical development.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative MDM2 inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our laboratory has designed and optimized spirooxindoles as a new class of MDM2 inhibitors and has advanced compound <b>2</b> (MI-77301) into clinical development.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> One shortcoming of <b>2</b> and its earlier analogues that we have found is that they slowly isomerize in solution.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> To overcome this stability issue, we recently reported the design of new spirooxindoles containing two identical substituents at C-2 of the pyrrolidine ring, which can undergo a rapid and irreversible conversion to a single diastereoisomer.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In the present study, we report an extensive structure–activity relationship (SAR) study for this class of MDM2 inhibitors. This study has led to the discovery of <b>60</b> (AA-115/APG-115), a highly potent, chemically stable and efficacious MDM2 inhibitor, which has entered clinical development for cancer treatment (ClinicalTrials.gov identifier for <b>60</b>: NCT02935907).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our exploration started with lead molecule <b>6</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) that binds to MDM2 with <i>K</i><sub>i</sub> = 2.9 nM, inhibits the growth of the SJSA-1 cancer cell line with IC<sub>50</sub> = 190 nM, and achieves strong tumor growth inhibition but not complete tumor regression in an SJSA-1 osteosarcoma xenograft model in mice.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In a search for superior compounds, we have performed extensive modifications of <b>6</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Chemical structure of compound <b>6</b> and five regions (A–E) where chemical modifications were made. (B) Cocrystal structure of <b>2</b> (light blue spheres, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TRF">5TRF</a>) and model of the binding mode of <b>6</b> (green sticks) in complex with MDM2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To guide our chemical modifications, we modeled the structure of compound <b>6</b> in a complex with MDM2 based upon the cocrystal structure of compound <b>2</b> complexed with human MDM2 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Our model shows that the oxindolephenyl, 3-chloro-2-fluorophenyl, and cyclohexyl groups of <b>6</b> project into the Trp23, Leu26, and Phe19 p53 binding pockets of the MDM2 protein and the 4-hydroxyl of the <i>N</i>-cyclohexylcarboxamide group forms a hydrogen bond with Lys94 of MDM2 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). Guided by this model, we performed extensive modifications on five regions of the molecule (labeled as sites A–E, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).</div><div class="NLM_p">We began by replacing the 4-hydroxycyclohexyl group at site D in compound <b>6</b> with a methyl group, giving compound <b>7</b>. Since compounds <b>6</b> and <b>7</b> have similar binding affinities to MDM2, we have used either compound <b>6</b> or <b>7</b> as the template for modifications of site A (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Replacement of the cyclohexyl group at site A with 4-piperidinyl group led to compound <b>8</b>, which has no appreciable binding up to 2 μM to MDM2. Methylation or acetylation of the amine group in <b>8</b> resulted in compound <b>9</b> or <b>10</b>, respectively, and these also have very weak affinities for MDM2. Replacement of the cyclohexyl group at site A in <b>6</b> with 4-tetrahydro-2<i>H</i>-pyran generated compound <b>11</b>, which has a moderate binding affinity to MDM2 (<i>K</i><sub>i</sub> = 75.9 nM). Introduction of two fluorine substituents at the 4-position of the cyclohexyl group in compound <b>6</b> resulted in compound <b>12</b>, which has a good affinity to MDM2 (<i>K</i><sub>i</sub> = 9.8 nM) but is 4 times less potent than <b>6</b>. However, introduction of two methyl groups at the same 4-position in <b>6</b> yielded compound <b>15</b>, which has a <i>K</i><sub>i</sub> value of <1 nM to MDM2 and is several times more potent than <b>6</b>. Replacement of the cyclohexyl group with a cyclobutyl group generated compound <b>13</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which is 6 times less potent than <b>6</b>. Installation of methyl groups at the 3-position of the cyclobutyl ring led to compound <b>14</b>, which is equally potent as compound <b>6</b> and 7 times more potent than compound <b>13</b>. Hence, our SAR data for site A clearly show that a hydrophobic group is highly desirable for achieving a strong binding affinity to MDM2, and cyclohexyl, 4,4′-dimethylcyclohexyl, and 3,3′-cyclobutyl groups are the most preferred.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationship of Pyrrolidine-2-spirocyclohexyl Substituent<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0019.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0020.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>Table a</sup><p class="last">Value of one experiment.</p></div><div class="footnote" id="t1fn3"><sup>Table b</sup><p class="last">Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="footnote" id="t1fn1"><sup>Table c</sup><p class="last">Values are average of at least two tests.</p></div></div><div></div></div><div class="NLM_p">Next, we explored modifications of the 3-chloro-2-fluorophenyl and the oxindolephenyl substituents (sites B and C in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A, respectively). To improve solubility, we inserted one or more nitrogen atoms into the aryl rings, producing compounds <b>16</b>, <b>17</b>, <b>18</b>, and <b>19</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Insertion of a nitrogen into the 3-chloro-2-fluorophenyl substituent (ring B) gave <b>16</b>, which has a <i>K</i><sub>i</sub> of 77 nM, 26 times weaker than <b>6</b>. Interestingly, although the Trp23 pocket is hydrophobic in nature, compounds <b>17</b>, <b>18</b>, and <b>19</b> containing a pyridinyl or a pyrimidinyl oxindole group (ring C) are all quite potent with <i>K</i><sub>i</sub> = 13–14 nM. Our data, however, are consistent with a previous study, which showed that a compound containing a chloropyridyl oxindole group is a potent MDM2 inhibitor.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This previous study also showed that replacing the oxindole with a thienopyrrolone led to potent MDM2 inhibitors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We therefore synthesized compound <b>20</b> containing a thienopyrrolone, which has a <i>K</i><sub>i</sub> of 6.5 nM and is 2-fold less potent than <b>6</b>. We found that the thiophene group in <b>20</b> can be oxidized during the oxidative removal of the chiral auxiliary, preventing further investigation of this compound.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the B and C Aryl Rings<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0021.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0022.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are average of at least two tests.</p></div></div><div></div></div><div class="NLM_p">Our modeling of <b>6</b> and the cocrystal structure of <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) showed that the carbonyl of the amide (site E) forms a hydrogen bond with His96 of the MDM2 protein but the amino group does not interact with the MDM2 protein. We evaluated a series of five-membered heteroaromatic rings as the amide bioisoteres (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Among these replacements, we found that heteroaromatic rings with carboxylic acid substituents, e.g., <b>21</b>, <b>22</b>, <b>26</b>, and <b>27</b> have the best binding affinities with <i>K</i><sub>i</sub> values between 1 and 3 nM. Unfortunately, these compounds show weak cell growth inhibitory activity (IC<sub>50</sub> > 2 μM, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) in the SJSA-1 cancer cells, probably because the negatively charged acid group in these compounds decreases their cell permeability. We therefore converted the acid group in compound <b>21</b> to an amide but found that the resulting compound <b>28</b> is 20 times less potent than <b>21</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Carboxamide (E) Bioisostere Replacement<a class="ref internalNav" href="#t3fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0023.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0024.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn2"><div class="footnote" id="t3fn2"><sup>Table a</sup><p class="last">Value of only one experimnent.</p></div><div class="footnote" id="t3fn3"><sup>Table b</sup><p class="last">NT = not tested.</p></div><div class="footnote" id="t3fn1"><sup>Table c</sup><p class="last">Values are average of at least two experiments.</p></div></div><div></div></div><div class="NLM_p">Our modeling of <b>6</b> and the cocrystal structure of <b>2</b> also showed that the 4-hydroxyl on the cyclohexylcarboxamide substituent of <b>6</b> forms a hydrogen bond with Lys94 of the MDM2 protein (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). We synthesized a series of compounds containing either a terminal carboxylic acid or a sulfone to investigate the effect on binding (compounds <b>29</b>–<b>38</b>) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). These modifications resulted in a series of compounds with high affinities. In particular, compounds <b>31</b>, <b>32</b>, and <b>33</b> bind to MDM2 with <i>K</i><sub>i</sub> < 1 nM and are more than 3 times more potent than <b>6</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Carboxamide Substituent (D)<a class="ref internalNav" href="#t4fn1" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0025.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0026.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn2"><div class="footnote" id="t4fn2"><sup>Table a</sup><p class="last">Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="footnote" id="t4fn3"><sup>Table b</sup><p class="last">NT = not tested.</p></div><div class="footnote" id="t4fn4"><sup>Table c</sup><p class="last">Value of one time testing.</p></div><div class="footnote" id="t4fn1"><sup>Table d</sup><p class="last">Values are average of at least two tests.</p></div></div><div></div></div><div class="NLM_p">We tested the cell growth inhibitory activity of compounds <b>29</b>–<b>38</b> in the SJSA-1 cell line, and the data are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Among this series of compounds, <b>32</b>, <b>33</b>, and <b>38</b> have the best antiproliferative activity with IC<sub>50</sub> values of 0.22, 0.15, and 0.24 μM, respectively.</div><div class="NLM_p">We further evaluated compound <b>33</b> for its pharmacodynamic (PD) effect in the SJSA-1 xenograft tissue. Our PD data showed that a single, oral administration of <b>33</b> at 100 mg/kg is very effective in inducing upregulation of MDM2, p53, and p21 proteins at both 3 and 6 h time-points in the SJSA-1 tumor tissue, indicating strong activation of p53 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Upon the basis of its promising PD data, we evaluated compound <b>33</b> for its antitumor efficacy in the SJSA-1 xenograft model (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B,C). While compound <b>33</b> can effectively retard tumor growth, it failed to achieve tumor regression. During the course of our research, we also observed that compound <b>33</b> can decompose in solution, particularly in cell culture media (panels A and B in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). To analyze the potential structural features affecting the stability of <b>33</b>, we determined the stability of compound <b>31</b> with a flexible butanoic acid group, compound <b>6</b> with a 4-hydroxylcyclohexyl group, and <b>33</b>. Compound <b>6</b> had negligible (<1%) decomposition (panel C in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). On the other hand, compound <b>31</b> showed 18% decomposition after 2 days in cell culture media, which is greater than that observed for compound <b>33</b> (panel D in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). On the basis of these results, we proposed that the carboxylic group assists in the decomposition of <b>33</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pharmacodynamics (PD) effect of <b>33</b> in SJSA-1 tumors in mice. Mice were given a single, oral dose of the vehicle, or <b>33</b> at 100 mg/kg and sacrificed at indicated time points. West blotting was performed on harvested tumor tissue to probe MDM2, p53, p21, PAPR, cleaved PARP (cl-PAPR) proteins. (B) Antitumor activity of <b>33</b> in the SJSA-1 osteosarcoma tumor xenograft model in mice. Compound <b>33</b> was administered via oral gavage at 100 mg/kg daily for 14 days. (C) Body weight change of mice during administration of <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Proposed Mechanism of Decomposition for <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(A) Stability of compound <b>33</b> in various solutions. Compound <b>33</b> was incubated in CH<sub>3</sub>CN/H<sub>2</sub>O, MeOH/H<sub>2</sub>O, or cell culture media, and the % composition of <b>33</b> in the solutions was determined daily for 2 days by UPLC (ultraperformance liquid chromatography) and plotted. (B, C, D) UPLC/MS spectrum of <b>33</b>, <b>6</b>, and <b>31</b>, respectively, after incubation for 2 days in cell culture media. Peaks are labeled with retention time followed by molecular weight.</p></p></figure><div class="NLM_p">We next performed further chemical modifications of <b>33</b> with the goal to improve its chemical stability, cellular potency, and in vivo efficacy.</div><div class="NLM_p">We investigated if replacement of the cyclohexyl group with an even more rigid aryl group can prevent the decomposition. A series of compounds containing an <i>N</i>-arylcarboxamide substituent were synthesized and tested (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). These compounds all display very high binding affinities to MDM2, superior to that of <b>6</b> and equivalent to that of <b>33</b>. The cell growth inhibition of SJSA-1 cells by these compounds was determined (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Compounds <b>39</b> (MI-1061)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>44</b> displayed the best cellular activity among the compounds in this series and are 3 times more potent than compound <b>33</b> in inhibition of cell growth in the SJSA-1 cell line. Compound <b>39</b> was found in our previous study<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> to be very stable in solution. Furthermore, <b>39</b> was capable of achieving partial tumor regression in the SJSA-1 xenograft model as shown in our previous report.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of (Aryl acid)carboxamides<a class="ref internalNav" href="#t5fn1" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0027.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0028.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn2"><div class="footnote" id="t5fn2"><sup>Table a</sup><p class="last">Value of one time testing.</p></div><div class="footnote" id="t5fn3"><sup>Table b</sup><p class="last">NT = not tested.</p></div><div class="footnote" id="t5fn4"><sup>Table c</sup><p class="last">Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="footnote" id="t5fn1"><sup>Table d</sup><p class="last">Values are average of at least three tests.</p></div></div><div></div></div><div class="NLM_p">We next combined all the favorable modifications on sites A and D and designed and synthesized compound <b>54</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Compound <b>54</b> has a very high binding affinity to MDM2 (IC<sub>50</sub> = 2.4 nM, <i>K</i><sub>i</sub> < 1 nM, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) and potently inhibits cell growth of SJSA-1 cells with IC<sub>50</sub> = 13 nM (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design of Compound <b>54</b> by Combining the Optimal Substituents of Sites A and D</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></p></figure><div class="NLM_p">We assessed the antitumor activity of compound <b>54</b> in the SJSA-1 xenograft model in mice, with compound <b>2</b> included as the control (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Compound <b>54</b> effectively inhibits tumor growth in a dose-dependent manner compared to the vehicle control. While compound <b>54</b> at 50 mg/kg daily dosing effectively retards tumor growth, at 100 mg/kg it achieves a maximum of 87% tumor regression during the treatment. However, while compound <b>2</b> at 100 mg/kg achieves complete tumor regression, compound <b>54</b> fails to do so.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Antitumor activity of compound <b>54</b>, in comparison to compound <b>2</b> in the SJSA-1 osteosarcoma tumor xenograft model in mice. Compound <b>54</b> was administered via oral gavage at 50 or 100 mg/kg daily for 14 days and compound <b>2</b> was administered via oral gavage at 100 mg/kg daily for 14 days. (B) Changes in body weight of mice during animal dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pharmacokinetic (PK) studies in rats (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) showed that with oral administration, compounds <b>39</b> and <b>54</b> achieve considerably lower <i>C</i><sub>max</sub> and AUC values than compound <b>2</b>, suggesting that further improvement of the oral PK for compounds <b>39</b> and <b>54</b> is needed in order to achieve stronger in vivo antitumor activity. Since <b>39</b> and <b>54</b> achieve comparable tumor regression in the SJSA-1 xenograft model and <b>39</b> is less hydrophobic than <b>54</b>, we have selected compound <b>39</b> for further optimization of its PK properties and in vivo efficacy.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetics Table for Comparison of <b>39</b>, <b>54</b>, <b>56</b>, <b>59</b>, <b>60</b>, and <b>2</b> in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>39</b></th><th class="colsep0 rowsep0" align="center"><b>54</b></th><th class="colsep0 rowsep0" align="center"><b>56</b></th><th class="colsep0 rowsep0" align="center"><b>59</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1553</td><td class="colsep0 rowsep0" align="left">968</td><td class="colsep0 rowsep0" align="left">8234</td><td class="colsep0 rowsep0" align="left">4391</td><td class="colsep0 rowsep0" align="left">5453</td><td class="colsep0 rowsep0" align="left">4547</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po AUC (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">6799</td><td class="colsep0 rowsep0" align="left">10188</td><td class="colsep0 rowsep0" align="left">73603</td><td class="colsep0 rowsep0" align="left">35205</td><td class="colsep0 rowsep0" align="left">39083</td><td class="colsep0 rowsep0" align="left">17230</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po <i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv AUC (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">8633</td><td class="colsep0 rowsep0" align="left">14767</td><td class="colsep0 rowsep0" align="left">82241</td><td class="colsep0 rowsep0" align="left">28825</td><td class="colsep0 rowsep0" align="left">38265</td><td class="colsep0 rowsep0" align="left">4630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv CL (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">0.690</td><td class="colsep0 rowsep0" align="left">0.119</td><td class="colsep0 rowsep0" align="left">0.352</td><td class="colsep0 rowsep0" align="left">0.257</td><td class="colsep0 rowsep0" align="left">1.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv <i>V</i><sub>ss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="left">2.14</td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">0.734</td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">2.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">31.5</td><td class="colsep0 rowsep0" align="left">27.6</td><td class="colsep0 rowsep0" align="left">35.0</td><td class="colsep0 rowsep0" align="left">48.6</td><td class="colsep0 rowsep0" align="left">40.3</td><td class="colsep0 rowsep0" align="left">74.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">antitumor efficacy</td><td class="colsep0 rowsep0" align="left">86% regression</td><td class="colsep0 rowsep0" align="left">87% regression</td><td class="colsep0 rowsep0" align="left">no regression</td><td class="colsep0 rowsep0" align="left">100% regression</td><td class="colsep0 rowsep0" align="left">100% regression</td><td class="colsep0 rowsep0" align="left">100% regression</td></tr></tbody></table></div></div><div class="NLM_p">In our attempt to further improve the oral PK properties of compound <b>39</b> while retaining its high binding affinity to MDM2 and cellular potency, we investigated the replacement of the benzoic acid with nonclassical benzoic acid mimetics such as a bicyclo[1.1.1]pentane-1-carboxylic acid<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> or a bicyclo[2.2.2]octane-1-carboxylic acid. These efforts led to the design and synthesis of compounds <b>55</b> and <b>56</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Compound <b>55</b> binds to MDM2 with a high affinity (IC<sub>50</sub> = 6.4 nM, <i>K</i><sub>i</sub> < 1 nM) but is 5 times less potent than compound <b>39</b> in inhibition of cell growth in the SJSA-1 cell line. In comparison, compound <b>56</b> has a high binding affinity to MDM2 (IC<sub>50</sub> = 3.7 nM, <i>K</i><sub>i</sub> < 1 nM) and is as potent as compound <b>39</b> in inhibition of cell growth in the SJSA-1 cell line (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> and <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Replacement of the Benzoic Acid in Compound <b>39</b> with Nonclassical Benzoic Acid Bioisosteres</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR of Benzoic Acid Nonclassical Bioisosteres and Alkylation of the Pyrrolidine Nitrogen<a class="ref internalNav" href="#t7fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0029.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0030.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn2"><div class="footnote" id="t7fn2"><sup>Table a</sup><p class="last">Value from one experiment.</p></div><div class="footnote" id="t7fn3"><sup>Table b</sup><p class="last">Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="footnote" id="t7fn1"><sup>Table c</sup><p class="last">Values are average of at least two independent experiments.</p></div></div><div></div></div><div class="NLM_p">A PK study in rats showed that <b>56</b> has a higher plasma exposure than compound <b>2</b> based upon both the <i>C</i><sub>max</sub> (8234 vs 4547 μg/L) and AUC values (73603 vs 17230 h·μg/L). However, our PD experiment showed that oral administration of compound <b>56</b> at 100 mg/kg induces only modest p53 activation and no cleavage of PARP and caspase-3 in the SJSA-1 xenograft tumor tissue in mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Consistent with the PD data, compound <b>56</b> at 100 mg/kg administered daily for 14 days demonstrates only a very moderate tumor growth inhibition in the SJSA-1 xenograft model in mice (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Hence, the antitumor activity of <b>56</b> is much inferior to that achieved by <b>2</b>, <b>39</b>, and <b>54</b>. Because of its excellent in vitro cellular potency and excellent plasma exposure, the modest p53 activation and antitumor activity achieved by compound <b>56</b> suggests that this compound has a poor penetration into the xenograft tumor tissue. Accordingly, we investigated strategies with which to improve the tissue penetration while retaining high binding affinity to MDM2, potent cellular activity, and good oral bioavailability of compound <b>56</b>.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Antitumor activity of compounds <b>39</b> and <b>56</b> in the SJSA-1 osteosarcoma xenograft model in mice. (B) Body weight change of mice during administration period.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We investigated three strategies to improve the tissue penetration: (1) decreasing the lipophilicity of the molecule; (2) reducing the acidity of carboxylic acids; and (3) increasing the basicity of the nitrogen atom in the pyrrolidine core.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Fluorine substitution on aliphatic groups is known to decrease lipophilicity.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> We therefore synthesized compound <b>57</b> with a 4,4-difluorocyclohexyl group at carbon-2 of the pyrrolidine core (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). For the second strategy, we replaced the carboxylic acid group with an acyl sulfonamide bioisostere, which resulted in <b>58</b> (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). For the third strategy, we installed a methyl or ethyl group on the nitrogen of the pyrrolidine core, which led to <b>59</b> and <b>60</b>, respectively (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).</div><div class="NLM_p">Compound <b>57</b> binds to MDM2 with a high affinity but is less potent than <b>56</b> and is 2 times less potent than <b>56</b> in inhibition of cell growth in the SJSA-1 cell line (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Compound <b>58</b> is 2 times less potent than <b>56</b> in binding to MDM2 and is 4 times less potent than <b>56</b> in inhibition of cell growth in the SJSA-1 cell line (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). The PD study showed that oral administration of <b>57</b> or <b>58</b> at 100 mg/kg only has a modest effect on activation of p53 and induction of cleavage of PARP and caspase-3 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic (PD) analysis of the effect of MDM2 inhibitors in SJSA-1 tumors. Mice bearing SJSA-1 tumors were dosed with a single oral dose of <b>56</b>, <b>57</b>, <b>58</b>, <b>59</b>, <b>60</b> and <b>2</b> at 100 mg/kg and the tumors were harvested at 6 and 24 hours for western blot analysis. (A, B) PD of <b>56</b>, <b>57</b> and <b>58</b> show modest activation of p53 as seen with the low levels of p53, MDM2, and p21; (C) Compounds <b>59</b>, <b>60</b> and <b>2</b> show robust activation of p53 as seen with increased levels of p53, MDM2, ubiquitinated MDM2 (ub-MMD2) and p21, and induce strong apoptosis as seen with increased levels of cleaved PARP (cl-PAPR) and cleaved caspase-3 (cl-Casp3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In comparison, compounds <b>59</b> and <b>60</b> bind to MDM2 with a high binding affinity (<i>K</i><sub>i</sub> < 1 nM, <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Both compounds potently inhibit cell growth in the SJSA-1 cell line with IC<sub>50</sub> values of 70 and 60 nM, respectively, and are thus as potent as compound <b>56</b> (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). PD experiments showed that a single, oral dose of <b>59</b> and <b>60</b> at 100 mg/kg achieves strong p53 activation, with the effect persisting for 24 h in the SJSA-1 xenograft tumor tissue (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Compounds <b>59</b> and <b>60</b> also achieve strong apoptosis induction in the SJSA-1 xenograft tumor, based upon cleavage of PARP and caspase-3 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C).</div><div class="NLM_p">We next tested <b>59</b> and <b>60</b> for the antitumor activity in the SJSA-1 xenograft model (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Compound <b>59</b> or <b>60</b> orally administered at 30 mg/kg daily for 14 days effectively inhibits tumor growth. Compound <b>59</b> or <b>60</b> orally administered at 100 mg/kg daily for 14 days effectively achieves complete and long-lasting tumor regression. In comparison, compound <b>56</b> at 100 mg/kg inhibits tumor growth only moderately in the same experiment (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). Compounds <b>56</b>, <b>59</b>, and <b>60</b> cause no or minimal weight loss during the entire experiment (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0007.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Antitumor activity of compound <b>59</b>, <b>60</b> in comparison to <b>56</b> in the SJSA-1 osteosarcoma xenograft model in mice. Compound <b>59</b> and <b>60</b> were administered at 30 mg/kg or 100 mg/kg daily for 14 days and <b>56</b> at 100 mg/kg daily for 14 days. (B) Animal weight changes of mice during the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our PK studies in rats with oral administration showed that <b>59</b> and <b>60</b> achieve a <i>C</i><sub>max</sub> value similar to that of <b>2</b> but have a 2 times higher AUC than compound <b>2</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><div class="NLM_p">We evaluated compounds <b>56</b>, <b>59</b>, and <b>60</b> for their activity and selectivity in a number of human cancer cell lines of different tumor types (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Consistent with their mechanism of action, these three compounds potently inhibit cell growth in cancer cell lines with wild-type p53 and display outstanding selectivity in cancer cell lines with deleted p53. Compound <b>60</b> is the most potent compound, achieving IC<sub>50</sub> values of 38, 18, and 104 nM in the RS4;11 acute leukemia, LNCaP prostate cancer, and HCT116 colon cancer cell lines, respectively.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Cell Growth Inhibition Activity of <b>56</b>, <b>59</b>, and <b>60</b> in Different Human Cancer Cell Lines<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">cell growth inhibition (IC<sub>50</sub>)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">tumor type</th><th class="colsep0 rowsep0" align="center">p53 status</th><th class="colsep0 rowsep0" align="center"><b>56</b></th><th class="colsep0 rowsep0" align="center"><b>59</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SJSA-1</td><td class="colsep0 rowsep0" align="left">osteosarcoma</td><td class="colsep0 rowsep0" align="left">wild-type</td><td class="colsep0 rowsep0" align="left">89 ± 33 (nM)</td><td class="colsep0 rowsep0" align="left">70 ± 21(nM)</td><td class="colsep0 rowsep0" align="left">60 ± 22 (nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Saos2</td><td class="colsep0 rowsep0" align="left">osteosarcoma</td><td class="colsep0 rowsep0" align="left">null</td><td class="colsep0 rowsep0" align="left">26.7 ± 5.1 (μM)</td><td class="colsep0 rowsep0" align="left">25 ± 6 (μM)</td><td class="colsep0 rowsep0" align="left">22.7 ± 4.7 (μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RS4;11</td><td class="colsep0 rowsep0" align="left">leukemia</td><td class="colsep0 rowsep0" align="left">wild-type</td><td class="colsep0 rowsep0" align="left">62 ± 26 (nM)</td><td class="colsep0 rowsep0" align="left">56 ± 18 (nM)</td><td class="colsep0 rowsep0" align="left">38 ± 5 (nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP</td><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">wild-type</td><td class="colsep0 rowsep0" align="left">36 ± 19 (nM)</td><td class="colsep0 rowsep0" align="left">30 ± 15 (nM)</td><td class="colsep0 rowsep0" align="left">18 ± 13 (nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC3</td><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">null</td><td class="colsep0 rowsep0" align="left">12.3 ± 2.5 (μM)</td><td class="colsep0 rowsep0" align="left">24 ± 5 (μM)</td><td class="colsep0 rowsep0" align="left">22 ± 7.2 (μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT116</td><td class="colsep0 rowsep0" align="left">colon cancer</td><td class="colsep0 rowsep0" align="left">wild-type</td><td class="colsep0 rowsep0" align="left">137 ± 31 (nM)</td><td class="colsep0 rowsep0" align="left">117 ± 33 (nM)</td><td class="colsep0 rowsep0" align="left">104 ± 36 (nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT116 p53–/–</td><td class="colsep0 rowsep0" align="left">colon cancer</td><td class="colsep0 rowsep0" align="left">knockout</td><td class="colsep0 rowsep0" align="left">14 ± 2 (μM)</td><td class="colsep0 rowsep0" align="left">18 ± 8 (μM)</td><td class="colsep0 rowsep0" align="left">8 ± 1 (μM)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are average of at least three independent experiments.</p></div></div></div><div class="NLM_p">We next evaluated compound <b>60</b> for its antitumor activity in the RS4;11 acute leukemia xenograft model in mice. Compound <b>60</b> effectively inhibits tumor growth in a dose-dependent manner and achieves partial tumor regression at 100 mg/kg, daily, oral administration for 14 days, or at 200 mg/kg weekly dosing for 3 weeks (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Compound <b>60</b> is also well tolerated at all doses and schedules in this experiment.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0008.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Antitumor activity of compound <b>60</b> in the RS4; 11 acute lymphoblastic leukemia xenograft model in mice. Compound <b>60</b> was administered at 50 mg/kg, 75 mg/kg, or 100 mg/kg daily for 14 days and 200 mg/kg weekly for 3 weeks. (B) Animal body weight of mice during administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We evaluated the chemical stability of compound <b>60</b> in three different solutions and found that this compound is very stable in solutions for a period of 7 days (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). In comparison, compound <b>2</b> slowly isomerizes in solutions and retains only 93–96% purity after 7 days (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0009.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Stability comparison of compounds <b>2</b> and <b>60</b> in (A) 1:1 CH<sub>3</sub>CN to H<sub>2</sub>O; (B) 1:1 MeOH to H<sub>2</sub>O; (C) cell culture media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To explore achiral substituents in carbon-2 of the pyrrolidine core, the compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were synthesized using the method<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The azomethine ylide generated in situ by reaction of the chiral amine (<b>62</b>) with the cyclic ketone (<b>63</b>) was allowed to react with <b>61</b> in a 1,3-dipolar cycloaddition reaction, generating the chiral spirooxindoles (<b>6a</b>–<b>15a</b>). Reaction of this morpholine (<b>6a</b>–<b>15a</b>) with an aliphatic amine led to the open-ring compound (<b>6b</b>–<b>15b</b>). Upon oxidation with ceric ammonium nitrate (CAN), <b>6c</b>–<b>15c</b> were formed as a mixture of two diastereoisomers. “Aging” in acetonitrile/water resulted in formation of the single diastereoisomers <b>6</b>–<b>15</b>.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>6</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, reflux, 2 h; (b) R<sub>1</sub>NH<sub>2</sub>, THF, reflux overnight; (c) CH<sub>3</sub>CN/H<sub>2</sub>O (1:1), CAN, 15 min; (d) CH<sub>3</sub>CN/H<sub>2</sub>O, overnight.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> shows the method by which the B and C aryl rings were replaced. First the intermediates <b>16b</b>–<b>20b</b> were synthesized by condensation of the pyrrolidones (<b>16a</b>–<b>20a</b>) with an arylaldehyde. Subsequently, the compounds (<b>16</b>–<b>20</b>) in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> were obtained by using the intermediates (<b>16b</b>–<b>20b</b>), which are equivalent to <b>61</b>, in the synthetic method outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>16</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, piperidine, reflux.</p></p></figure><div class="NLM_p">Compounds containing various five-membered heteroaromatic rings as bioisostere replacements for the carboxamide group E were synthesized as outlined in <a class="ref internalNav" href="#sch6" aria-label="Schemes 6">Schemes 6</a> and <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. The <i>N</i>-methylpyrrolidine (<b>65</b>) was generated by reductive amination of <b>64</b> with paraformaldehyde and NaBH(OAc)<sub>3</sub>. Hydrolysis of the methyl ester (<b>65</b>) was followed by conversion of the acid (<b>66</b>) to the corresponding carboxamide (<b>67</b>). Refluxing of <b>67</b> with Lawesson’s reagent produced the thioamide (<b>68</b>) which was reacted with an α-bromoketone in a Hantzsch thiazole synthesis reaction, generating the thiazoles <b>69</b> and <b>70</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Basic hydrolysis of the esters produced the acid analogues <b>21</b> and <b>27</b>. Compound <b>21</b> was further elaborated by amide coupling, generating the carboxamide (<b>28</b>).</div><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>21</b>, <b>27</b>, and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM/AcOH (1:1), paraformaldehyde, NaBH(OAc)<sub>3</sub>; (b) THF/MeOH/H<sub>2</sub>O, LiOH·H<sub>2</sub>O; (c) DCE, CDI, DIEA, 50 °C 30 min, then NH<sub>4</sub>OH; (d) DCM, Lawesson’s reagent, reflux overnight; (e) (1) THF, BrCH<sub>2</sub>COR, Et<sub>3</sub>N, reflux overnight, (2) DME, TFAA, pyridine, −20 °C to rt, 30 min; (f) THF/MeOH/H<sub>2</sub>O (1:1:1), NaOH, rt, prep-HPLC.</p></p></figure><figure id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>22</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCE, CDI, DIEA, DMAP, 50 °C for 30 min, then <b>71</b>, <b>74</b>, <b>76</b>, <b>78</b>, and reflux; (b) (1) THF, Deoxo-Fluor, −20 °C for 30 min, (2) BrCCl<sub>3</sub>, DBU at rt overnight; (c) THF/H<sub>2</sub>O (2:1), LiOH·H<sub>2</sub>O, rt for 30 min, then preparative HPLC; (d) pyridine, 100 °C for 4 h; (e) DCM, PPh<sub>3</sub>, I<sub>2</sub>, Et<sub>3</sub>N, rt; (f) DCM, Lawesson’s reagent, reflux overnight.</p></p></figure><div class="NLM_p">Several five-membered heteroaromatic rings were formed from the carboxylic acid (<b>66</b>). The carboxylic acid (<b>66</b>) was activated with CDI (1,1′-carbonyldiimidazole), and this was followed by addition of commercially available compounds <b>71</b>, <b>74</b>, <b>76</b>, <b>78</b>, resulting in the formation of intermediates <b>72</b>, <b>75</b>, <b>77</b>, <b>79</b>, respectively. Cyclization to the respective five-membered heteroaromatic compounds (<b>73</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>23</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>24</b>,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>25</b>, <b>80</b>) was accomplished under the conditions outlined in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. The carboxylic acid compounds <b>22</b> and <b>26</b> were produced by hydrolysis of the esters in compounds <b>73</b> and <b>80</b>, respectively.</div><div class="NLM_p">The compounds in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were obtained by the synthesis outlined in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. Activation of the carboxylic acid (<b>29</b>) by HATU (1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate) followed by addition of an alkylamine gave the <i>N</i>-alkylcarboxamide intermediates <b>30</b>, <b>36</b>, <b>38</b>, <b>31</b>–<b>35</b>, <b>37</b>, <b>55</b>, and <b>56</b>. When <i>N</i>-arylamines were used, HATU failed to accomplish the coupling, but the coupling was successful when the acid was activated with Ph<sub>2</sub>POCl <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and produced the <i>N</i>-arylcarboxamides <b>39</b>–<b>48</b>, <b>50</b>, and <b>51</b>. Basic hydrolysis of the esters produced the carboxylic acid compounds listed in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Further elaboration of the acids (<b>56</b> to give <b>58</b>; <b>39</b> to give <b>49</b> and <b>52</b>; and <b>44</b> to give <b>53</b>) was accomplished by CDI activation of the carboxylic acid followed by reaction with the respective amine.</div><figure id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compounds in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM, HATU, DIEA, alkylamine; (b) THF/MeOH/H<sub>2</sub>O (1:1:1), LiOH·H<sub>2</sub>O for alkyl esters or NaOH for aryl esters; (c) DCM, Ph<sub>2</sub>POCl, DIEA 30 min, then arylamine and DMAP; (d) DCE, CDI, DIEA, DMAP, 50 °C for 30 min, then R<sub>2</sub>NH<sub>2</sub> and reflux.</p></p></figure><div class="NLM_p">Reductive amination of <b>56</b> with paraformaldehyde or acetaldehyde produced <b>59</b> and <b>60</b> as shown in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>.</div><figure id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>59</b> and <b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM/AcOH (1:1), paraformaldehyde or acetaldehyde, NaBH(OAc)<sub>3</sub>, rt overnight.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we have performed an extensive SAR study on spirooxindoles containing two substituents at the carbon-2 of the pyrrolidine core as MDM2 inhibitors. Extensive modifications in five different regions of the molecule have led to discovery of a number of potent and highly efficacious MDM2 inhibitors. In particular, compound <b>60</b> has a very high binding affinity to MDM2 (<i>K</i><sub>i</sub> < 1 nM), potently activates wild-type p53, inhibits cell growth with low nanomolar IC<sub>50</sub> values in human cancer cell lines carrying wild-type p53, and demonstrates an outstanding cellular selectivity over human cancer cell lines with deleted p53. Compound <b>60</b> is very stable in solutions, has excellent oral pharmacokinetics, and effectively activates p53 in the SJSA-1 xenograft tumor tissue in mice following a single oral administration. Significantly, <b>60</b> achieves complete and long-lasting regression of the SJSA-1 xenograft tumors in mice and demonstrates strong antitumor activity in the RS4;11 acute leukemia model at well tolerated dose schedules. Compound <b>60</b> has been advanced into phase I clinical development for the treatment of human cancer.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Information</h3><div class="NLM_p">Unless otherwise stated, all commercial reagents were used as supplied without further purification and all reactions were performed under a nitrogen atmosphere in dry solvents under anhydrous conditions. NMR spectra were obtained on either a Bruker 300 UltraShield spectrometer at a <sup>1</sup>H frequency of 300 MHz and <sup>13</sup>C frequency of 75 MHz or Bruker 400 Ascend spectrometer at a <sup>1</sup>H frequency of 400 MHz and <sup>13</sup>C frequency of 100 MHz. Chemical shifts (δ) are reported in parts per million (ppm) relative to an internal standard. The final products were purified on a preparative HPLC (Waters 2545, quaternary gradient module) with a SunFire Prep C18 OBD 5 μm, 50 mm × 100 mm reverse phase column. The mobile phase was a gradient of solvent A (H<sub>2</sub>O with 0.1% TFA) and solvent B (MeOH with 0.1% TFA or MeCN with 0.1% TFA) at a flow rate of 40 mL/min and 1%/2 min increase of solvent B or a flow rate of 60 mL/min and 1%/min increase of solvent B. All final compounds have purity of ≥95% as determined by Waters ACQUITY UPLC using reverse phase column (SunFire, C18-5 μm, 4.6 mm × 150 mm) and a solvent gradient of A (H<sub>2</sub>O with 0.1% of TFA) and solvent D (MeOH with 0.1% of TFA) or A (H<sub>2</sub>O with 0.1% of TFA) and solvent B (CH<sub>3</sub>CN with 0.1% of TFA). ESI mass spectrum analysis was performed on a Thermo-Scientific LCQ Fleet mass spectrometer. No PAINS liability was found in any of the compounds presented as determined by analysis in the online filter SmartsFilter (<a href="http://pasilla.health.unm.edu/tomcat/biocomp/smartsfilter" class="extLink">http://pasilla.health.unm.edu/tomcat/biocomp/smartsfilter</a>).</div><div class="NLM_p">Compounds <b>6</b>, <b>13</b>, <b>29</b>, <b>39</b> and intermediate <b>64</b> were reported previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compounds <b>16b</b>–<b>20b</b> were synthesized as reported previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">Compounds <b>7</b>–<b>20</b> were synthesized according to our reported method<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which is described below for the synthesis of compound <b>6</b>.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>6</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h3><div class="NLM_p last">In a round-bottom flask, (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (500 mg, 1.62 mmol), (5<i>R</i>,6S)-5,6-diphenyl-2-morpholinone (492 mg, 1.94 mmol), and cyclohexanone (4.86 mmol) were suspended in toluene (10 mL) and heated at reflux for 2 h at 140 °C. Then the reaction was allowed to cool to room temperature and the solvent was removed by rotoevaporation. The crude product was purified by column chromatography (the compound was eluted with 100% DCM) to give 665 mg (64% yield) of <b>6a</b> as a pale yellow solid. <i>trans</i>-4-Aminocyclohexanol (475 mg, 4.13 mmol) was added to a solution of <b>6a</b> (530 mg, 0.826 mmol) in THF (20 mL) and heated at reflux overnight. Then the reaction was cooled to room temperature and the solvent was removed by rotoevaporation. The crude <b>6b</b> was purified by column chromatography to produce 224 mg of <b>6b</b>. Cerium ammonium nitrate (324 mg, 0.592 mmol) was added to a solution of the resulting <b>6b</b> (224 mg, 0.296 mmol) in MeCN (6 mL) and stirred for 5 min at room temperature, then H<sub>2</sub>O (6 mL) was added. After stirring the reaction for an additional 10 min, it was quenched with saturated sodium bicarbonate, brine was added, and the solution was extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered through Celite and the solvent was removed by rotoevaporation to produce crude <b>6c</b> as a mixture of diastereisomers. The crude material was dissolved in a 3:1 mixture of MeOH/H<sub>2</sub>O that was acidified with TFA and aged. After 2 days this solution was purified by preparative HPLC. The combined fractions of the pure compound were concentrated and then redissolved in a minimum amount of MeCN, H<sub>2</sub>O was added, and the solution was frozen and lyophilized to produce the TFA salt of <b>6</b> (116 mg, 70% yield) as a white powder. Chemical data were reported previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>7</b>)</h3><div class="NLM_p last"><b>7</b> was obtained using the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.29 (br s, 1H), 7.63 (t, 1H, <i>J</i> = 7.2 Hz), 7.51 (dd, 1H, <i>J</i> = 2.4, 8.2 Hz), 7.39 (t, 1H, <i>J</i> = 7.6 Hz), 7.21–7.07 (m, 2H), 6.77 (d, 1H, <i>J</i> = 1.5 Hz), 5.13 (d, 1H, <i>J</i> = 10.9 Hz), 4.83 (d, 1H, <i>J</i> = 11.0 Hz), 2.83 (d, 1H, <i>J</i> = 8.3 Hz), 2.73 (s, 3H), 2.17 (d, 1H, <i>J</i> = 15.3 Hz), 2.04–1.68 (m, 5H), 1.52 (q, 1H, <i>J</i> = 14.6 Hz), 1.31–1.09 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 476.25 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (3<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-methyl-2-oxodispiro[indoline-3,3′-pyrrolidine-2′,4″-piperidine]-5′-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Starting with <i>tert</i>-butyl 4-oxopiperidine-1-carboxylate in place of cyclohexanone, compound <b>8-Boc</b> (compound <b>8</b> with <i>N</i>-Boc piperidine) was prepared according to the synthetic method described for the preparation of <b>6</b>. Compound <b>8-Boc</b> was dissolved in trifluoroacetic acid and stirred. After 30 min the trifluoroacetic acid was removed and the crude was purified by HPLC to give <b>8</b> (TFA salt). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.24 (br s, 1H), 7.64 (t, 1H, <i>J</i> = 7.2 Hz), 7.49 (dd, 1H, <i>J</i> = 2.2, 8.1 Hz), 7.27 (t, 1H, <i>J</i> = 7.3 Hz), 7.13–7.03 (m, 2H), 6.68 (s, 1H), 4.79 (d, 1H, <i>J</i> = 9.6 Hz), 4.64 (d, 1H, <i>J</i> = 9.6 Hz), 3.70 (t, 1H, <i>J</i> = 13.1 Hz), 3.44–3.18 (m, 3H), 2.77 (d, 3H, <i>J</i> = 4.3 Hz), 2.39 (d, 1H, <i>J</i> = 14.5 Hz), 2.10–1.88 (m, 2H), 1.50–1.26 (m, 1H). ESI-MS <i>m</i>/<i>z</i> 477.17 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (3<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>,1″-dimethyl-2-oxodispiro[indoline-3,3′-pyrrolidine-2′,4″-piperidine]-5′-carboxamide (<b>9</b>)</h3><div class="NLM_p last">Starting with 1-methylpiperidin-4-one in place of cyclohexanone, compound <b>9</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.25 (br s, 1H), 7.62 (t, 1H, <i>J</i> = 7.3 Hz), 7.47 (dd, 1H, <i>J</i> = 2.1, 8.2 Hz), 7.25 (t, 1H, <i>J</i> = 7.5 Hz), 7.12–7.01 (m, 2H), 6.77 (d, 1H, <i>J</i> = 1.6 Hz), 4.76 (d, 1H, <i>J</i> = 9.5 Hz), 4.62 (d, 1H, <i>J</i> = 9.5 Hz), 3.75 (t, 1H, <i>J</i> = 12.5 Hz), 3.52–3.40 (m, 2H), 3.24–3.12 (m, 1H), 2.86 (s, 3H), 2.76 (d, 3H, <i>J</i> = 4.0 Hz), 2.40 (d, 1H, <i>J</i> = 14.4 Hz), 2.12–1.86 (m, 2H), 1.54–1.34 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 491.08 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3<i>R</i>,4′<i>S</i>,5′<i>R</i>)-1″-Acetyl-6-chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-methyl-2-oxodispiro[indoline-3,3′-pyrrolidine-2′,4″-piperidine]-5′-carboxamide (<b>10</b>)</h3><div class="NLM_p last">Starting with 1-acetylpiperidin-4-one in place of cyclohexanone, compound <b>10</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.63 (t, 1H, <i>J</i> = 7.8 Hz), 7.47 (dd, 1H, <i>J</i> = 2.6, 8.2 Hz), 7.31 (t, 1H, <i>J</i> = 8.3 Hz), 7.15–7.04 (m, 2H), 6.75 (d, 1H, <i>J</i> = 1.7 Hz), 4.77 (d, 1H, <i>J</i> = 10.1 Hz), 4.61 (d, 0.5H, <i>J</i> = 16.4 Hz, rotamer), 4.43 (d, 0.5H, <i>J</i> = 11.9 Hz, rotamer), 4.00 (d, 0.5H, <i>J</i> = 13.1 Hz, rotamer), 3.85 (d, 0.5H, <i>J</i> = 12.6 Hz, rotamer), 3.81–3.68 (m, 1H), 2.76 (s, 3H), 2.56–2.40 (m, 1H), 2.16–1.76 (m, 5H), 1.45–1.11 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 519.17 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (3<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2-oxo-2″,3″,5″,6″-tetrahydrodispiro[indoline-3,3′-pyrrolidine-2′,4″-pyran]-5′-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Starting with tetrahydro-4<i>H</i>-pyran-4-one in place of cyclohexanone, compound <b>11</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.19 (d, <i>J</i> = 7.9 Hz 1H), 7.63 (ddd, 1H, <i>J</i> = 1.5, 6.5, 7.9 Hz), 7.51 (dd, 1H, <i>J</i> = 2.3, 8.2 Hz), 7.37 (t, 1H, <i>J</i> = 8.3 Hz), 7.19–7.07 (m, 2H), 6.80 (d, 1H, <i>J</i> = 1.9 Hz), 5.02 (d, 1H, <i>J</i> = 10.8 Hz), 4.74 (d, 1H, <i>J</i> = 10.8 Hz), 4.11–3.93 (m, 2H), 3.87 (dd, 1H, <i>J</i> = 3.9, 12.4 Hz), 3.69–3.55 (m, 2H), 3.50–3.38 (m, 1H), 2.62 (d, 1H, <i>J</i> = 13.2 Hz), 2.26–2.12 (m, 1H), 2.04–1.73 (m, 4H), 1.70–1.17 (m, 5H), 1.08 (ddd, 1H, <i>J</i> = 3.5, 12.7, 24.0 Hz); ESI-MS <i>m</i>/<i>z</i> 562.67 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-4,4-difluoro-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>12</b>)</h3><div class="NLM_p last">Starting with 4,4-difluorocyclohexan-1-one in place of cyclohexanone, compound <b>12</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.12 (d, 1H, <i>J</i> = 8.1 Hz), 7.62 (t, 1H, <i>J</i> = 7.2 Hz), 7.49 (dd, 1H, <i>J</i> = 2.3, 8.2 Hz), 7.33 (t, 1H, <i>J</i> = 8.3 Hz), 7.16–7.05 (m, 2H), 6.78 (d, 1H, <i>J</i> = 1.9 Hz), 4.77 (d, 1H, <i>J</i> = 10.3 Hz), 3.70–3.41 (m, 2H), 2.74–1.64 (m, 11H), 1.48–1.21 (m, 4H), 1.18–1.02 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 596.75 (M + 1)<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-3,3-dimethyl-2″-oxodispiro[cyclobutane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Starting with 3,3-dimethylcyclobutan-1-one in place of cyclohexanone, compound <b>14</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.61 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 7.52 (ddd, 1H, <i>J</i> = 1.5, 6.4, 7.9 Hz), 7.39 (ddd, 1H, <i>J</i> = 1.5, 7.3, 8.6 Hz), 7.18–7–11 (m, 2H), 6.89 (d, 1H, <i>J</i> = 1.9 Hz), 4.92 (d, 1H, <i>J</i> = 10.9 Hz), 4.46 (d, 1H, <i>J</i> = 10.9 Hz), 3.68–3.58 (m, 1H), 3.50–3.39 (m, 1H), 2.78 (dd, 2H, <i>J</i> = 14.5, 39.1 Hz), 2.37 (d, 1H, <i>J</i> = 14.2 Hz), 1.95–1.76 (m, 3H), 1.69–1.59 (m, 1H), 1.38–1.17 (m, 7H), 0.98 (ddd, 1H, <i>J</i> = 3.6, 12.9, <i>J</i> = 24.3 Hz), 0.54 (s, 3H); ESI-MS <i>m</i>/<i>z</i> 560.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-4,4-dimethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Starting with 4,4-dimethylcyclohexan-1-one in place of cyclohexanone, compound <b>15</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.62 (t, 1H, <i>J</i> = 7.9 Hz), 7.48 (dd, 1H, <i>J</i> = 1.4, 7.8 Hz), 7.35–7.25 (m, 1H), 7.15–7.04 (m, 2H), 6.78 (d, 1H, <i>J</i> = 1.7 Hz), 4.73 (d, 1H, <i>J</i> = 9.9 Hz), 3.67–3.57 (m, 1H), 3.52–3.43 (m, 1H), 2.08–1.64 (m, 8H), 1.58–1.42 (m, 2H), 1.41–1.20 (m, 6H), 0.98 (s, 3H), 0.73 (s, 3H); ESI-MS <i>m</i>/<i>z</i> 588.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (3′<i>R</i>,4′<i>R</i>,5′<i>R</i>)-6″-Chloro-4′-(5-chloropyridin-3-yl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Starting with (<i>E</i>)-6-chloro-3-((5-chloropyridin-3-yl)methylene)indolin-2-one (<b>16b</b>) in place of (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (<b>61</b>), compound <b>16</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.45 (d, 1H, <i>J</i> = 2.1 Hz), 8.24 (d, 1H, <i>J</i> = 1.7 Hz), 7.89 (s, 1H), 7.60 (d, 1H, <i>J</i> = 8.2 Hz), 7.14 (dd, 1H, <i>J</i> = 1.8, 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.8 Hz), 5.10 (d, 1H, <i>J</i> = 10.9 Hz), 4.47 (d, 1H, <i>J</i> = 10.9 Hz), 3.73–3.57 (m, 1H), 3.50–3.36 (m, 1H), 2.83 (d, 1H, <i>J</i> = 12.5 Hz), 2.17 (d, 1H, <i>J</i> = 14.3 Hz), 2.03–1.70 (m, 8H), 1.70–1.13 (m, 7H), 1.08–0.88 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 543.75 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-pyrrolo[3,2-<i>c</i>]pyridine]-5′-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Starting with (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)-1,3-dihydro-2<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridin-2-one (<b>17b</b>) in place of (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (<b>61</b>), compound <b>17</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.32 (s, 1H), 7.58 (t, 1H, <i>J</i> = 6.7 Hz), 7.36–7.27 (m, 1H), 7.11 (t, 1H, <i>J</i> = 8.6 Hz), 6.81 (s, 1H) 3.67–3.57 (m, 1H), 3.55–3.45 (m, 1H), 2.01–1.51 (m, 10H), 1.42–1.00 (m, 8H); ESI-MS <i>m</i>/<i>z</i> 561.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-pyrrolo[2,3-<i>b</i>]pyridine]-5′-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Starting with (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)-1,3-dihydro-2<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-one (<b>18b</b>) in place of (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (<b>61</b>), compound <b>18</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.89 (dd, 1H, <i>J</i> = 2.14, 7.84 Hz), 7.61 (t, 1H, <i>J</i> = 7.43 Hz), 7.40 (t, 1H, <i>J</i> = 7.14 Hz), 7.17 (t, 1H, <i>J</i> = 8.40 Hz), 7.12 (d, 1H, <i>J</i> = 7.96 Hz), 5.07–4.94 (m, 1H), 4.78 (d, 1H, <i>J</i> = 10.91 Hz), 3.71–3.57 (m, 1H), 3.51–3.39 (m, 1H), 2.89–2.66 (m, 1H), 2.17–2.02 (m, 1H), 1.99–1.43 (m, 10H), 1.43–1.11 (m, 5H), 1.09–0.93 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 561.58 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-2″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-6″-oxo-6″,7″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,5″-pyrrolo[2,3-<i>d</i>]pyrimidine]-5′-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Starting with (<i>E</i>)-2-chloro-5-(3-chloro-2-fluorobenzylidene)-5,7-dihydro-6<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-one (<b>19b</b>) in place of (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (<b>61</b>), compound <b>19</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.55 (d, 1H, <i>J</i> = 2.2 Hz), 7.55 (t, 1H, <i>J</i> = 7.8 Hz), 7.39 (t, 1H, <i>J</i> = 7.0 Hz), 7.16 (t, 1H, <i>J</i> = 7.9 Hz), 3.67–3.56 (m, 1H), 3.53–3.43 (m, 1H), 1.99–1.48 (m, 10H), 1.42–1.04 (m, 8H); ESI-MS <i>m</i>/<i>z</i> 562.33 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (3′<i>R</i>,4′<i>R</i>,5′<i>R</i>)-2″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-((1<i>r</i>,4<i>R</i>)-4-hydroxycyclohexyl)-5″-oxo-4″,5″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,6″-thieno[3,2-<i>b</i>]pyrrole]-5′-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Starting with (<i>Z</i>)-2-chloro-6-(3-chloro-2-fluorobenzylidene)-4,6-dihydro-5<i>H</i>-thieno[3,2-<i>b</i>]pyrrol-5-one (<b>20b</b>) in place of (<i>E</i>)-6-chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one (<b>61</b>), compound <b>20</b> was prepared according to the synthetic method described for the preparation of <b>6</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.40 (td, 2H, <i>J</i> = 6.8, 15.1 Hz), 7.15 (t, 1H, <i>J</i> = 8.0 Hz), 6.71 (s, 1H), 4.58 (d, 1H, <i>J</i> = 10.3 Hz), 4.45 (d, 1H, <i>J</i> = 10.4 Hz), 3.68–3.57 (m, 1H), 3.53–3.43 (m, 1H), 2.16 (d, 1H, <i>J</i> = 11.4 Hz), 2.00–1.79 (m, 4H), 1.77–1.46 (m, 7H), 1.40–1.07 (m, 6H); ESI-MS <i>m</i>/<i>z</i> 566.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-5′-yl)thiazole-4-carboxylic Acid (<b>21</b>)</h3><div class="NLM_p last">Ethyl 3-bromo-2-oxopropanoate (48 mg, 0.244 mmol) and triethylamine (0.033 mL, 0.244 mmol), were added to a solution of <b>68</b> (30 mg, 0.061 mmol) in THF (3 mL) and refluxed overnight. Then the reaction was cooled, and the solvent was removed. The crude product was redissolved in DME (3 mL), and to this solution, at −20 °C, was added trifluoracetic anhydride (0.025 mL, 0.183 mmol) and pyridine (0.025 mL, 0.305 mmol), and then the reaction was allowed to warm to rt. After 30 min, saturated sodium bicarbonate solution was added and the reaction was extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered, and purified by column chromatography to produce 18 mg of compound <b>69</b>. Lithium hydroxide monohydrate (50 mg, 1.19 mmol) was added to a solution of <b>69</b> (18 mg, 0.031 mmol) in THF/MeOH/H<sub>2</sub>O (1:1:1, 3 mL). After 2 h the reaction was quenched with ammonium chloride, and brine was added and extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered, concentrated and the crude was purified by preparative HPLC to produce compound <b>21</b> (TFA salt). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.34 (s, 1H), 7.70 (t, 1H, <i>J</i> = 6.8 Hz), 7.53 (d, 1H, <i>J</i> = 7.1 Hz), 7.27 (t, 1H, <i>J</i> = 7.5 Hz), 7.13–7.03 (m, 2H), 6.73 (d, 1H, <i>J</i> = 1.8 Hz), 5.78–5.59 (m, 1H), 4.81–4.68 (m, 1H), 3.10 (s, 3H), 2.51–2.38 (m, 1H), 2.25 (d, 1H, <i>J</i> = 15.1 Hz), 2.13–1.94 (m, 1H), 1.87–1.10 (m, 7H); ESI-MS <i>m</i>/<i>z</i> 560.33 (M + H)<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure A: Amide Coupling to Compound <b>66</b></h3><div class="NLM_p last">CDI (3 equiv), DIEA (5 equiv), DMAP (1 equiv) were added to a suspension of compound <b>66</b> (1 equiv) in 1,2-dichloroethane and heated at 50 °C. After 30 min, the respective amine (5 equiv) was added and the reaction was refluxed overnight. Then the solvent was removed and the crude product was purified to produce the carboxamide.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-5′-yl)oxazole-4-carboxylic Acid (<b>22</b>)</h3><div class="NLM_p last">Compound <b>72</b> was produced according to general procedure A. At −20 °C, Deoxo-Fluor (50 μL) was added to a solution of <b>72</b> (51 mg) in THF (3 mL). After 30 min bromotrichloromethane (500 μL) and DBU (400 μL) were added and the reaction was allowed to warm to room temperature. After 5 h the reaction was quenched with saturated sodium bicarbonate (stirred for 5 min) and then extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered, and purified by column chromatography to produce 34 mg of compound <b>73</b>. Lithium hydroxide monohydrate (60 mg, 1.43 mmol) was added to a solution of <b>73</b> (34 mg, 0.061 mmol) in THF/H<sub>2</sub>O (1:1, 4 mL). After 2 h the reaction was quenched with TFA, concentrated and the crude was redissolved in 3:1 MeOH/H<sub>2</sub>O and purified by HPLC to produce <b>22</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.50 (s, 1H), 7.62–7.53 (m, 2H), 7.24 (t, 1H, <i>J</i> = 7.3 Hz), 7.07 (dd, 1H, <i>J</i> = 1.7, 8.2 Hz), 7.03 (t, 1H, <i>J</i> = 8.1 Hz), 6.73 (d, 1H, <i>J</i> = 1.8 Hz), 5.34 (d, 1H, <i>J</i> = 10.3 Hz), 5.02 (d, 1H, <i>J</i> = 11.6 Hz), 2.97 (s, 3H), 2.33 (d, 1H, <i>J</i> = 13.1 Hz), 2.15 (d, 1H, <i>J</i> = 14.1 Hz), 1.95–1.85 (m, 1H), 1.74–1.44 (m, 5H), 1.38–1.26 (m, 1H), 1.19–1.05 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 544.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-5′-(3-methyl-1,2,4-oxadiazol-5-yl)dispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-2″-one (<b>23</b>)</h3><div class="NLM_p last">Starting with 50 mg of compound <b>66</b>, compound <b>75</b> was obtained using general procedure A. Crude <b>75</b> was dissolved in pyridine (5 mL) and heated to 100 °C. After 5 h the solution was cooled and the solvent was removed by rotoevaporation and then the crude product was purified by HPLC to produce <b>23</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.60 (ddd, 1H, <i>J</i> = 1.5, 6.4, 7.9 Hz), 7.50 (dd, 1H, <i>J</i> = 3.0, 8.2 Hz), 7.25 (ddd, 1H, <i>J</i> = 1.6, 7.2, <i>J</i> = 8.6 Hz), 7.07–7.01 (m, 2H), 6.72 (d, 1H, <i>J</i> = 1.9 Hz), 5.30 (d, 1H, <i>J</i> = 11.0 Hz), 4.98 (d, 1H, <i>J</i> = 11.1 Hz), 2.99 (s, 3H), 2.32 (s, 3H), 2.24 (d, 1H, <i>J</i> = 13.2 Hz), 2.19–2.10 (m, 1H), 1.86–1.47 (m, 6H), 1.21 (ddd, 1H, <i>J</i> = 5.0, 12.6 Hz, 13.9 Hz), 1.15–1.02 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 514.92 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-5′-(5-methyl-1,3,4-oxadiazol-2-yl)dispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-2″-one (<b>24</b>)</h3><div class="NLM_p last">Starting with 77 mg of compound <b>66</b>, 63 mg of <b>77</b> was obtained using general procedure A. A solution of <b>77</b> (30 mg, 0.056 mmol) in DCM (3 mL) was slowly added to a solution of PPh<sub>3</sub> (30 mg, 0.112 mmol), Et<sub>3</sub>N (31 μL), and iodine (28 mg, 0.112 mmol) in DCM (1 mL). After 3 h, H<sub>2</sub>O and brine were added and extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered, concentrated and the crude product was purified by HPLC to produce compound <b>24</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.60 (t, 1H, <i>J</i> = 7.9 Hz), 7.51 (dd, 1H, <i>J</i> = 2.9, 8.2 Hz), 7.25 (t, 1H, <i>J</i> = 8.3 Hz), 7.08–7.00 (m, 2H), 6.72 (d, 1H, <i>J</i> = 1.9 Hz), 5.29 (d, 1H, <i>J</i> = 11.1 Hz), 4.95 (d, 1H, <i>J</i> = 10.8 Hz), 2.95 (s, 3H), 2.52 (s, 3H), 2.24 (d, 1H, <i>J</i> = 13.8 Hz), 2.15 (dd, 1H, <i>J</i> = 2.3, 14.1 Hz), 1.86–1.02 (m, 8H); ESI-MS <i>m</i>/<i>z</i> 515.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-5′-(5-methyl-1,3,4-thiadiazol-2-yl)dispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-2″-one (<b>25</b>)</h3><div class="NLM_p last">Lawesson’s reagent (45 mg, 0.112 mmol) was added to a solution of <b>77</b> (30 mg, 0.056 mmol) in DCM and refluxed. After standing overnight the solvent was removed and the crude was purified by HPLC to produce compound <b>25</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.69 (t, 1H, <i>J</i> = 7.9 Hz), 7.46 (dd, 1H, <i>J</i> = 2.8, 8.2 Hz), 7.25 (t, 1H, <i>J</i> = 8.4 Hz), 7.08 (dt, 1H, <i>J</i> = 1.1, 8.1 Hz), 7.03 (dd, 1H, <i>J</i> = 2.0, 8.2 Hz), 6.72 (d, 1H, <i>J</i> = 1.9 Hz), 5.50 (d, 1H, <i>J</i> = 10.2 Hz), 4.63 (d, 1H, <i>J</i> = 11.0 Hz), 3.00 (s, 3H), 2.71 (s, 3H), 2.27 (d, 1H, <i>J</i> = 13.0 Hz), 2.23–2.15 (m, 1H), 1.88 (t, 1H, <i>J</i> = 11.6 Hz), 1.83–1.60 (m, 4H), 1.60–1.49 (m, 1H), 1.31–1.07 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 531.17 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-5′-yl)-5-methyloxazole-4-carboxylic Acid (<b>26</b>)</h3><div class="NLM_p last">Starting with 44 mg of compound <b>66</b>, 25 mg of <b>79</b> was obtained using general procedure A. Cyclization to generate <b>80</b> (13 mg) was accomplished according to the same procedure used to obtain <b>24</b>. Lithium hydroxide monohydrate (30 mg, 0.715 mmol) was added to a solution of <b>80</b> (13 mg, 0.023 mmol) in THF/H<sub>2</sub>O (1:1, 2 mL). After 2 h the reaction was quenched with TFA, concentrated and the crude was redissolved in 3:1 MeOH/H<sub>2</sub>O and purified by HPLC to produce <b>26</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.60 (t, 1H, <i>J</i> = 7.2 Hz), 7.52 (dd, 1H, <i>J</i> = 2.7, 8.1 Hz), 7.21 (t, 1H, <i>J</i> = 8.3 Hz), 7.07–6.98 (m, 2H), 6.70 (d, 1H, <i>J</i> = 1.9 Hz), 5.07 (d, 1H, <i>J</i> = 10.8 Hz), 4.91 (d, 1H, <i>J</i> = 11.7 Hz), 2.83 (s, 3H), 2.59 (s, 3H), 2.31–2.23 (m, 1H), 2.12–2.04 (m, 1H), 1.85–1.02 (m, 8H); ESI-MS <i>m</i>/<i>z</i> 558.75 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(2-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-5′-yl)thiazol-4-yl)acetic Acid (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was produced using the same synthetic strategy used for <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.65 (t, 1H, <i>J</i> = 6.7 Hz), 7.57 (d, 1H, <i>J</i> = 7.1 Hz), 7.42 (s, 1H), 7.27 (t, 1H, <i>J</i> = 8.2 Hz), 7.13–7.04 (m, 2H), 6.75 (d, 1H, <i>J</i> = 1.9 Hz), 5.92–5.70 (m, 1H), 3.78 (s, 2H), 3.20 (s, 3H), 2.58–2.44 (m, 1H), 2.26 (d, 1H, <i>J</i> = 13.8 Hz), 2.22–2.08 (m, 1H), 1.83–1.43 (m, 5H), 1.38–1.27 (m, 1H), 1.25–1.13 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 574.08 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indolin]-5′-yl)thiazole-4-carboxamide (<b>28</b>)</h3><div class="NLM_p last">Starting with acid <b>21</b> in place of <b>66</b>, compound <b>28</b> was produced using general procedure A. Crude <b>28</b> was purified by HPLC to produce <b>28</b> as its TFA salt. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.11 (s, 1H), 7.75 (t, 1H, <i>J</i> = 7.2 Hz), 7.42 (d, 1H, <i>J</i> = 8.1 Hz), 7.26 (t, 1H, <i>J</i> = 8.46 Hz), 7.09 (t, 1H, <i>J</i> = 7.83), 7.01 (dd, 1H, <i>J</i> = 1.7, 8.1 Hz), 6.71 (d, 1H, <i>J</i> = 1.8 Hz), 3.00 (s, 3H), 2.36–2.16 (m, 2H), 2.09–2.00 (m, 1H), 1.91–1.52 (m, 5H), 1.38–1.24 (m, 1H), 1.21–1.06 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 559.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure B: Amide Coupling of Alkylamines</h3><div class="NLM_p last">HATU (2 equiv) and DIEA (4 equiv) were added to a suspension of acid compound <b>29</b> (1 equiv) in DCM. After 10 min, alkylamine (4 equiv) was added. After 12 h, the reaction was concentrated and purified by column chromatography to produce alkyl amide compounds.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> General Procedure C: Hydrolysis of Alkyl Esters</h3><div class="NLM_p last">LiOH·H<sub>2</sub>O (3 equiv) was added to a solution of ester (1 equiv) in THF/MeOH/H<sub>2</sub>O (1:1:1). After 2 h, TFA was added and the solution was concentrated, redissolved in MeOH/H<sub>2</sub>O (3:1), and purified by reverse phase preparative HPLC. The pure fractions were combined and lyophilized to give the carboxylic acid products (TFA salt) as a white powder.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure D: Amide Coupling of Arylamines</h3><div class="NLM_p last">Ph<sub>2</sub>POCl (3 equiv) and DIEA (5 equiv) were added to a suspension of compound <b>29</b> (1 equiv) in DCM. After 30 min, arylamine (4 equiv) and DMAP (1 equiv) were added. After 12 h, the reaction was concentrated and purified by column chromatography to produce arylamide compounds.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> General Procedure E: Hydrolysis of Aryl Esters</h3><div class="NLM_p last">NaOH (3 equiv) was added to a solution of ester (1 equiv) in THF/MeOH/H<sub>2</sub>O (1:1:1). After 2 h, TFA was added and the reaction was concentrated, redissolved in MeOH/H<sub>2</sub>O (3:1), and purified by reverse phase preparative HPLC. The pure fractions were combined and lyophilized to give the carboxylic acid products as the TFA salt as a white powder.</div></div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-(methylsulfonyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>30</b>)</h3><div class="NLM_p last">Starting with compound <b>29</b> in place of <b>66</b>, compound <b>30</b> was obtained according to general procedure A. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.61 (t, 1H, <i>J</i> = 7.5 Hz), 7.53 (dd, 1H, <i>J</i> = 2.1, 8.2 Hz), 7.33 (t, 1H, <i>J</i> = 8.0 Hz), 7.17–7.06 (m, 2H), 6.76 (d, 1H, <i>J</i> = 1.7 Hz), 4.98 (d, 1H, <i>J</i> = 10.4 Hz), 3.09 (s, 3H), 2.60 (d, 1H, <i>J</i> = 13.7 Hz), 2.09 (d, 1H, <i>J</i> = 16.1 Hz), 2.01–1.43 (m, 6H), 1.34–1.06 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 540.08 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)butanoic Acid (<b>31</b>)</h3><div class="NLM_p last"><b>31</b> was obtained according to general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (t, 1H, <i>J</i> = 7.1 Hz), 7.51 (dd, 1H, <i>J</i> = 2.2, 8.3 Hz), 7.39 (t, 1H, <i>J</i> = 7.5 Hz), 7.17 (t, 1H, <i>J</i> = 8.1 Hz), 7.11 (dd, 1H, <i>J</i> = 1.6, 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.6 Hz), 5.12 (d, 1H, <i>J</i> = 11.0 Hz), 4.80 (d, 1H, <i>J</i> = 11.1 Hz), 3.21–3.04 (m, 1H), 2.81 (d, 1H, <i>J</i> = 7.4 Hz), 2.17 (d, 1H, <i>J</i> = 12.0 Hz), 2.06 (t, 2H, <i>J</i> = 7.4 Hz), 2.01–1.84 (m, 3H), 1.84–1.40 (m, 5H), 1.32–1.12 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 548.42 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (1<i>R</i>,3<i>r</i>)-3-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)cyclobutane-1-carboxylic Acid (<b>32</b>)</h3><div class="NLM_p last"><b>32</b> was obtained by general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.65 (t, 1H, <i>J</i> = 7.0 Hz), 7.49 (dd, 1H, <i>J</i> = 1.7, 8.0 Hz), 7.40 (t, 1H, <i>J</i> = 7.3 Hz), 7.18 (t, 1H, <i>J</i> = 8.0 Hz), 7.11 (d, 1H, <i>J</i> = 8.3 Hz), 6.79 (s, 1H), 5.06 (d, <i>J</i> = 10.8, 1H), 4.79 (d, 1H, <i>J</i> = 10.8 Hz), 4.47 (p, 1H, <i>J</i> = 8.1 Hz), 2.96–2.71 (m, 2H), 2.63–2.38 (m, 2H), 2.29–2.08 (m, 2H), 2.05–1.83 (m, 4H), 1.76 (d, 2H, <i>J</i> = 16.2 Hz), 1.62–1.39 (m, 1H), 1.33–1.11 (m, 2H) ESI-MS <i>m</i>/<i>z</i> 560.50 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (1<i>R</i>,4<i>r</i>)-4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)cyclohexane-1-carboxylic Acid (<b>33</b>)</h3><div class="NLM_p last"><b>33</b> was obtained by general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (t, 1H, <i>J</i> = 7.1 Hz), 7.49 (d, 1H, <i>J</i> = 8.1 Hz), 7.39 (t, 1H, <i>J</i> = 7.5 Hz), 7.17 (t, 1H, <i>J</i> = 8.1 Hz), 7.11 (d, 1H, <i>J</i> = 8.1 Hz), 6.79 (s, 1H), 5.08 (d, 1H, <i>J</i> = 11.1 Hz), 4.79 (d, 1H, <i>J</i> = 11.1 Hz), 3.72–3.54 (m, 1H), 2.84 (d, 1H, <i>J</i> = 8.4 Hz), 2.25–2.07 (m, 2H), 2.04–1.84 (m, 6H), 1.77 (d, 2H, <i>J</i> = 12.0 Hz), 1.63 (d, 1H, <i>J</i> = 13.0 Hz), 1.56–1.34 (m, 3H), 1.32–1.11 (m, 3H), 0.99–0.82 (m, 1H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ ppm 179.01, 178.21, 167.66, 157.76 (d, J<sub>C–F</sub> = 248.87 Hz), 145.27, 137.07, 132.35, 129.50, 128.91, 126.48 (d, <i>J</i><sub>C–F</sub> = 4.74 Hz), 123.39, 122.45, 122.31, 122.05, 121.87, 111.77, 73.24, 67.76, 62.25, 46.72, 46.68, 43.15, 32.33, 32.09, 32.07, 31.37, 28.79, 28.72, 25.35, 23.11, 21.70; ESI-MS <i>m</i>/<i>z</i> 588.33 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (1<i>S</i>,4<i>s</i>)-4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)cyclohexane-1-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p last"><b>34</b> was obtained according to general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD3OD) δ ppm 7.67 (t, 1H, <i>J</i> = 6.61 Hz), 7.49 (dd, 1H, <i>J</i> = 2.0, 8.1 Hz), 7.37 (t, 1H, <i>J</i> = 7.5 Hz), 7.16 (t, 1H, <i>J</i> = 7.9 Hz), 7.10 (dd, 1H, <i>J</i> = 1.7, 8.3 Hz), 6.79 (d, 1H, <i>J</i> = 1.7 Hz), 5.20 (d, 1H, <i>J</i> = 11.3 Hz), 4.76 (d, 1H, <i>J</i> = 11.2 Hz), 3.89–3.75 (m, 1H), 2.84 (d, 1H, <i>J</i> = 9.1 Hz), 2.41–2.29 (m, 1H), 2.20 (d, 1H, <i>J</i> = 15.3 Hz), 2.03–1.12 (m, 16H); ESI-MS <i>m</i>/<i>z</i> 588.50 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (1<i>R</i>,4<i>r</i>)-4-(((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)methyl)cyclohexane-1-carboxylic Acid (<b>35</b>)</h3><div class="NLM_p last"><b>35</b> was obtained according to general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.36–8.26 (m, 1H), 7.67 (t, 1H, <i>J</i> = 6.8 Hz), 7.52 (d, 1H, <i>J</i> = 8.2 Hz), 7.42 (t, 1H, <i>J</i> = 7.5 Hz), 7.20 (t, 1H, d <i>J</i> = 8.0 Hz), 7.12 (dd, 1H, <i>J</i> = 1.4, 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.5 Hz), 5.14 (d, 1H, <i>J</i> = 11.1 Hz), 4.78 (d, 1H, <i>J</i> = 11.3 Hz), 3.48–3.34 (m, 1H), 2.90–2.64 (m, 2H), 2.19 (d, 1H, <i>J</i> = 11.3 Hz), 2.09–1.70 (m, 8H), 1.61–1.11 (m, 8H), 0.79–0.59 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 602.58 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-(1,1-dioxidotetrahydro-2<i>H</i>-thiopyran-4-yl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>36</b>)</h3><div class="NLM_p last"><b>36</b> was obtained according to general procedure B. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (t, 1H, <i>J</i> = 7.1 Hz), 7.49 (dd, 1H, <i>J</i> = 2.1, 8.1 Hz), 7.41 (t, 1H, <i>J</i> = 7.5 Hz), 7.18 (t, 1H, <i>J</i> = 9.9 Hz), 7.11 (dd, 1H, <i>J</i> = 1.6, 8.2 Hz), 6.79 (d, 1H, <i>J</i> = 1.6 Hz), 5.10 (d, 1H, <i>J</i> = 11.1 Hz), 4.80 (d, 1H, <i>J</i> = 11.2 Hz), 4.10–3.94 (m, 1H), 3.27–2.91 (m, 3H), 2.88–2.74 (m, 2H), 2.35–1.64 (m, 10H), 1.52 (q, 1H, <i>J</i> = 13.9 Hz), 1.31–1.11 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 594.50 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-(4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)piperidin-1-yl)acetic Acid (<b>37</b>)</h3><div class="NLM_p last"><b>37</b> was obtained according to general procedure B followed by general procedure C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.66 (t, 1H, <i>J</i> = 7.1 Hz), 7.48 (dd, 1H, <i>J</i> = 2.1, 8.2 Hz), 7.39 (t, 1H, <i>J</i> = 7.3 Hz), 7.17 (t, 1H, <i>J</i> = 8.0 Hz), 7.10 (dd, 1H, <i>J</i> = 1.6, 8.1 Hz), 6.79 (d, 1H, <i>J</i> = 1.7 Hz), 5.12 (d, 1H, <i>J</i> = 11.0 Hz), 4.80 (d, 1H, <i>J</i> = 10.9 Hz), 4.05–3.89 (m, 2H), 3.79–3.39 (m, 2H), 3.29–3.04 (m, 2H), 2.79 (d, 1H, <i>J</i> = 9.4 Hz), 2.17 (d, 2H, <i>J</i> = 9.4 Hz), 2.03–1.42 (m, 8H), 1.42–1.33 (m, 2H), 1.31–1.10 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 603.67 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-<i>N</i>-(1-Acetylazetidin-3-yl)-6″-chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>38</b>)</h3><div class="NLM_p last"><b>38</b> was obtained according to general procedure B. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (t, 1H, <i>J</i> = 7.2 Hz), 7.50 (dd, 1H, <i>J</i> = 1.8, 8.2 Hz), 7.40 (t, 1H, <i>J</i> = 7.7 Hz), 7.17 (t, 1H, <i>J</i> = 8.1 Hz), 7.11 (dd, 1H, <i>J</i> = 1.7, 8.2 Hz), 6.79 (s, 1H), 5.10 (d, 1H, <i>J</i> = 10.6 Hz), 4.64–4.36 (m, 2H), 4.29–4.11 (m, 1H), 4.09–3.56 (m, 2H), 2.79 (d, 1H, <i>J</i> = 9.8 Hz), 2.16 (d, 1H, <i>J</i> = 14.9 Hz), 2.01–1.68 (m, 8H), 1.64–1.37 (m, 1H), 1.34–1.11 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 560.08 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)benzoic Acid (<b>40</b>)</h3><div class="NLM_p last"><b>40</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD3OD) δ ppm 8.14 (s, 1H), 7.84–7.67 (m, 3H), 7.55 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 7.48–7.34 (m, 2H), 7.19 (t, 1H, <i>J</i> = 8.0 Hz), 7.12 (dd, 1H, <i>J</i> = 1.6, 8.2 Hz), 6.79 (d, 1H, <i>J</i> = 1.6 Hz), 5.29 (d, 1H, <i>J</i> = 11.0 Hz), 4.97 (d, 1H, <i>J</i> = 10.7 Hz), 2.96–2.84 (m, 1H), 2.18 (d, <i>J</i> = 14.0 Hz 1H), 2.08–1.85 (m, 3H), 1.78 (d, 2H, <i>J</i> = 12.2 Hz), 1.63–1.42 (m, 1H), 1.35–1.13 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 582.58 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-(((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)methyl)benzoic Acid (<b>41</b>)</h3><div class="NLM_p last"><b>41</b> was obtained according to general procedure B followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.87 (d, 2H, <i>J</i> = 8.2 Hz), 7.66 (t, 1H, <i>J</i> = 7.0 Hz), 7.50 (dd, 1H, <i>J</i> = 2.3, 8.3 Hz), 7.40 (t, 1H, <i>J</i> = 7.6 Hz), 7.22–7.08 (m, 2H), 7.04 (d, 2H, <i>J</i> = 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.6 Hz), 5.20 (d, 1H, <i>J</i> = 11.2 Hz), 4.80 (d, 1H, <i>J</i> = 11.1 Hz), 4.66 (d, 1H, <i>J</i> = 15.3 Hz), 4.20 (d, 1H, <i>J</i> = 15.3 Hz), 2.83 (d, 1H, <i>J</i> = 10.0 Hz), 2.20 (d, 1H, <i>J</i> = 15.8 Hz), 2.04–1.85 (m, 3H), 1.77 (d, 2H, <i>J</i> = 11.9 Hz), 1.52 (q, 1H, <i>J</i> = 13.7 Hz), 1.33–1.10 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 596.33 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-(4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)phenyl)acetic Acid (<b>42</b>)</h3><div class="NLM_p last"><b>42</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.70 (t, 1H, <i>J</i> = 7.8 Hz), 7.52 (dd, 1H, <i>J</i> = 2.5, 8.2 Hz), 7.47 (d, 2H, <i>J</i> = 8.6 Hz), 7.35 (t, 1H, <i>J</i> = 8.1 Hz), 7.24 (d, 2H, <i>J</i> = 8.6 Hz), 7.16 (t, 1H, <i>J</i> = 8.0 Hz), 7.10 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.9 Hz), 5.20 (d, 1H, <i>J</i> = 9.8 Hz), 4.93 (d, 1H, <i>J</i> = 10.8 Hz), 3.57 (s, 2H), 2.87–2.69 (m, 1H), 2.13 (d, 1H, <i>J</i> = 13.3 Hz), 1.99–1.70 (m, 5H), 1.64–1.48 (m, 1H), 1.27–1.12 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 596.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)-2-methoxybenzoic Acid (<b>43</b>)</h3><div class="NLM_p last"><b>43</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.83 (d, 1H, <i>J</i> = 8.51 Hz), 7.70 (t, 1H, <i>J</i> = 6.92 Hz), 7.62 (s, 1H), 7.52 (dd, 1H, <i>J</i> = 2.17, 8.08 Hz), 7.35 (t, 1H, <i>J</i> = 7.08 Hz), 7.20–7.02 (m, 3H), 6.78 (d, 1H, <i>J</i> = 1.71 Hz), 5.24–5.09 (m, 1H), 4.94 (d, 1H, <i>J</i> = 10.49 Hz), 3.89 (s, 3H), 2.80–2.58 (m, 1H), 2.09 (d, 1H, <i>J</i> = 14.12 Hz), 2.01–1.47 (m, 6H), 1.26–1.09 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 612.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)-3-methoxybenzoic Acid (<b>44</b>)</h3><div class="NLM_p last"><b>44</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.26 (d, 1H, <i>J</i> = 8.6 Hz), 7.79 (t, 1H, <i>J</i> = 7.1 Hz), 7.66 (dd, 1H, <i>J</i> = 1.4, 8.4 Hz), 7.60 (s, 1H), 7.51 (dd, 1H, <i>J</i> = 2.2, 8.3 Hz), 7.40 (t, 1H, <i>J</i> = 8.2 Hz), 7.21 (t, 1H, <i>J</i> = 8.6 Hz), 7.10 (dd, 1H, <i>J</i> = 1.8, 8.1 Hz), 6.79 (d, 1H, <i>J</i> = 1.7 Hz), 5.49–5.23 (m, 1H), 3.80 (s, 3H), 2.68–2.47 (m, 1H), 2.21–1.52 (m, 7H), 1.35–1.07 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 612.17 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)-2-fluorobenzoic Acid (<b>45</b>)</h3><div class="NLM_p last"><b>45</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.90 (t, 1H, <i>J</i> = 8.4 Hz), 7.74–7.61 (m, 2H), 7.55 (dd, 1H, <i>J</i> = 2.5, 8.2 Hz), 7.38 (t, 1H, <i>J</i> = 7.2 Hz), 7.26 (dd, 1H, <i>J</i> = 1.7, 8.6 Hz), 7.19 (t, 1H, <i>J</i> = 8.2 Hz), 7.12 (dd, 1H, <i>J</i> = 1.8, 8.2 Hz), 6.80 (d, 1H, <i>J</i> = 1.7 Hz), 5.31 (d, 1H, <i>J</i> = 10.8 Hz), 4.97 (d, 1H, <i>J</i> = 10.8 Hz), 2.94–2.84 (m, 1H), 2.20 (d, 1H, <i>J</i> = 15.7 Hz), 2.06–1.85 (m, 3H), 1.79 (d, 2H, <i>J</i> = 10.9 Hz), 1.65–1.43 (m, 1H), 1.34–1.11 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 600.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)-3-fluorobenzoic Acid (<b>46</b>)</h3><div class="NLM_p last"><b>46</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.21 (t, 1H, <i>J</i> = 8.0 Hz), 7.91–7.79 (m, 1H), 7.79–7.67 (m, 2H), 7.52 (dd, 1H, <i>J</i> = 2.4, 8.2 Hz), 7.37 (t, 1H, <i>J</i> = 7.3 Hz), 7.25–7.06 (m, 2H), 6.79 (d, 1H, <i>J</i> = 1.7 Hz), 5.41 (d, 1H, <i>J</i> = 9.4 Hz), 2.81–2.67 (m, 1H), 2.14 (d, 1H, <i>J</i> = 14.7 Hz), 2.00–1.84 (m, 3H), 1.84–1.70 (m, 2H), 1.68–1.47 (m, 1H), 1.41–1.09 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 600.83 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)picolinic Acid (<b>47</b>)</h3><div class="NLM_p last"><b>47</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.80 (s, 1H), 8.27 (d, 1H, <i>J</i> = 8.8 Hz), 8.15 (d, 1H, <i>J</i> = 8.7 Hz), 7.71 (t, 1H, <i>J</i> = 7.2 Hz), 7.55 (d, 1H, <i>J</i> = 8.7 Hz), 7.37 (t, 1H, <i>J</i> = 7.1 Hz), 7.18 (t, 1H, <i>J</i> = 7.9 Hz), 7.12 (d, 1H, <i>J</i> = 8.1 Hz), 6.80 (s, 1H), 5.30 (d, 1H, <i>J</i> = 11.1 Hz), 5.00 (d, 1H, <i>J</i> = 10.8 Hz), 2.90–2.75 (m, 1H), 2.16 (d, 1H, <i>J</i> = 16.9 Hz), 2.06–1.84 (m, 3H), 1.78 (d, 2H, <i>J</i> = 13.2 Hz), 1.66–1.42 (m, 1H), 1.32–1.11 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 583.96 (M + 1)<sup>+</sup>.</div></div><div id="sec5_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 5-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)furan-2-carboxylic Acid (<b>48</b>)</h3><div class="NLM_p last"><b>48</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.66 (t, 1H, <i>J</i> = 7.23 Hz), 7.49 (dd, 1H, <i>J</i> = 2.46, 8.24 Hz), 7.31 (t, 1H, <i>J</i> = 7.44 Hz), 7.22 (d, 1H, <i>J</i> = 3.60 Hz), 7.16–7.04 (m, 2H), 6.76 (d, 1H, <i>J</i> = 1.68 Hz), 6.51 (d, 1H, <i>J</i> = 3.53 Hz), 5.06–4.90 (m, 2H), 2.53–2.37 (m, 1H), 2.06–1.50 (m, 7H), 1.25–1.00 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 572.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-(4-((methylsulfonyl)carbamoyl)phenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Starting with compound <b>39</b> in place of <b>66</b>, compound <b>49</b> was obtained according to general procedure A. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.89 (d, 2H, <i>J</i> = 8.8 Hz), 7.78–7.66 (m, 3H), 7.52 (dd, 1H, <i>J</i> = 2.5, 8.4 Hz), 7.36 (t, 1H, <i>J</i> = 7.8 Hz), 7.17 (t, 1H, <i>J</i> = 7.6 Hz), 7.11 (dd, 1H, <i>J</i> = 1.7, 8.2 Hz), 6.79 (d, 1H, <i>J</i> = 1.7 Hz), 5.31–5.15 (m, 1H), 3.35 (s, 3H), 2.89–2.70 (m, 1H), 2.13 (d, 1H, <i>J</i> = 13.6 Hz), 2.03–1.70 (m, 5H), 1.68–1.46 (m, 1H), 1.35–1.12 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 659.67 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxo-<i>N</i>-(4-sulfamoylphenyl)dispiro- [cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>50</b>)</h3><div class="NLM_p last"><b>50</b> was obtained according to general procedure D. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.60–7.50 (m, 3H), 7.39 (dd, 1H, <i>J</i> = 2.24, 8.22 Hz), 7.30 (t, 1H, <i>J</i> = 6.96 Hz), 7.12–7.02 (m, 2H), 6.73 (d, 1H, <i>J</i> = 1.59 Hz), 6.64 (d, 2H, <i>J</i> = 8.68 Hz), 4.80 (d, 1H, <i>J</i> = 10.19 Hz), 4.62 (d, 1H, <i>J</i> = 10.28 Hz), 2.24 (d, 1H, <i>J</i> = 13.09 Hz), 1.94 (d, 1H, <i>J</i> = 13.01 Hz), 1.88–1.41 (m, 6H), 1.20–0.93 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 617.17 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-(4-(methylsulfonyl)phenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>51</b>)</h3><div class="NLM_p last"><b>51</b> was obtained according to general procedure D. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.91 (d, 2H, <i>J</i> = 8.80 Hz), 7.82 (d, 2H, <i>J</i> = 8.85 Hz), 7.70 (t, 1H, <i>J</i> = 6.71 Hz), 7.52 (dd, 1H, <i>J</i> = 2.42, 8.17 Hz), 7.35 (t, 1H, <i>J</i> = 7.58 Hz), 7.16 (t, 1H, <i>J</i> = 8.05 Hz), 7.10 (dd, 1H, <i>J</i> = 1.84, 8.21 Hz), 6.78 (d, 1H, <i>J</i> = 1.80 Hz), 5.20 (d, 1H, <i>J</i> = 14.03 Hz), 4.94 (d, 1H, <i>J</i> = 10.48 Hz), 3.09 (s, 3H), 2.80–2.63 (m, 1H), 2.11 (d, 1H, <i>J</i> = 13.18 Hz), 2.01–1.46 (m, 6H), 1.31–1.08 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 616.58 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-<i>N</i>-(4-Carbamoylphenyl)-6″-chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>52</b>)</h3><div class="NLM_p last">Starting with compound <b>39</b> in place of <b>66</b>, compound <b>52</b> was obtained according to general procedure A. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.85 (d, 2H, <i>J</i> = 8.9,Hz), 7.70 (t, 1H, <i>J</i> = 7.9 Hz), 7.65 (d, 2H, <i>J</i> = 8.8 Hz), 7.51 (dd, 1H, <i>J</i> = 2.4, 8.2 Hz), 7.34 (t, 1H, <i>J</i> = 7.1 Hz), 7.15 (t, 1H, <i>J</i> = 8.0 Hz), 7.09 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 6.78 (d, 1H, <i>J</i> = 1.9 Hz), 5.22–5.10 (m, 1H), 4.93 (d, 1H, <i>J</i> = 9.6 Hz), 2.81–2.58 (m, 1H), 2.09 (d, 1H, <i>J</i> = 12.4 Hz), 1.99–1.67 (m, 5H), 1.67–1.50 (m, 1H), 1.28–1.10 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 581.33 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-<i>N</i>-(4-Carbamoyl-2-methoxyphenyl)-6″-chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>53</b>)</h3><div class="NLM_p last">Starting with compound <b>44</b> in place of <b>66</b>, compound <b>53</b> was obtained according to general procedure A. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.24 (d, 1H, <i>J</i> = 8.4 Hz), 7.75 (t, 1H, <i>J</i> = 7.0 Hz), 7.55–7.45 (m, 3H), 7.35 (t, 1H, <i>J</i> = 7.0 Hz), 7.15 (t, 1H, <i>J</i> = 7.9 Hz), 7.06 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 6.76 (d, 1H, <i>J</i> = 1.9 Hz), 5.34–5.10 (m, 1H), 3.85 (s, 3H), 2.57–2.31 (m, 1H), 2.18–1.96 (m, 2H), 1.91–1.57 (m, 5H), 1.25–1.05 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 611.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-4,4-dimethyl-2″-oxodispiro[cyclo- hexane-1,2'-pyrrolidine-3′,3″-indoline]-5'-carboxamido)benzoic Acid (<b>54</b>)</h3><div class="NLM_p last"><b>54</b> was obtained according to general procedure D followed by general procedure E. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.98 (d, 2H, <i>J</i> = 8.7 Hz), 7.70 (t, 1H, <i>J</i> = 7.7 Hz), 7.64 (d, 2H, <i>J</i> = 8.7 Hz), 7.57 (dd, 1H, <i>J</i> = 2.4, 8.2 Hz), 7.38 (t, 1H, <i>J</i> = 8.2 Hz), 7.19 (t, 1H, <i>J</i> = 8.1 Hz), 7.13 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 6.81 (d, 1H, <i>J</i> = 1.9 Hz), 5.29 (d, 1H, <i>J</i> = 10.5 Hz), 4.97 (d, 1H, <i>J</i> = 10.8 Hz), 2.75 (d, 1H, <i>J</i> = 13.6 Hz), 2.13 (dt, 1H, <i>J</i> = 4.2, 14.0 Hz), 2.04 (d, 1H, <i>J</i> = 13.4 Hz), 1.87 (dt, 1H, <i>J</i> = 3.4, 14.2 Hz), 1.64 (d, 1H, <i>J</i> = 14.7 Hz), 1.53–1.34 (m, 3H), 1.02 (s, 3H), 0.77 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 178.48, 169.09, 168.51, 157.71 (d, <i>J</i><sub>C–F</sub> = 249.3 Hz), 145.30, 142.77, 136.94, 132.18, 131.88(2C), 129.50, 128.91, 128.25, 126.32 (d, J<sub>C–F</sub> = 4.6 Hz), 123.29, 122.77, 122.28 (d, J<sub>C–F</sub> = 19.1 Hz), 120.51(2C), 111.75, 72.59, 68.33, 62.99, 46.84, 35.75, 34.45, 32.21, 30.00, 28.07, 27.96, 23.63; ESI-MS <i>m</i>/<i>z</i> 610.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 3-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[1.1.1]pentane-1-carboxylic Acid (<b>55</b>)</h3><div class="NLM_p last"><b>55</b> was obtained using the same synthetic strategy described for <b>56</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.61 (t, 1H, <i>J</i> = 6.55 Hz), 7.49 (dd, 1H, <i>J</i> = 2.34, 8.20 Hz), 7.39 (t, 1H, <i>J</i> = 6.90 Hz), 7.15 (t, 1H, <i>J</i> = 8.53 Hz), 7.10 (dd, 1H, <i>J</i> = 1.94, 8.22 Hz), 6.78 (d, 1H, <i>J</i> = 1.88 Hz), 4.98 (d, 1H, <i>J</i> = 10.87 Hz), 4.78 (d, 1H, <i>J</i> = 10.92 Hz), 2.84–2.71 (m, 1H), 2.26 (s, 6H), 2.14 (d, 1H, <i>J</i> = 13.90 Hz), 2.02–1.67 (m, 5H), 1.60–1.38 (m, 1H), 1.31–1.10 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 572.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (<b>56</b>)</h3><div class="NLM_p last">HATU (616 mg, 1.62 mmol) and DIEA (0.550 mL, 3.24 mmol) were added to a suspension of acid <b>29</b> (500 mg, 1.08 mmol) in DCM (15 mL) and stirred. After 10 min, methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate (396 mg, 2.16 mmol) and DMAP (132 mg, 1.08 mmol) were added to the reaction. After overnight, the solvent was removed in vacuo and the crude was purified by column chromatography to give 549 mg of interemediate <b>56-ester</b>. LiOH·H<sub>2</sub>O (110 mg, 2.62 mmol) and sodium hydroxide (105 mg, 2.62 mmol) were added to a solution of interemidiate <b>56-ester</b> (549 mg, 0.873 mmol) dissolved in a mixture of THF (3 mL), H<sub>2</sub>O (3 mL), and MeOH (3 mL). After the hydrolysis was complete, as determined by TLC, the reaction was quenched with TFA (3 mL) and stirred. After 5 min, the solution was concentrated in vacuo (not to dryness) and the resulting oil was redissolved in CH<sub>3</sub>CN and H<sub>2</sub>O (1:1) and the solution was purified by preparative HPLC. The purified fractions were combined, concentrated in vacuo, redissolved in H<sub>2</sub>O, frozen, and lyophilized to give <b>56</b> (TFA salt) as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.63 (t, 1H, <i>J</i> = 6.84 Hz), 7.45 (d, 1H, <i>J</i> = 6.76 Hz), 7.35 (t, 1H, <i>J</i> = 7.21 Hz), 7.18–7.04 (m, 2H), 6.77 (dd, 1H, <i>J</i> = 1.26 Hz), 4.68 (d, 1H, <i>J</i> = 10.61 Hz), 2.73–2.48 (m, 1H), 2.16–1.98 (m, 1H), 1.98–1.43 (m, 18H), 1.27–1.02 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 180.79, 178.22, 167.86, 157.78 (d, J<sub>C–F</sub> = 248.9 Hz), 145.23, 137.07, 132.32, 129.39, 128.99, 126.45 (d, <i>J</i><sub>C–F</sub> = 4.9 Hz), 123.39, 122.50, 122.17, 122.15 (d, <i>J</i><sub>C–F</sub> = 19.3 Hz), 111.77, 73.22, 67.72, 62.58, 52.82, 46.96 (d, <i>J</i><sub>C–F</sub> = 3.5 Hz), 38.96, 32.17, 31.36, 30.41(3C), 29.45(3C), 25.35, 23.08, 21.74; ESI-MS <i>m</i>/<i>z</i> 614.92 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-4,4-difluoro-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (<b>57</b>)</h3><div class="NLM_p last"><b>57</b> was obtained using the same synthetic strategy described for <b>56</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.71 (s, 1H), 7.63 (t, 1H, <i>J</i> = 6.61 Hz), 7.50 (dd, 1H, <i>J</i> = 2.08, 8.18 Hz), 7.36 (t, 1H, <i>J</i> = 7.54 Hz), 7.18–7.05 (m, 2H), 6.79 (d, 1H, <i>J</i> = 1.83 Hz) 4.96 (d, 1H, <i>J</i> = 10.48 Hz), 4.71 (d, 1H, <i>J</i> = 10.51 Hz), 2.78 (d, 1H, <i>J</i> = 14.25 Hz), 2.59–1.91 (m, 6H), 1.91–1.70 (m, 12H), 1.53–1.33 (m, 1H); ESI-MS <i>m</i>/<i>z</i> 650.92 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-<i>N</i>-(4-((methylsulfonyl)carbamoyl)-bicyclo[2.2.2]octan-1-yl)-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamide (<b>58</b>)</h3><div class="NLM_p last">CDI (49 mg, 0.303 mmol), DIEA (88 μL, 0.505 mmol), and DMAP (cat.) were added to a solution of <b>56</b> (62 mg, 0.101 mmol) in 1,2-dichloroethane (10 mL), and the reaction was heated to 40 °C. After 20 min, methanesulfonamide (96 mg, 1.01 mmol) was added and the reaction was refluxed. After overnight, the sovent was removed in vacuo and the crude was purified by prepartive HPLC to give <b>58</b> (TFA salt) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (t, 1H, <i>J</i> = 7.23 Hz), 7.45 (dd, 1H, <i>J</i> = 1.93, 8.22 Hz), 7.36 (t, 1H, <i>J</i> = 7.23 Hz), 7.18–7.04 (m, 2H), 6.77 (d, 1H, <i>J</i> = 1.66 Hz), 4.69 (d, 1H, <i>J</i> = 10.70 Hz), 3.19 (s, 3H), 2.75–2.52 (m, 1H), 2.21–1.99 (m, 1H), 1.99–1.44 (m, 17H), 1.41–1.27 (m, 1H), 1.27–1.03 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 691.42 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (<b>59</b>)</h3><div class="NLM_p last">Paraformaldehyde (15 mg, 0.506 mmol) was added to a solution of compound <b>56</b> (20 mg, 0.028 mmol) dissolved in AcOH (1 mL). After 15 min sodium triacetoxyborohydride (59 mg, 0.28 mmol) was added, and after reacting overnight, the reaction was quenched with saturated ammonium chloride solution and extracted with EtOAc. The EtOAc solvent was evaporated in vacuo, and the resulting oil was redissolved in a solution of MeCN and H<sub>2</sub>O (1:1 with 0.1% TFA) and purified by preparative HPLC. The pure <b>59</b> fractions were combined, concentrate in vacuo, redissolved in H<sub>2</sub>O (with minimum amount of MeCN), frozen, and lyophilized to give <b>59</b> as the TFA salt as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.94 (s, 1H), 7.61–7.52 (m, 2H), 7.40 (t, 1H, <i>J</i> = 7.32 Hz), 7.19–7.08 (m, 2H), 6.78 (d, 1H, <i>J</i> = 1.56 Hz), 4.99 (d, 1H, <i>J</i> = 11.86 Hz), 4.63 (d, 1H, <i>J</i> = 12.06 Hz), 3.27 (s, 3H), 2.61–2.48 (m, 1H), 2.32–2.14 (m, 2H), 1.88–1.40 (m, 18H), 1.37–1.12 (m, 1H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 180.74, 178.21, 166.55, 157.74 (d, <i>J</i><sub>C–F</sub> = 249.6 Hz), 144.90, 137.11, 132.39, 129.80, 129.09, 126.30 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 124.00, 123.43, 122.31 (d, <i>J</i><sub>C–F</sub> = 19.2 Hz), 121.63 (d, J<sub>C–F</sub> = 13.6 Hz), 111.77, 77.98, 73.06, 67.67, 52.98, 46.56, 40.34, 38.97, 34.28, 30.38(3C), 29.44(3C), 28.97, 24.95, 23.57, 22.07; ESI-MS <i>m</i>/<i>z</i> 628.83 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (<b>60</b>)</h3><div class="NLM_p last"><b>60</b> was obtained using the same synthetic strategy described for <b>59</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 7.63 (t, 1H, <i>J</i> = 7.04 Hz), 7.56–7.48 (m, 2H), 7.42 (t, 1H, <i>J</i> = 7.39 Hz), 7.18 (t, 1H, <i>J</i> = 7.96 Hz), 7.10 (d, 1H, <i>J</i> = 8.06 Hz), 6.79 (s, 1H), 5.08–4.96 (m, 1H), 4.57 (d, 1H, <i>J</i> = 11.85 Hz), 4.18–3.99 (m, 1H), 3.87–3.69 (m, 1H), 2.70–2.54 (m, 1H), 2.36–2.13 (m, 2H), 1.94–1.45 (m, 18H), 1.39 (t, 3H, <i>J</i> = 6.65 Hz), 1.32–1.14 (m, 1H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 180.95, 180.06, 177.01, 157.71 (d, J<sub>C–F</sub> = 247.1 Hz), 144.91, 135.39, 130.37, 129.74 (d, <i>J</i><sub>C–F</sub> = 1.6 Hz), 129.34 (d, J<sub>C–F</sub> = 2.5 Hz), 126.86 (d, <i>J</i><sub>C–F</sub> = 12.5 Hz), 126.47, 125.46 (d, <i>J</i><sub>C–F</sub> = 4.6 Hz), 122.27, 121.50 (d, <i>J</i><sub>C–F</sub> = 19.7 Hz), 110.69, 74.84, 72.58, 71.05, 51.51, 48.09, 47.36, 39.17, 37.56, 30.84(3C), 29.61(3C), 29.25, 26.37, 24.25, 23.14, 17.04; ESI-MS <i>m</i>/<i>z</i> 642.50 (M + H)<sup>+</sup>.</div></div><div id="sec5_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-methyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carbothioamide (<b>68</b>)</h3><div class="NLM_p last">Intermediate <b>64</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (1.0 g, 2.09 mmol) was dissolved in a mixture of DCM (10 mL) and AcOH (10 mL). Paraformaldehyde (1.13 g, 37.62 mmol) was added, and after 10 min NaBH(OAc)<sub>3</sub> (4.43 g, 20.9 mmol) was added in portions. After 4 h, as determined by TLC, the reaction was complete. Saturated NH<sub>4</sub>Cl (aq) was added to the reaction which was then extracted with EtOAc. The EtOAc solution was washed with NaOH (1 M) and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by column chromatography to give 764 mg of intermediate <b>65</b>. Sodium hydroxide (320 mg, 8.0 mmol) was added to a solution of intermediate <b>65</b> (764 mg, 1.6 mmol) dissolved in a mixture of THF (3 mL), H<sub>2</sub>O (3 mL), and MeOH (3 mL), and the solution was heated to 45–50 °C. After hydrolysis was complete, as determined by TLC, the reaction was cooled, neutralized with 2 M HCl, and extracted with EtOAc. The EtOAc solution was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the acid intermediate <b>66</b> as a solid that was used without further purification. CDI (315 mg, 1.94 mmol) and DIEA (0.450 mL, 2.59 mmol) were added to a solution of <b>66</b> (300 mg, 0.648 mmol) in THF (15 mL) and heated to 50 °C. After 30 min ammonium hydroxide was was added. After standing overnight, H<sub>2</sub>O was added and the reaction was extracted with EtOAc. The EtOAc solution was dried over sodium sulfate, filtered, concentrated, and purified by column chromatography to give 240 mg of compound <b>67</b>. Lawesson’s reagent (102 mg, 0.252 mmol) was added to a solution of compound <b>67</b> (60 mg, 0.126 mmol) in DCM (3 mL) and refluxed overnight. Then the reaction was cooled, the solvent was removed, and the crude was column chromatographed to produce 60 mg of <b>68</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.66 (ddd, 1H, <i>J</i> = 1.4, 6.4, 7.9 Hz), 7.53 (dd, 1H, <i>J</i> = 2.5, 8.3 Hz), 7.38 (t, 1H, <i>J</i> = 7.3 Hz), 7.15 (t, 1H, <i>J</i> = 8.0 Hz), 7.10 (dd, 1H, <i>J</i> = 1.9, 8.2 Hz), 6.77 (d, 1H, <i>J</i> = 1.9 Hz), 5.48 (br s, 1H), 4.71 (d, 1H, <i>J</i> = 11.2 Hz), 3.37 (s, 3H), 2.38 (d, 1H, <i>J</i> = 14.2 Hz), 2.19–2.02 (m, 1H), 1.99–1.85 (m, 1H), 1.83–1.61 (m, 4H), 1.50–1.36 (m, 1H), 1.35–1.16 (m, 2H); ESI-MS <i>m</i>/<i>z</i> 492.67 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Fluorescence Polarization-Based (FP-Based) Protein Binding Assay, Cell Growth Inhibition Assay, Pharmacodynamics (PD) Study in SJSA-1 Xenograft Model, and in Vivo Efficacy Study</h3><div class="NLM_p last">These assays were performed according to the previously reported procedures.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> All the in vivo studies were performed under an animal protocol (PRO00005315) approved by the University Committee on Use and Care of Animals of the University of Michigan, in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Computational Methods</h3><div class="NLM_p last">Docking studies were performed using our previously reported structure of MDM2 in complex with <b>2</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TRF">5TRF</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with the GOLD<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> program (version 5.2). For each genetic algorithm (GA) run, a maximum number of 200 000 operations were performed on a population of five islands of 100 individuals. Operator weights for crossover, mutation, and migration were set to 95, 95, and 10, respectively, and the Chemscore<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> fitness function was used to evaluate the docked conformations. Docking was terminated after 10 runs for each ligand, and the top 10 conformations were saved for analysis of the predicted binding modes.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01665">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01665" class="ext-link">10.1021/acs.jmedchem.6b01665</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_002.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_001.csv">jm6b01665_si_001.csv (6.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_002.pdb">jm6b01665_si_002.pdb (67.37 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01665" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaomeng Wang</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8782-6950" title="Orcid link">http://orcid.org/0000-0002-8782-6950</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#35665d545a58505b527540585c565d1b505140"><span class="__cf_email__" data-cfemail="65360d040a08000b022510080c060d4b000110">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Aguilar</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianfeng Lu</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liu Liu</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ding Du</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4615-5433" title="Orcid link">http://orcid.org/0000-0002-4615-5433</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denzil Bernard</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna McEachern</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sally Przybranowski</span> - <span class="hlFld-Affiliation affiliation">University
of Michigan Comprehensive Cancer Center, and Departments of Internal
Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoqin Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruijuan Luo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Wen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duxin Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hengbang Wang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianfeng Wen</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangfeng Wang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yifan Zhai</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Guo</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dajun Yang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Ascentage Biomed Development Inc., China
Medical City, Taizhou, Jiangsu 225300, China</span>; 
    <span class="hlFld-Affiliation affiliation">Suzhou Ascentage
Pharma Inc., Suzhou, Jiangsu 215123, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Experimental Research, Sun Yat-Sen University Cancer Center, State
Key Laboratory of Oncology in South China, Collaborative Innovation
Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The University of Michigan has filed a patent on AA-115 and its analogues, and Shaomeng Wang, Angelo Aguilar, Jianfeng Lu, Liu Liu, and Donna McEachern are co-inventors of the patent. The patent application covering AA-115 and its analogues has been licensed by Ascentage Pharma Group for clinical development in which Shaomeng Wang is a co-founder, owns stock, and serves as a paid consultant. Shaomeng Wang and the University of Michigan also receive a research grant from Ascentage Pharma Group.<br /></br></div></li></ul></div><div class="ack" id="ACK-d56e6931-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study is supported in part by grants from the National Institutes of Health (Grant R01CA121279 to S.W.), the National Cancer Institute Cancer Center Core grant (P30CA046592) to the University of Michigan Comprehensive Cancer Center, a grant from Ascentage Pharma Group to the University of Michigan (to S.W.), the Key New Drug Creation project of the major science and technology program (Grant 2012ZX09401005, China), National “863” Grant (2012AA020305, China), and Science & Technology Innovation Team Grant of Guangdong Province (Grant 2013Y114) to Jiangsu Ascentage Biomed Development Inc.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i86" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i86"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i87" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i87"> Abbreviations Used</h2><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">CAN</td><td class="NLM_def"><p class="first last">ceric ammonium nitrate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoracetic anhydride</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancer: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1016/S0065-230X(08)60785-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0065-230X%2808%2960785-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancer%3A+the+first+ten+thousand+mutations&doi=10.1016%2FS0065-230X%2808%2960785-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2808%2960785-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252808%252960785-X%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancer%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1999%26volume%3D77%26spage%3D81%26epage%3D137%26doi%3D10.1016%2FS0065-230X%2808%2960785-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vousden, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53 in health and disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1038/nrm2147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1038%2Fnrm2147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=17380161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=275-283&author=K.+H.+Vousdenauthor=D.+P.+Lane&title=p53+in+health+and+disease&doi=10.1038%2Fnrm2147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">p53 in health and disease</span></div><div class="casAuthors">Vousden, Karen H.; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-283</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As a component of the response to acute stress, p53 has a well established role in protecting against cancer development.  However, it is now becoming clear that p53 can have a much broader role and can contribute to the development, life expectancy and overall fitness of an organism.  Although the function of p53 as a tumor suppressor ensures that we can't live without it, an integrated view of p53 suggests that not all of its functions are conducive to a long and healthy life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoND8MaF-_GGbVg90H21EOLACvtfcHk0ljn2FX8g4o3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlygsr0%253D&md5=c39c719e12d6cb436786acb162101b28</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2147%26sid%3Dliteratum%253Aachs%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D275%26epage%3D283%26doi%3D10.1038%2Fnrm2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Momand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambetti, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span><span class="refDoi"> DOI: 10.1016/0092-8674(92)90644-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2F0092-8674%2892%2990644-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1535557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Ogs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1992&pages=1237-1245&author=J.+Momandauthor=G.+P.+Zambettiauthor=D.+C.+Olsonauthor=D.+Georgeauthor=A.+J.+Levine&title=The+mdm-2+oncogene+product+forms+a+complex+with+the+p53+protein+and+inhibits+p53-mediated+transactivation&doi=10.1016%2F0092-8674%2892%2990644-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation</span></div><div class="casAuthors">Momand, Jamil; Zambetti, Gerard P.; Olson, David C.; George, Donna; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1237-45</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A cellular phosphoprotein with an apparent mol. mass of 90 kd (p90) that forms a complex with both mutant and wild-type p53 protein has been characterized, purified, and identified.  The protein was identified as a product of the murine double minute 2 gene (mdm-2).  The mdm-2 gene enhances the tumorigenic potential of cells when it is overexpressed and encodes a putative transcription factor.  To det. if mdm-2 could modulate p53 transactivation, a p53-responsive element from the muscle creatine kinase gene was employed.  A wild-type p53-expressing plasmid enhanced the expression of the p53-responsive element when cotransfected into cells that contain no endogenous p53.  When a cosmid expressing mdm-2 was transfected with this p53-expressing plasmid, the transactivation of the p53-responsive element was inhibited.  Thus, a product of the mdm-2 oncogene forms a tight complex with the p53 protein, and the mdm-2 oncogene can inhibit p53-mediated transactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UJbHLRWEsLVg90H21EOLACvtfcHk0lh8jiyQ7ZoZvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Ogs7o%253D&md5=448d8b28555303773d76084e2d8b32ee</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990644-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990644-R%26sid%3Dliteratum%253Aachs%26aulast%3DMomand%26aufirst%3DJ.%26aulast%3DZambetti%26aufirst%3DG.%2BP.%26aulast%3DOlson%26aufirst%3DD.%2BC.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520mdm-2%2520oncogene%2520product%2520forms%2520a%2520complex%2520with%2520the%2520p53%2520protein%2520and%2520inhibits%2520p53-mediated%2520transactivation%26jtitle%3DCell%26date%3D1992%26volume%3D69%26spage%3D1237%26epage%3D1245%26doi%3D10.1016%2F0092-8674%2892%2990644-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Freedman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Functions of the MDM2 oncoprotein</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1007/s000180050273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1007%2Fs000180050273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10065155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=96-107&author=D.+A.+Freedmanauthor=L.+Wuauthor=A.+J.+Levine&title=Functions+of+the+MDM2+oncoprotein&doi=10.1007%2Fs000180050273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Functions of the MDM2 oncoprotein</span></div><div class="casAuthors">Freedman, D. A.; Wu, L.; Levine, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review is given with 79 refs.  The p53 protein is activated in response to physiol. stress resulting in either a G 1 arrest of cells or apoptosis.  As such, p53 must be tightly regulated, and the MDM2 oncoprotein plays a central role in that regulatory process.  The transcription of the Mdm2 oncogene is induced by the p53 protein after DNA damage, and the MDM2 protein then binds to p53 and blocks its activities as a tumor suppressor and promotes its degrdn.  These 2 proteins thus form an autoregulatory feedback loop in which p53 pos. regulates MDM2 levels and MDM2 neg. regulates p53 levels and activity.  Immediately after UV irradn. MDM2 mRNA and protein levels fall in a p53-independent fashion, resulting in increased p53 levels.  The p53 protein is then activated as a transcription factor by posttranslational modification permitting p53 to initiate its cell-cycle arrest or apoptotic (programmed cell death) functions.  At later times, after the repair of DNA, MDM2 levels increase in a p53-dependent fashion.  This induction of MDM2 results in the inhibition of p53 transcriptional activity and the degrdn. of p53 protein.  MDM2-p53 complexes in the nucleus are transported to the cytoplasm via signals present in the MDM2 protein, where p53 is degraded in the proteasome.  Thus MDM2 acts as a nuclear-cytoplasmic shuttle for the p53 protein.  There are many levels at which this process is regulated, and as such there are many places for chemotherapeutic interventions.  The amino-terminal domain of the MDM2 protein is all that is required to bind the p53 protein.  The MDM2 protein has addnl. domains and therefore may have addnl. functions.  Any of these MDM2 domains may contribute to MDM2's activities as an oncogene independent of its inhibition of the tumor suppressor functions of p53.  Thus MDM2 itself could be a target for cancer therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRcPEDlOyBLVg90H21EOLACvtfcHk0lh8jiyQ7ZoZvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2lsLY%253D&md5=634456f449df4433ccf8ba9d7e23808b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs000180050273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050273%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DFunctions%2520of%2520the%2520MDM2%2520oncoprotein%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D1999%26volume%3D55%26spage%3D96%26epage%3D107%26doi%3D10.1007%2Fs000180050273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bond, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">MDM2 is a central node in the p53 pathway: 12 years and counting</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.2174/1568009053332627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.2174%2F1568009053332627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=15720184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVeqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=3-8&author=G.+L.+Bondauthor=W.+W.+Huauthor=A.+J.+Levine&title=MDM2+is+a+central+node+in+the+p53+pathway%3A+12+years+and+counting&doi=10.2174%2F1568009053332627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MDM2 is a central node in the p53 pathway: 12 years and counting</span></div><div class="casAuthors">Bond, Gareth L.; Hu, Wenwei; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Twelve years ago, the Mdm2 oncogene was shown to bind to and inhibit the tumor suppressor protein, p53.  During the past 12 years, both genetic and biochem. studies have demonstrated that Mdm2 is a key neg. regulator of the tumor suppressor p53.  Mdm2 and p53 form an oscillating auto-regulatory feedback loop, which is tightly controlled to allow the appropriate response to environmental stresses to suppress tumor formation.  When Mdm2 activity is inappropriately heightened, as it is in many human tumors, p53 activity is attenuated and tumor susceptibility arises.  The p53 gene is mutated in 50% of all human tumors, but in those tumors that retain wild type p53, inhibiting Mdm2 activity could activate p53 tumor suppression and therefore provide a therapeutic strategy for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe_fHLgXrKRrVg90H21EOLACvtfcHk0lh0iAw0Q5T5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVeqt7w%253D&md5=a2c578da4c2d390cd893ec240b6bd9e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568009053332627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009053332627%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DG.%2BL.%26aulast%3DHu%26aufirst%3DW.%2BW.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DMDM2%2520is%2520a%2520central%2520node%2520in%2520the%2520p53%2520pathway%253A%252012%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2005%26volume%3D5%26spage%3D3%26epage%3D8%26doi%3D10.2174%2F1568009053332627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">The p53-mdm-2 autoregulatory feedback loop</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1101/gad.7.7a.1126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1101%2Fgad.7.7a.1126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=8319905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK3sXlslGhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=1126-1132&author=X.+Wuauthor=J.+H.+Bayleauthor=D.+Olsonauthor=A.+J.+Levine&title=The+p53-mdm-2+autoregulatory+feedback+loop&doi=10.1101%2Fgad.7.7a.1126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The p53-mdm-2 autoregulatory feedback loop</span></div><div class="casAuthors">Wu, Xiangwei; Bayle, J. Henri; Olson, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7A</span>),
    <span class="NLM_cas:pages">1126-31</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    </div><div class="casAbstract">The p53 protein can bind to a set of specific DNA sequences, and this may activate the transcription of genes adjacent to these DNA elements.  The mdm-2 gene is shown here to contain a p53 DNA-binding site and a genetically responsive element such that expression of the mdm-2 gene can be regulated by the level of wild-type p53 protein.  The mdm-2 protein, in turn, can complex with p53 and decrease its ability to act as a pos. transcription factor at the mdm-2 gene-responsive element.  In this way, the mdm-2 gene is autoregulated.  The p53 protein regulates the mdm-2 gene at the level of transcription, and the mdm-2 protein regulates the p53 protein at the level of its activity.  This creates a feedback loop that regulates both the activity of the p53 protein and the expression of the mdm-2 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyvx38hSAdLbVg90H21EOLACvtfcHk0lh0iAw0Q5T5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlslGhtLo%253D&md5=ee1ae7f78e5c76e94507718527504079</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1101%2Fgad.7.7a.1126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.7.7a.1126%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBayle%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520p53-mdm-2%2520autoregulatory%2520feedback%2520loop%26jtitle%3DGenes%2520Dev.%26date%3D1993%26volume%3D7%26spage%3D1126%26epage%3D1132%26doi%3D10.1101%2Fgad.7.7a.1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Juven-Gershon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oren, M.</span><span> </span><span class="NLM_article-title">Mdm2: the ups and downs</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10203572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK1MXjsF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=71-83&author=T.+Juven-Gershonauthor=M.+Oren&title=Mdm2%3A+the+ups+and+downs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mdm2: the ups and downs</span></div><div class="casAuthors">Juven-Gershon, Tamar; Oren, Moshe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review with 110 refs., including sections entitled introduction; Mdm2: the cancer connection; the Mdm2 protein; the mdm2-p53 autoregulatory loop; post-translational regulation of Mdm2; Mdm2-p53 interactions: potential target for therapeutic intervention; protein partners of Mdm2: who else besides p53; p53-independent activities of Mdm2; effects of Mdm2 on development, differentiation, and cell cycle regulation; family connections; and conclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojR2A0M5ypIrVg90H21EOLACvtfcHk0lh0iAw0Q5T5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsF2mtb4%253D&md5=37dab158ebc840fcc56a182bdd68d3a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuven-Gershon%26aufirst%3DT.%26aulast%3DOren%26aufirst%3DM.%26atitle%3DMdm2%253A%2520the%2520ups%2520and%2520downs%26jtitle%3DMol.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Momand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, G.</span><span> </span><span class="NLM_article-title">MDM2--master regulator of the p53 tumor suppressor protein</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/S0378-1119(99)00487-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0378-1119%2899%2900487-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2000&pages=15-29&author=J.+Momandauthor=H.+H.+Wuauthor=G.+Dasgupta&title=MDM2%2D%2Dmaster+regulator+of+the+p53+tumor+suppressor+protein&doi=10.1016%2FS0378-1119%2899%2900487-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2899%2900487-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252899%252900487-4%26sid%3Dliteratum%253Aachs%26aulast%3DMomand%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%2BH.%26aulast%3DDasgupta%26aufirst%3DG.%26atitle%3DMDM2--master%2520regulator%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DGene%26date%3D2000%26volume%3D242%26spage%3D15%26epage%3D29%26doi%3D10.1016%2FS0378-1119%2899%2900487-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small-molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1126/science.1092472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small-molecule+antagonists+of+MDM2&doi=10.1126%2Fscience.1092472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0ljN9S0uLhcdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small-molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848%26doi%3D10.1126%2Fscience.1092472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">p53 Activation by small molecules: application in oncology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4491</span><span class="NLM_x">–</span> <span class="NLM_lpage">4499</span><span class="refDoi"> DOI: 10.1021/jm058174k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058174k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlarsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4491-4499&author=L.+T.+Vassilev&title=p53+Activation+by+small+molecules%3A+application+in+oncology&doi=10.1021%2Fjm058174k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">p53 Activation by Small Molecules: Application in Oncology</span></div><div class="casAuthors">Vassilev, Lyubomir T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4491-4499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  P53 activation by small mols. and their application in chemoprevention are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8McGVTfuxrVg90H21EOLACvtfcHk0ljN9S0uLhcdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlarsLc%253D&md5=44ee6a039c0c5ad69e218de742de0d53</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm058174k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058174k%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3Dp53%2520Activation%2520by%2520small%2520molecules%253A%2520application%2520in%2520oncology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4491%26epage%3D4499%26doi%3D10.1021%2Fjm058174k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Targeting the MDM2-p53 interaction for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5318</span><span class="NLM_x">–</span> <span class="NLM_lpage">5324</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-5136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1158%2F1078-0432.CCR-07-5136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=18765522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5318-5324&author=S.+Shangaryauthor=S.+Wang&title=Targeting+the+MDM2-p53+interaction+for+cancer+therapy&doi=10.1158%2F1078-0432.CCR-07-5136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MDM2-p53 Interaction for Cancer Therapy</span></div><div class="casAuthors">Shangary, Sanjeev; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5318-5324</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  P53 is a powerful tumor suppressor and is an attractive cancer therapeutic target because it can be functionally activated to eradicate tumors.  The gene encoding p53 protein is mutated or deleted in half of human cancers, which inactivates its tumor suppressor activity.  In the remaining cancers with wild-type p53 status, its function is effectively inhibited through direct interaction with the human murine double minute 2 (MDM2) oncoprotein.  Blocking the MDM2-p53 interaction to reactivate the p53 function is a promising cancer therapeutic strategy.  This review will highlight the advances in the design and development of small-mol. inhibitors of the MDM2-p53 interaction as a cancer therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtwmcFovaS7Vg90H21EOLACvtfcHk0liMB0IHmUWwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbzK&md5=830e9b394b8d99261d3681ad8d450612</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-5136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-5136%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520MDM2-p53%2520interaction%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5318%26epage%3D5324%26doi%3D10.1158%2F1078-0432.CCR-07-5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Targeting the MDM2-p53 protein-protein interaction for new cancer therapeutics</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1007/978-3-642-28965-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1007%2F978-3-642-28965-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=57-79&author=S.+M.+Wangauthor=Y.+J.+Zhaoauthor=D.+Bernardauthor=A.+Aguilarauthor=S.+Kumar&title=Targeting+the+MDM2-p53+protein-protein+interaction+for+new+cancer+therapeutics&doi=10.1007%2F978-3-642-28965-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MDM2-p53 protein-protein interaction for new cancer therapeutics</span></div><div class="casAuthors">Wang, Shaomeng; Zhao, Yujun; Bernard, Denzil; Aguilar, Angelo; Kumar, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Topics in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">57-80</span>CODEN:
                <span class="NLM_cas:coden">TMCOB8</span>;
        ISSN:<span class="NLM_cas:issn">1862-2461</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The p53 tumor suppressor protein is a transcriptional factor that plays a key role in regulation of several cellular processes including the cell cycle, apoptosis, DNA repair, and angiogenesis.  The murine double minute 2 (MDM2) protein is the primary cellular inhibitor of p53, functioning through direct interaction with p53.  Design of non-peptide, small-mol. inhibitors that block the MDM2-p53 interaction has been sought as an attractive strategy to activate p53 for the treatment of cancer and other human diseases.  Major advances have been made in the design of small-mol. inhibitors of the MDM2-p53 interaction in recent years, and several compds. have moved into advanced preclin. development or clin. trials.  In this chapter, we will highlight these advances in the design and development of MDM2 inhibitors, and discuss lessons learned from these efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz8RJm7ymBbbVg90H21EOLACvtfcHk0liMB0IHmUWwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgsrfF&md5=1765c7b13fe3f7480cd9e8f6ead691ff</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-28965-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-28965-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DY.%2BJ.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520MDM2-p53%2520protein-protein%2520interaction%2520for%2520new%2520cancer%2520therapeutics%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D57%26epage%3D79%26doi%3D10.1007%2F978-3-642-28965-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Carry, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2Fj.bmcl.2013.03.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2480-2485&author=J.+C.+Carryauthor=C.+Garcia-Echeverria&title=Inhibitors+of+the+p53%2Fhdm2+protein-protein+interaction-path+to+the+clinic&doi=10.1016%2Fj.bmcl.2013.03.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DCarry%26aufirst%3DJ.%2BC.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520p53%252Fhdm2%2520protein-protein%2520interaction-path%2520to%2520the%2520clinic%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2480%26epage%3D2485%26doi%3D10.1016%2Fj.bmcl.2013.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ray-Coquard, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blay, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Cesne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span> </span><span class="NLM_article-title">Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span><span class="refDoi"> DOI: 10.1016/S1470-2045(12)70474-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS1470-2045%2812%2970474-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=23084521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wqur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1133-1140&author=I.+Ray-Coquardauthor=J.+Y.+Blayauthor=A.+Italianoauthor=A.+Le+Cesneauthor=N.+Penelauthor=J.+Zhiauthor=F.+Heilauthor=R.+Ruegerauthor=B.+Gravesauthor=M.+Dingauthor=D.+Gehoauthor=S.+A.+Middletonauthor=L.+T.+Vassilevauthor=G.+L.+Nicholsauthor=B.+N.+Bui&title=Effect+of+the+MDM2+antagonist+RG7112+on+the+P53+pathway+in+patients+with+MDM2-amplified%2C+well-differentiated+or+dedifferentiated+liposarcoma%3A+an+exploratory+proof-of-mechanism+study&doi=10.1016%2FS1470-2045%2812%2970474-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study</span></div><div class="casAuthors">Ray-Coquard, Isabelle; Blay, Jean-Yves; Italiano, Antoine; Le Cesne, Axel; Penel, Nicolas; Zhi, Jianguo; Heil, Florian; Rueger, Ruediger; Graves, Bradford; Ding, Meichun; Geho, David; Middleton, Steven A.; Vassilev, Lyubomir T.; Nichols, Gwen L.; Bui, Binh Nguyen</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1133-1140</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report a proof-of-mechanism study of RG7112, a small-mol. MDM2 antagonist, in patients with chemotherapy-naive primary or relapsed well-differentiated or dedifferentiated MDM2-amplified liposarcoma who were eligible for resection.  Patients with well-differentiated or dedifferentiated liposarcoma were enrolled at four centers in France.  Patients received up to three 28-day neoadjuvant treatment cycles of RG7112 1440 mg/m2 per day for 10 days.  If a patient progressed at any point after the first cycle, the lesion was resected or, if unresectable, an end-of-study biopsy was done.  The primary endpoint was to assess markers of RG7112-dependent MDM2 inhibition and P53 pathway activation (P53, P21, MDM2, Ki-67, macrophage inhibitory cytokine-1 [MIC-1], and apoptosis).  All analyses were per protocol.  This trial is registered with EudraCT, no. 2009-015522-10.  Between June 3, and Dec 14, 2010, 20 patients were enrolled and completed pretreatment and day 8 biopsies. 18 of 20 patients had TP53 wild-type tumors and two carried missense TP53 mutations. 14 of 17 assessed patients had MDM2 gene amplification.  Compared with baseline, P53 and P21 concns., assessed by immunohistochem., had increased by a median of 4·86 times (IQR 4·38-7·97; p=0·0001) and 3·48 times (2·05-4·09; p=0·0001), resp., at day 8 (give or take 2 days).  At the same timepoint, relative MDM2 mRNA expression had increased by a median of 3·03 times (1·23-4·93; p=0·003) that at baseline.  The median change from baseline for Ki-67-pos. tumor cells was -5·05% (IQR -12·55 to 0·05; p=0·01).  Drug exposure correlated with blood concns. of MIC-1 (p<0·0001) and haematol. toxicity.  One patient had a confirmed partial response and 14 had stable disease.  All patients experienced at least one adverse event, mostly nausea (14 patients), vomiting (11 patients), asthenia (nine patients), diarrhoea (nine patients), and thrombocytopenia (eight patients).  There were 12 serious adverse events in eight patients, the most common of which were neutropenia (six patients) and thrombocytopenia (three patients).  MDM2 inhibition activates the P53 pathway and decreases cell proliferation in MDM2-amplified liposarcoma.  This study suggests that it is feasible to undertake neoadjuvant biopsy-driven biomarker studies in liposarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5gE_ssOHMbVg90H21EOLACvtfcHk0ljRzELkRCv9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wqur3K&md5=ef950cefb26da53bc624fc45e8e006e9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2812%2970474-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252812%252970474-6%26sid%3Dliteratum%253Aachs%26aulast%3DRay-Coquard%26aufirst%3DI.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DLe%2BCesne%26aufirst%3DA.%26aulast%3DPenel%26aufirst%3DN.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DRueger%26aufirst%3DR.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DGeho%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DNichols%26aufirst%3DG.%2BL.%26aulast%3DBui%26aufirst%3DB.%2BN.%26atitle%3DEffect%2520of%2520the%2520MDM2%2520antagonist%2520RG7112%2520on%2520the%2520P53%2520pathway%2520in%2520patients%2520with%2520MDM2-amplified%252C%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%253A%2520an%2520exploratory%2520proof-of-mechanism%2520study%26jtitle%3DLancet%2520Oncol.%26date%3D2012%26volume%3D13%26spage%3D1133%26epage%3D1140%26doi%3D10.1016%2FS1470-2045%2812%2970474-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span><span class="refDoi"> DOI: 10.1021/jm501092z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501092z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1038-1052&author=Y.+Zhaoauthor=A.+Aguilarauthor=D.+Bernardauthor=S.+Wang&title=Small-molecule+inhibitors+of+the+MDM2-p53+protein-protein+interaction+%28MDM2+Inhibitors%29+in+clinical+trials+for+cancer+treatment&doi=10.1021%2Fjm501092z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment</span></div><div class="casAuthors">Zhao, Yujun; Aguilar, Angelo; Bernard, Denzil; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Design of small-mol. inhibitors (MDM2 inhibitors) to block the MDM2-p53 protein-protein interaction has been pursued as a new cancer therapeutic strategy.  In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compds. have been advanced into early phase clin. trials for the treatment of human cancers.  Here, we review the design, synthesis, properties, preclin., and clin. studies of these clin.-stage MDM2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNa9aW1Kz1Q7Vg90H21EOLACvtfcHk0ljRzELkRCv9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P&md5=2e58318782d7e0a04bf3398db8782984</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501092z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520protein-protein%2520interaction%2520%2528MDM2%2520Inhibitors%2529%2520in%2520clinical%2520trials%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1038%26epage%3D1052%26doi%3D10.1021%2Fjm501092z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7112: A small-molecule MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1021/ml4000657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wovkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.+J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+A+small-molecule+MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fml4000657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0lhq31YJGa1L5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520A%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469%26doi%3D10.1021%2Fml4000657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span><span class="refDoi"> DOI: 10.1021/jm400487c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtValsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.+J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.+J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fjm400487c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Ding, Qingjie; Zhang, Zhuming; Liu, Jin-Jun; Jiang, Nan; Zhang, Jing; Ross, Tina M.; Chu, Xin-Jie; Bartkovitz, David; Podlaski, Frank; Janson, Cheryl; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir T.; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5979-5983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Restoration of p53 activity by inhibition of the p53-MDM2 interaction has been considered an attractive approach for cancer treatment.  However, the hydrophobic protein-protein interaction surface represents a significant challenge for the development of small-mol. inhibitors with desirable pharmacol. profiles.  RG7112 was the first small-mol. p53-MDM2 inhibitor in clin. development.  Here, the authors report the discovery and characterization of a second generation clin. MDM2 inhibitor, RG7388, with superior potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bhb1040eXrVg90H21EOLACvtfcHk0lhq31YJGa1L5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtValsLzJ&md5=714bcfd797cf5850384239989c94a2c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983%26doi%3D10.1021%2Fjm400487c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaux, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barriere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman-Luca, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos-Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorge-Bernat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debussche, L.</span><span> </span><span class="NLM_article-title">SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5855</span><span class="NLM_x">–</span> <span class="NLM_lpage">5865</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1158%2F0008-5472.CAN-14-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=25145672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5855-5865&author=S.+Wangauthor=W.+Sunauthor=Y.+Zhaoauthor=D.+McEachernauthor=I.+Meauxauthor=C.+Barriereauthor=J.+A.+Stuckeyauthor=J.+L.+Meagherauthor=L.+Baiauthor=L.+Liuauthor=C.+G.+Hoffman-Lucaauthor=J.+Luauthor=S.+Shangaryauthor=S.+Yuauthor=D.+Bernardauthor=A.+Aguilarauthor=O.+Dos-Santosauthor=L.+Besretauthor=S.+Guerifauthor=P.+Pannierauthor=D.+Gorge-Bernatauthor=L.+Debussche&title=SAR405838%3A+an+optimized+inhibitor+of+MDM2-p53+interaction+that+induces+complete+and+durable+tumor+regression&doi=10.1158%2F0008-5472.CAN-14-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression</span></div><div class="casAuthors">Wang, Shaomeng; Sun, Wei; Zhao, Yujun; McEachern, Donna; Meaux, Isabelle; Barriere, Cedric; Stuckey, Jeanne A.; Meagher, Jennifer L.; Bai, Longchuan; Liu, Liu; Hoffman-Luca, Cassandra Gianna; Lu, Jianfeng; Shangary, Sanjeev; Yu, Shanghai; Bernard, Denzil; Aguilar, Angelo; Dos-Santos, Odette; Besret, Laurent; Guerif, Stephane; Pannier, Pascal; Gorge-Bernat, Dimitri; Debussche, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5855-5865</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite the risk of applying a selection for p53 mutations that escape MDM2 control, blocking MDM2-p53 protein-protein interaction has long been considered by many to offer an attractive cancer therapeutic strategy, a position strongly supported by the findings of this preclin. study.  Blocking the oncoprotein murine double minute 2 (MDM2)-p53 protein-protein interaction has long been considered to offer a broad cancer therapeutic strategy, despite the potential risks of selecting tumors harboring p53 mutations that escape MDM2 control.  In this study, we report a novel small-mol. inhibitor of the MDM2-p53 interaction, SAR405838 (MI-77301), that has been advanced into phase I clin. trials.  SAR405838 binds to MDM2 with Ki = 0.88 nmol/L and has high specificity over other proteins.  A cocrystal structure of the SAR405838:MDM2 complex shows that, in addn. to mimicking three key p53 amino acid residues, the inhibitor captures addnl. interactions not obsd. in the p53-MDM2 complex and induces refolding of the short, unstructured MDM2 N-terminal region to achieve its high affinity.  SAR405838 effectively activates wild-type p53 in vitro and in xenograft tumor tissue of leukemia and solid tumors, leading to p53-dependent cell-cycle arrest and/or apoptosis.  At well-tolerated dose schedules, SAR405838 achieves either durable tumor regression or complete tumor growth inhibition in mouse xenograft models of SJSA-1 osteosarcoma, RS4;11 acute leukemia, LNCaP prostate cancer, and HCT-116 colon cancer.  Remarkably, a single oral dose of SAR405838 is sufficient to achieve complete tumor regression in the SJSA-1 model.  Mechanistically, robust transcriptional upregulation of PUMA induced by SAR405838 results in strong apoptosis in tumor tissue, leading to complete tumor regression.  Our findings provide a preclin. basis upon which to evaluate SAR405838 as a therapeutic agent in patients whose tumors retain wild-type p53.  Cancer Res; 74(20); 5855-65. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptKSwfNhNzNLVg90H21EOLACvtfcHk0lg5OMZYzTnWmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjsr7M&md5=5b35759e14fe4c1ae4e734775c4334a0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0799%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DMeaux%26aufirst%3DI.%26aulast%3DBarriere%26aufirst%3DC.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHoffman-Luca%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DDos-Santos%26aufirst%3DO.%26aulast%3DBesret%26aufirst%3DL.%26aulast%3DGuerif%26aufirst%3DS.%26aulast%3DPannier%26aufirst%3DP.%26aulast%3DGorge-Bernat%26aufirst%3DD.%26aulast%3DDebussche%26aufirst%3DL.%26atitle%3DSAR405838%253A%2520an%2520optimized%2520inhibitor%2520of%2520MDM2-p53%2520interaction%2520that%2520induces%2520complete%2520and%2520durable%2520tumor%2520regression%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D5855%26epage%3D5865%26doi%3D10.1158%2F0008-5472.CAN-14-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1021/jm401753e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1454-1472&author=D.+Sunauthor=Z.+Liauthor=Y.+Rewauthor=M.+Gribbleauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=X.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+Fisherauthor=B.+M.+Foxauthor=J.+Fuauthor=A.+Z.+Gonzalezauthor=F.+Gonzalez-Lopez+De+Turisoauthor=J.+B.+Houzeauthor=X.+Huangauthor=M.+Jiangauthor=L.+Jinauthor=F.+Kayserauthor=J.+J.+Liuauthor=M.+C.+Loauthor=A.+M.+Longauthor=B.+Lucasauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+Mihalicauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+L.+Petersonauthor=P.+Rovetoauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=M.+Totevaauthor=Y.+Wangauthor=Y.+C.+Wangauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=M.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+Zhuauthor=S.+H.+Olsonauthor=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+MDM2-p53+inhibitor+in+clinical+development&doi=10.1021%2Fjm401753e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development</span></div><div class="casAuthors">Sun, Daqing; Li, Zhihong; Rew, Yosup; Gribble, Michael; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chen, Xiaoqi; Chow, David; Deignan, Jeffrey; Duquette, Jason; Eksterowicz, John; Fisher, Benjamin; Fox, Brian M.; Fu, Jiasheng; Gonzalez, Ana Z.; Gonzalez-Lopez De Turiso, Felix; Houze, Jonathan B.; Huang, Xin; Jiang, Min; Jin, Lixia; Kayser, Frank; Liu, Jiwen; Lo, Mei-Chu; Long, Alexander M.; Lucas, Brian; McGee, Lawrence R.; McIntosh, Joel; Mihalic, Jeff; Oliner, Jonathan D.; Osgood, Tao; Peterson, Matthew L.; Roveto, Philip; Saiki, Anne Y.; Shaffer, Paul; Toteva, Maria; Wang, Yingcai; Wang, Yu Chung; Wortman, Sarah; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Yu, Ming; Zhao, Xiaoning; Zhou, Jing; Zhu, Jiang; Olson, Steven H.; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1454-1472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the discovery of AM-8553 (1), a potent and selective piperidinone inhibitor of the MDM2-p53 interaction.  Continued research investigation of the N-alkyl substituent of this series, focused in particular on a previously underutilized interaction in a shallow cleft on the MDM2 surface, led to the discovery of a one-carbon tethered sulfone which gave rise to substantial improvements in biochem. and cellular potency.  Further investigation produced AMG 232 (2), which is currently being evaluated in human clin. trials for the treatment of cancer.  Compd. 2 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9.1 nM), with remarkable pharmacokinetic properties and in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft model (ED50 = 9.1 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjly0O6c42NbVg90H21EOLACvtfcHk0lijxZcOiIv27g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitbY%253D&md5=91197d328d40f6fa2f6c37819149427f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DGribble%26aufirst%3DM.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DGonzalez-Lopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DMihalic%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520MDM2-p53%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1454%26epage%3D1472%26doi%3D10.1021%2Fjm401753e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Holzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valat-Stachyra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouisset-Leonard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissot-Soldermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruetz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessier, F.</span><span> </span><span class="NLM_article-title">Discovery of a dihydroisoquinolinone derivative (NVP-CGM097): a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6348</span><span class="NLM_x">–</span> <span class="NLM_lpage">6358</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00810</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00810" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyrurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6348-6358&author=P.+Holzerauthor=K.+Masuyaauthor=P.+Furetauthor=J.+Kallenauthor=T.+Valat-Stachyraauthor=S.+Ferrettiauthor=J.+Berghausenauthor=M.+Bouisset-Leonardauthor=N.+Buschmannauthor=C.+Pissot-Soldermannauthor=C.+Rynnauthor=S.+Ruetzauthor=S.+Stutzauthor=P.+Cheneauthor=S.+Jeayauthor=F.+Gessier&title=Discovery+of+a+dihydroisoquinolinone+derivative+%28NVP-CGM097%29%3A+a+highly+potent+and+selective+MDM2+inhibitor+undergoing+phase+1+clinical+trials+in+p53wt+tumors&doi=10.1021%2Facs.jmedchem.5b00810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors</span></div><div class="casAuthors">Holzer, Philipp; Masuya, Keiichi; Furet, Pascal; Kallen, Joerg; Valat-Stachyra, Therese; Ferretti, Stephane; Berghausen, Joerg; Bouisset-Leonard, Michele; Buschmann, Nicole; Pissot-Soldermann, Carole; Rynn, Caroline; Ruetz, Stephan; Stutz, Stefan; Chene, Patrick; Jeay, Sebastien; Gessier, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6348-6358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a result of our efforts to discover novel p53:MDM2 protein-protein interaction inhibitors useful for treating cancer, the potent and selective MDM2 inhibitor NVP-CGM097 (I) with an excellent in vivo profile was selected as a clin. candidate and is currently in phase 1 clin. development.  This article provides an overview of the discovery of this new clin. p53:MDM2 inhibitor.  The following aspects are addressed: mechanism of action, scientific rationale, binding mode, medicinal chem., pharmacokinetic and pharmacodynamic properties, and in vivo pharmacol./toxicol. in preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5qgUnQrBbkLVg90H21EOLACvtfcHk0lijxZcOiIv27g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyrurvI&md5=bf887aa5428654a86fd89a482a07e226</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00810%26sid%3Dliteratum%253Aachs%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DValat-Stachyra%26aufirst%3DT.%26aulast%3DFerretti%26aufirst%3DS.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DBouisset-Leonard%26aufirst%3DM.%26aulast%3DBuschmann%26aufirst%3DN.%26aulast%3DPissot-Soldermann%26aufirst%3DC.%26aulast%3DRynn%26aufirst%3DC.%26aulast%3DRuetz%26aufirst%3DS.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DGessier%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520a%2520dihydroisoquinolinone%2520derivative%2520%2528NVP-CGM097%2529%253A%2520a%2520highly%2520potent%2520and%2520selective%2520MDM2%2520inhibitor%2520undergoing%2520phase%25201%2520clinical%2520trials%2520in%2520p53wt%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6348%26epage%3D6358%26doi%3D10.1021%2Facs.jmedchem.5b00810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10486</span><span class="NLM_x">–</span> <span class="NLM_lpage">10498</span><span class="refDoi"> DOI: 10.1021/jm501541j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501541j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10486-10498&author=A.+Aguilarauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=D.+Bernardauthor=J.+R.+Deschampsauthor=S.+Wang&title=Design+of+chemically+stable%2C+potent%2C+and+efficacious+MDM2+inhibitors+that+exploit+the+retro-mannich+ring-opening-cyclization+reaction+mechanism+in+spiro-oxindoles&doi=10.1021%2Fjm501541j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles</span></div><div class="casAuthors">Aguilar, Angelo; Sun, Wei; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Bernard, Denzil; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10486-10498</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spiropyrrolidineoxindoles such as I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were prepd. as inhibitors of the interaction between the proteins MDM2 and p53 for use as antitumor agents; the second-generation inhibitors incorporate sym. disubstitution in the pyrrolidine ring next to the spiro junction in order to facilitate isomerization via retro-Mannich/Mannich reactions to the more active stereoisomers (in which the aryl rings attached to the pyrrolidine are trans) as well as to improve stability in vitro and in vivo.  In particular, I (R = 4-HO2CC6H4) (MI-1061), which bound to MDM2 with a Ki value of 0.16 nM, showed excellent chem. stability and caused regression of human SJSA-1 xenograft tumors in mice.  The structures of diphenylhydroxyethyl spiropyrrolidineoxindole and spiropyrrolidineoxindolecarboxylate intermediates in the prepn. of I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_es94k2y2-rVg90H21EOLACvtfcHk0liFaFHryrKNpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O&md5=6399fb5e19fc8d69e40e6fd19721e270</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501541j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501541j%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520chemically%2520stable%252C%2520potent%252C%2520and%2520efficacious%2520MDM2%2520inhibitors%2520that%2520exploit%2520the%2520retro-mannich%2520ring-opening-cyclization%2520reaction%2520mechanism%2520in%2520spiro-oxindoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10486%26epage%3D10498%26doi%3D10.1021%2Fjm501541j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carry, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7234</span><span class="refDoi"> DOI: 10.1021/ja3125417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3125417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=7223-7234&author=Y.+Zhaoauthor=L.+Liuauthor=W.+Sunauthor=J.+Luauthor=D.+McEachernauthor=X.+Liauthor=S.+Yuauthor=D.+Bernardauthor=P.+Ochsenbeinauthor=V.+Fereyauthor=J.+C.+Carryauthor=J.+R.+Deschampsauthor=D.+Sunauthor=S.+Wang&title=Diastereomeric+spirooxindoles+as+highly+potent+and+efficacious+MDM2+inhibitors&doi=10.1021%2Fja3125417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors</span></div><div class="casAuthors">Zhao, Yujun; Liu, Liu; Sun, Wei; Lu, Jianfeng; McEachern, Donna; Li, Xiaoqin; Yu, Shanghai; Bernard, Denzil; Ochsenbein, Philippe; Ferey, Vincent; Carry, Jean-Christophe; Deschamps, Jeffrey R.; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7223-7234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the MDM2-p53 protein-protein interaction (MDM2 inhibitors) are being intensely pursued as a new therapeutic strategy for cancer treatment.  We previously published a series of spirooxindole-contg. compds. as a new class of MDM2 small-mol. inhibitors.  We report herein a reversible ring-opening-cyclization reaction for some of these spirooxindoles, which affords four diastereomers from a single compd.  Our biochem. binding data showed that the stereochem. in this class of compds. has a major effect on their binding affinities to MDM2, with >100-fold difference between the most potent and the least potent stereoisomers.  Our study has led to the identification of a set of highly potent MDM2 inhibitors with a stereochem. that is different from that of our previously reported compds.  The most potent compd. (MI-888) binds to MDM2 with a Ki value of 0.44 nM and achieves complete and long-lasting tumor regression in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEWm0CbFl2rVg90H21EOLACvtfcHk0liFaFHryrKNpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D&md5=5c05b0adc0d14506602d0884b64411b0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja3125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3125417%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DOchsenbein%26aufirst%3DP.%26aulast%3DFerey%26aufirst%3DV.%26aulast%3DCarry%26aufirst%3DJ.%2BC.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiastereomeric%2520spirooxindoles%2520as%2520highly%2520potent%2520and%2520efficacious%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D7223%26epage%3D7234%26doi%3D10.1021%2Fja3125417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active p53-MDM2 inhibitors RO5353 and RO2468 for potential clinical development</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1021/ml400359z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400359z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=124-127&author=Z.+Zhangauthor=X.+J.+Chuauthor=J.+J.+Liuauthor=Q.+Dingauthor=J.+Zhangauthor=D.+Bartkovitzauthor=N.+Jiangauthor=P.+Karnachiauthor=S.+S.+Soauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+potent+and+orally+active+p53-MDM2+inhibitors+RO5353+and+RO2468+for+potential+clinical+development&doi=10.1021%2Fml400359z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development</span></div><div class="casAuthors">Zhang, Zhuming; Chu, Xin-Jie; Liu, Jin-Jun; Ding, Qingjie; Zhang, Jing; Bartkovitz, David; Jiang, Nan; Karnachi, Prabha; So, Sung-Sau; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small-mol. MDM2 inhibitors to restore dysfunctional p53 activities represents a novel approach for cancer treatment.  In a previous communication, the efforts leading to the identification of a non-imidazoline MDM2 inhibitor, RG7388, were disclosed and revealed the desirable in vitro and in vivo pharmacol. properties that this class of pyrrolidine-based inhibitors possesses.  Given this richness and the crit. need for a wide variety of chem. structures to ensure success in the clinic, research was expanded to evaluate addnl. derivs.  Here we report two new potent, selective, and orally active p53-MDM2 antagonists, RO5353 and RO2468 (I and II, resp.), as follow-ups with promising potential for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhz706p6MGerVg90H21EOLACvtfcHk0liuocPhq2QMsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVal&md5=30b9dff342ff18ce8dafe7f564d4a771</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml400359z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400359z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520p53-MDM2%2520inhibitors%2520RO5353%2520and%2520RO2468%2520for%2520potential%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D124%26epage%3D127%26doi%3D10.1021%2Fml400359z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active gamma-secretase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3414</span><span class="NLM_x">–</span> <span class="NLM_lpage">3424</span><span class="refDoi"> DOI: 10.1021/jm300094u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300094u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3414-3424&author=A.+F.+Stepanauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=J.+K.+Dutraauthor=T.+J.+O%E2%80%99Sullivanauthor=K.+J.+DiRicoauthor=W.+S.+McDonaldauthor=A.+Wonauthor=P.+H.+Dorffauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=D.+R.+Riddellauthor=G.+W.+Kauffmanauthor=B.+L.+Kormosauthor=L.+Zhangauthor=Y.+Luauthor=S.+H.+Capettaauthor=M.+E.+Greenauthor=K.+Karkiauthor=E.+Sibleyauthor=K.+P.+Atchisonauthor=A.+J.+Hallgrenauthor=C.+E.+Oborskiauthor=A.+E.+Robshawauthor=B.+Sneedauthor=C.+J.+O%E2%80%99Donnell&title=Application+of+the+bicyclo%5B1.1.1%5Dpentane+motif+as+a+nonclassical+phenyl+ring+bioisostere+in+the+design+of+a+potent+and+orally+active+gamma-secretase+inhibitor&doi=10.1021%2Fjm300094u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300094u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300094u%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCapetta%26aufirst%3DS.%2BH.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DAtchison%26aufirst%3DK.%2BP.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DApplication%2520of%2520the%2520bicyclo%255B1.1.1%255Dpentane%2520motif%2520as%2520a%2520nonclassical%2520phenyl%2520ring%2520bioisostere%2520in%2520the%2520design%2520of%2520a%2520potent%2520and%2520orally%2520active%2520gamma-secretase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3414%26epage%3D3424%26doi%3D10.1021%2Fjm300094u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span><span> </span><span class="NLM_article-title">Plasma Protein Binding</span>. In  <span class="citation_source-book">Drug-like Properties: Concepts, Structure Design and Methods</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Chapter 14, pp  <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FB978-012369520-8.50015-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=187-196&author=E.+H.+Kerns&author=L.+Di&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FB978-012369520-8.50015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369520-8.50015-2%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DPlasma%2520Protein%2520Binding%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2008%26spage%3D187%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0liuocPhq2QMsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Smart, B. E.</span><span> </span><span class="NLM_article-title">Fluorine substituent effects (on bioactivity)</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/S0022-1139(01)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0022-1139%2801%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=3-11&author=B.+E.+Smart&title=Fluorine+substituent+effects+%28on+bioactivity%29&doi=10.1016%2FS0022-1139%2801%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine substituent effects (on bioactivity)</span></div><div class="casAuthors">Smart, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review, with 32 refs.,.  The characteristic effects of F and fluoroalkyl substituents on the physicochem. properties of mols. that are important to biol. activity of fluorinated compds. are highlighted.  The influence of fluorination on acidity, H-bonding, and lipophilicity that affect compd. absorption and distribution is described.  The current perspectives on F steric interactions and the controversial role of H-bonding involving the C-F bond are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6E1WbRFxuJ7Vg90H21EOLACvtfcHk0ljREs08N3Ii_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D&md5=bd8cda675e305cd19c4a4eb8db59e107</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2801%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252801%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DB.%2BE.%26atitle%3DFluorine%2520substituent%2520effects%2520%2528on%2520bioactivity%2529%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2001%26volume%3D109%26spage%3D3%26epage%3D11%26doi%3D10.1016%2FS0022-1139%2801%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Huchet, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">On the polarity of partially fluorinated methyl groups</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.jfluchem.2013.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2Fj.jfluchem.2013.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=119-128&author=Q.+A.+Huchetauthor=B.+Kuhnauthor=B.+Wagnerauthor=H.+Fischerauthor=M.+Kansyauthor=D.+Zimmerliauthor=E.+M.+Carreiraauthor=K.+Muller&title=On+the+polarity+of+partially+fluorinated+methyl+groups&doi=10.1016%2Fj.jfluchem.2013.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">On the polarity of partially fluorinated methyl groups</span></div><div class="casAuthors">Huchet, Quentin A.; Kuhn, Bernd; Wagner, Bjorn; Fischer, Holger; Kansy, Manfred; Zimmerli, Daniel; Carreira, Erick M.; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Indole and 5-methoxyindole derivs., substituted at C3 with Pr or 4-methylcyclohexyl scaffolds bearing varying degrees of fluorination of the terminal Me group, were prepd. and studied.  These compds. exhibit characteristic polarity patterns, measured either by log P or chromatog. capacity factors, which are consistent with the partially known lipophilicity pattern for the corresponding n-propylbenzene series.  Based on a simple CF bond vector anal., the polarity increase upon exchange of a terminal Me by a trifluoromethyl group in an aliph. substituent should be comparable to that arising from a single H/F exchange at the terminal Me group, while the vol. increase in the former case is three times larger than that in the latter.  This may explain the observation that replacement of a Me by a fluoromethyl group results in a more pronounced lowering of mol. lipophilicity than its replacement by a trifluoromethyl group.  The same anal. predicts a difluoromethyl group to exhibit a lipophilicity redn. similar to that of a fluoromethyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYIHkZh7XzVrVg90H21EOLACvtfcHk0ljREs08N3Ii_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFegs7c%253D&md5=83c0ebac3835db0f547d8235ffebcd14</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2013.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2013.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DHuchet%26aufirst%3DQ.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOn%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520methyl%2520groups%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2013%26volume%3D152%26spage%3D119%26epage%3D128%26doi%3D10.1016%2Fj.jfluchem.2013.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Moody, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span> </span><span class="NLM_article-title">Total synthesis of (+)-nostocyclamide</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1039/a704094f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1039%2Fa704094f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=601-607&author=C.+J.+Moodyauthor=M.+C.+Bagley&title=Total+synthesis+of+%28%2B%29-nostocyclamide&doi=10.1039%2Fa704094f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fa704094f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa704094f%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%252B%2529-nostocyclamide%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1998%26spage%3D601%26epage%3D607%26doi%3D10.1039%2Fa704094f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Phillips, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. R.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span><span class="refDoi"> DOI: 10.1021/ol005777b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol005777b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFKntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=1165-1168&author=A.+J.+Phillipsauthor=Y.+Utoauthor=P.+Wipfauthor=M.+J.+Renoauthor=D.+R.+Williams&title=Synthesis+of+functionalized+oxazolines+and+oxazoles+with+DAST+and+Deoxo-Fluor&doi=10.1021%2Fol005777b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor</span></div><div class="casAuthors">Phillips, Andrew J.; Uto, Yoshikazu; Wipf, Peter; Reno, Michael J.; Williams, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1168</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild and highly efficient cyclization of β-hydroxy amides, e.g., I, to oxazolines, e.g., II, is described using DAST and Deoxo-Fluor [(MeOCH2CH2)2NSF3] reagents.  E.g., Diethylaminosulfur trifluoride is added to a soln. of I in CH2Cl2 at -78° and stirred for 1 h; addn. of potassium carbonate to the soln. and warming to room temp. gives II in 86% yield.  DAST gives slightly higher yields for the cyclization of serine-contg. substrates while (MeOCH2CH2)2NSF3 gives higher yields with threonine-derived β-hydroxy amides.  A one-pot protocol for the synthesis of oxazoles from β-hydroxy amides is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX6dr0Wb8zCrVg90H21EOLACvtfcHk0ljgEyGYhqF4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFKntLk%253D&md5=f3431b30d0f3bd7f9a7591ae35a88edc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol005777b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol005777b%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DUto%26aufirst%3DY.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DReno%26aufirst%3DM.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26atitle%3DSynthesis%2520of%2520functionalized%2520oxazolines%2520and%2520oxazoles%2520with%2520DAST%2520and%2520Deoxo-Fluor%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D1165%26epage%3D1168%26doi%3D10.1021%2Fol005777b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Borg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estennebouhtou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csoregh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselink, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span> </span><span class="NLM_article-title">Synthesis of 1,2,4-oxadiazole-derived, 1,3,4-oxadiazole-derived, and 1,2,4-triazole-derived dipeptidomimetics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3112</span><span class="NLM_x">–</span> <span class="NLM_lpage">3120</span><span class="refDoi"> DOI: 10.1021/jo00115a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00115a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=3112-3120&author=S.+Borgauthor=G.+Estennebouhtouauthor=K.+Luthmanauthor=I.+Csoreghauthor=W.+Hesselinkauthor=U.+Hacksell&title=Synthesis+of+1%2C2%2C4-oxadiazole-derived%2C+1%2C3%2C4-oxadiazole-derived%2C+and+1%2C2%2C4-triazole-derived+dipeptidomimetics&doi=10.1021%2Fjo00115a029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00115a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00115a029%26sid%3Dliteratum%253Aachs%26aulast%3DBorg%26aufirst%3DS.%26aulast%3DEstennebouhtou%26aufirst%3DG.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DCsoregh%26aufirst%3DI.%26aulast%3DHesselink%26aufirst%3DW.%26aulast%3DHacksell%26aufirst%3DU.%26atitle%3DSynthesis%2520of%25201%252C2%252C4-oxadiazole-derived%252C%25201%252C3%252C4-oxadiazole-derived%252C%2520and%25201%252C2%252C4-triazole-derived%2520dipeptidomimetics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3112%26epage%3D3120%26doi%3D10.1021%2Fjo00115a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span> </span><span class="NLM_article-title">Total synthesis of (−)-muscoride A</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6522</span><span class="refDoi"> DOI: 10.1021/jo960891m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960891m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=6517-6522&author=P.+Wipfauthor=S.+Venkatraman&title=Total+synthesis+of+%28%E2%88%92%29-muscoride+A&doi=10.1021%2Fjo960891m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo960891m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960891m%26sid%3Dliteratum%253Aachs%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DVenkatraman%26aufirst%3DS.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-muscoride%2520A%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D6517%26epage%3D6522%26doi%3D10.1021%2Fjo960891m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljgEyGYhqF4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lj3ibVpEsSVPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Eldridge, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, R. P.</span><span> </span><span class="NLM_article-title">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1023/A:1007996124545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1023%2FA%3A1007996124545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=9385547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=425-445&author=M.+D.+Eldridgeauthor=C.+W.+Murrayauthor=T.+R.+Autonauthor=G.+V.+Paoliniauthor=R.+P.+Mee&title=Empirical+scoring+functions%3A+I.+The+development+of+a+fast+empirical+scoring+function+to+estimate+the+binding+affinity+of+ligands+in+receptor+complexes&doi=10.1023%2FA%3A1007996124545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span></div><div class="casAuthors">Eldridge, Matthew D.; Murray, Christopher W.; Auton, Timothy R.; Paolini, Gaia V.; Mee, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-445</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">This paper describes the development of a simple empirical scoring function designed to est. the free energy of binding for a protein-ligand complex when the 3D structure of the complex is known or can be approximated.  The function uses simple contact terms to est. lipophilic and metal-ligand binding contributions, a simple explicit form for hydrogen bonds and a term which penalizes flexibility.  The coeffs. of each term are obtained using a regression based on 82 ligand-receptor complexes for which the binding affinity is known.  The function reproduces the binding affinity of the complexes with a cross-validated error of 8.68 kJ/mol.  Tests on internal consistency indicate that the coeffs. obtained are stable to changes in the compn. of the training set.  The function is also tested on two test sets contg. a further 20 and 10 complexes, resp.  The deficiencies of this type of function are discussed and it is compared to approaches by other workers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJZ-k95NG1LVg90H21EOLACvtfcHk0lj3ibVpEsSVPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D&md5=ece4b881e181f3d5c1287af55efaf6b4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007996124545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007996124545%26sid%3Dliteratum%253Aachs%26aulast%3DEldridge%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DAuton%26aufirst%3DT.%2BR.%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DMee%26aufirst%3DR.%2BP.%26atitle%3DEmpirical%2520scoring%2520functions%253A%2520I.%2520The%2520development%2520of%2520a%2520fast%2520empirical%2520scoring%2520function%2520to%2520estimate%2520the%2520binding%2520affinity%2520of%2520ligands%2520in%2520receptor%2520complexes%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D425%26epage%3D445%26doi%3D10.1023%2FA%3A1007996124545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 75 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gianni Chessari, Ian R. Hardcastle, Jong Sook Ahn, Burcu Anil, Elizabeth Anscombe, Ruth H. Bawn, Luke D. Bevan, Timothy J. Blackburn, Ildiko Buck, Celine Cano, Benoit Carbain, Juan Castro, Ben Cons, Sarah J. Cully, Jane A. Endicott, Lynsey Fazal, Bernard T. Golding, Roger J. Griffin, Karen Haggerty, Suzannah J. Harnor, Keisha Hearn, Stephen Hobson, Rhian S. Holvey, Steven Howard, Claire E. Jennings, Christopher N. Johnson, John Lunec, Duncan C. Miller, David R. Newell, Martin E. M. Noble, Judith Reeks, Charlotte H. Revill, Christiane Riedinger, Jeffrey D. St. Denis, Emiliano Tamanini, Huw Thomas, Neil T. Thompson, Mladen Vinković, Stephen R. Wedge, Pamela A. Williams, Nicola E. Wilsher, Bian Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Yan Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 4071-4088. <a href="https://doi.org/10.1021/acs.jmedchem.0c02188" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02188%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252Band%252BOrally%252BActive%252BIsoindolinone%252BInhibitors%252Bof%252BMDM2-p53%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DChessari%26aufirst%3DGianni%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D18122020%26date%3D24032021%26volume%3D64%26issue%3D7%26spage%3D4071%26epage%3D4088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Taylor M. Sodano, Logan A. Combee, <span class="NLM_string-name hlFld-ContribAuthor">Corey R. J. Stephenson</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances and Outlook for the Isosteric Replacement of Anilines. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1785-1788. <a href="https://doi.org/10.1021/acsmedchemlett.9b00687" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00687%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252BAdvances%252Band%252BOutlook%252Bfor%252Bthe%252BIsosteric%252BReplacement%252Bof%252BAnilines%26aulast%3DSodano%26aufirst%3DTaylor%2BM.%26date%3D2020%26date%3D2020%26date%3D21022020%26volume%3D11%26issue%3D10%26spage%3D1785%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicole Blaquiere, Elisia Villemure, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7957-7985. <a href="https://doi.org/10.1021/acs.jmedchem.9b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BInhibiting%252BRING-Type%252BE3%252BUbiquitin%252BLigases%26aulast%3DBlaquiere%26aufirst%3DNicole%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31082019%26date%3D02042020%26date%3D06032020%26volume%3D63%26issue%3D15%26spage%3D7957%26epage%3D7985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Songjie Yu, Changcheng Jing, Adam Noble, <span class="NLM_string-name hlFld-ContribAuthor">Varinder K. Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed Enantioselective Synthesis of α-Chiral Bicyclo[1.1.1]pentanes by 1,3-Difunctionalization of [1.1.1]Propellane. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (14)
                                     , 5650-5655. <a href="https://doi.org/10.1021/acs.orglett.0c02017" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02017%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIridium-Catalyzed%252BEnantioselective%252BSynthesis%252Bof%252B%2525CE%2525B1-Chiral%252BBicyclo%25255B1.1.1%25255Dpentanes%252Bby%252B1%25252C3-Difunctionalization%252Bof%252B%25255B1.1.1%25255DPropellane%26aulast%3DYu%26aufirst%3DSongjie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D08072020%26volume%3D22%26issue%3D14%26spage%3D5650%26epage%3D5655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Farrukh Sajjad, Alavala Gopi Krishna Reddy, Jiuwei Che, Wenhao Hu, <span class="NLM_string-name hlFld-ContribAuthor">Dong Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Diastereoselective Synthesis of Fully Substituted Pyrrolidines from Anilines and Diazo Pyruvates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (8)
                                     , 3094-3098. <a href="https://doi.org/10.1021/acs.orglett.0c00846" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00846%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252BDiastereoselective%252BSynthesis%252Bof%252BFully%252BSubstituted%252BPyrrolidines%252Bfrom%252BAnilines%252Band%252BDiazo%252BPyruvates%26aulast%3DSajjad%26aufirst%3DFarrukh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06032020%26date%3D01042020%26volume%3D22%26issue%3D8%26spage%3D3094%26epage%3D3098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rohan R. Merchant, <span class="NLM_string-name hlFld-ContribAuthor">Jovan A. Lopez</span>. </span><span class="cited-content_cbyCitation_article-title">A General C(sp3)–C(sp3) Cross-Coupling of Benzyl Sulfonylhydrazones with Alkyl Boronic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (6)
                                     , 2271-2275. <a href="https://doi.org/10.1021/acs.orglett.0c00471" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BGeneral%252BC%252528sp3%252529%2525E2%252580%252593C%252528sp3%252529%252BCross-Coupling%252Bof%252BBenzyl%252BSulfonylhydrazones%252Bwith%252BAlkyl%252BBoronic%252BAcids%26aulast%3DMerchant%26aufirst%3DRohan%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06022020%26date%3D02032020%26volume%3D22%26issue%3D6%26spage%3D2271%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ying Huang, Hui-Lin Fang, Yi-Xin Huang, Jing Sun, <span class="NLM_string-name hlFld-ContribAuthor">Chao-Guo Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 7′-Arylidenespiro[indoline-3,1′-pyrrolizines] and 7′-Arylidenespiro[indene-2,1′-pyrrolizines] via [3 + 2] Cycloaddition and β-C–H Functionalized Pyrrolidine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (19)
                                     , 12437-12451. <a href="https://doi.org/10.1021/acs.joc.9b01920" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01920</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01920%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B7%2525E2%252580%2525B2-Arylidenespiro%25255Bindoline-3%25252C1%2525E2%252580%2525B2-pyrrolizines%25255D%252Band%252B7%2525E2%252580%2525B2-Arylidenespiro%25255Bindene-2%25252C1%2525E2%252580%2525B2-pyrrolizines%25255D%252Bvia%252B%25255B3%252B%25252B%252B2%25255D%252BCycloaddition%252Band%252B%2525CE%2525B2-C%2525E2%252580%252593H%252BFunctionalized%252BPyrrolidine%26aulast%3DHuang%26aufirst%3DYing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15072019%26date%3D19092019%26date%3D09092019%26volume%3D84%26issue%3D19%26spage%3D12437%26epage%3D12451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yangbing Li, Jiuling Yang, Angelo Aguilar, Donna McEachern, Sally Przybranowski, Liu Liu, Chao-Yie Yang, Mi Wang, Xin Han, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 448-466. <a href="https://doi.org/10.1021/acs.jmedchem.8b00909" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00909%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BMD-224%252Bas%252Ba%252BFirst-in-Class%25252C%252BHighly%252BPotent%25252C%252Band%252BEfficacious%252BProteolysis%252BTargeting%252BChimera%252BMurine%252BDouble%252BMinute%252B2%252BDegrader%252BCapable%252Bof%252BAchieving%252BComplete%252Band%252BDurable%252BTumor%252BRegression%26aulast%3DLi%26aufirst%3DYangbing%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D07062018%26date%3D10122018%26volume%3D62%26issue%3D2%26spage%3D448%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maxime Gicquel, Catherine Gomez, Maria Concepcion Garcia Alvarez, Olivier Pamlard, Vincent Guérineau, Eric Jacquet, Jérôme Bignon, Arnaud Voituriez, <span class="NLM_string-name hlFld-ContribAuthor">Angela Marinetti</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of p53-Murine Double Minute 2 (MDM2) Interactions with 3,3′-Spirocyclopentene Oxindole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9386-9392. <a href="https://doi.org/10.1021/acs.jmedchem.8b01137" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01137%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bp53-Murine%252BDouble%252BMinute%252B2%252B%252528MDM2%252529%252BInteractions%252Bwith%252B3%25252C3%2525E2%252580%2525B2-Spirocyclopentene%252BOxindole%252BDerivatives%26aulast%3DGicquel%26aufirst%3DMaxime%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19072018%26date%3D08102018%26date%3D17092018%26volume%3D61%26issue%3D20%26spage%3D9386%26epage%3D9392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qiaomei Jin, Jian Zhang, Cuihua Jiang, Dongjian Zhang, Meng Gao, <span class="NLM_string-name hlFld-ContribAuthor">Shihe Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Self [3 + 4] Cycloadditions of Isatin N,N′-Cyclic Azomethine Imine 1,3-Dipole with N-(o-Chloromethyl)aryl Amides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (15)
                                     , 8410-8416. <a href="https://doi.org/10.1021/acs.joc.8b01055" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01055%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSelf%252B%25255B3%252B%25252B%252B4%25255D%252BCycloadditions%252Bof%252BIsatin%252BN%25252CN%2525E2%252580%2525B2-Cyclic%252BAzomethine%252BImine%252B1%25252C3-Dipole%252Bwith%252BN-%252528o-Chloromethyl%252529aryl%252BAmides%26aulast%3DJin%26aufirst%3DQiaomei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D11062018%26date%3D30052018%26volume%3D83%26issue%3D15%26spage%3D8410%26epage%3D8416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Cheng  Yang</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Xiang-Hong  He</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Lei  Cui</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, and <span class="hlFld-ContribAuthor ">Bo  Han</span>  . </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Asymmetric Synthesis of Spiro-oxindole Piperidine Derivatives That Reduce Cancer Cell Proliferation by Inhibiting MDM2–p53 Interaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (24)
                                     , 6752-6755. <a href="https://doi.org/10.1021/acs.orglett.7b03516" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03516%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOrganocatalytic%252BAsymmetric%252BSynthesis%252Bof%252BSpiro-oxindole%252BPiperidine%252BDerivatives%252BThat%252BReduce%252BCancer%252BCell%252BProliferation%252Bby%252BInhibiting%252BMDM2%2525E2%252580%252593p53%252BInteraction%26aulast%3DYang%26aufirst%3DMing-Cheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13112017%26date%3D06122017%26date%3D15122017%26volume%3D19%26issue%3D24%26spage%3D6752%26epage%3D6755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianting  Zhou</span>, <span class="hlFld-ContribAuthor ">Xia  Song</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-spirooxindole 3
              H
              -indoles through Rh(
              iii
              )-catalyzed [4 + 1] redox-neutral spirocyclization of
              N
              -aryl amidines with diazo oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (15)
                                     , 4131-4137. <a href="https://doi.org/10.1039/D1QO00551K" title="DOI URL">https://doi.org/10.1039/D1QO00551K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00551K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00551K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Bof%252B3-spirooxindole%252B3%252BH%252B-indoles%252Bthrough%252BRh%252528%252Biii%252B%252529-catalyzed%252B%25255B4%252B%25252B%252B1%25255D%252Bredox-neutral%252Bspirocyclization%252Bof%252BN%252B-aryl%252Bamidines%252Bwith%252Bdiazo%252Boxindoles%26aulast%3DZhou%26aufirst%3DQianting%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D15%26spage%3D4131%26epage%3D4137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yayue  Dai</span>, <span class="hlFld-ContribAuthor ">Jianhao  Di</span>, <span class="hlFld-ContribAuthor ">Zeyang  Hao</span>, <span class="hlFld-ContribAuthor ">Xiangtai  Meng</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Spiro[benzo[
              b
              ]thiophene‐2(3
              H
              ),1′‐cyclopropan]‐3‐ones via Domino Reaction Between Thioaurones and Sulfur Ylides. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1449-1453. <a href="https://doi.org/10.1002/ajoc.202100117" title="DOI URL">https://doi.org/10.1002/ajoc.202100117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100117%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BSpiro%25255Bbenzo%25255B%252Bb%252B%25255Dthiophene%2525E2%252580%2525902%2525283%252BH%252B%252529%25252C1%2525E2%252580%2525B2%2525E2%252580%252590cyclopropan%25255D%2525E2%252580%2525903%2525E2%252580%252590ones%252Bvia%252BDomino%252BReaction%252BBetween%252BThioaurones%252Band%252BSulfur%252BYlides%26aulast%3DDai%26aufirst%3DYayue%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1449%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel  LaPlante</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (12)
                                     , 3079. <a href="https://doi.org/10.3390/cancers13123079" title="DOI URL">https://doi.org/10.3390/cancers13123079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13123079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13123079%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252Bthe%252BUbiquitin-Proteasome%252BSystem%252Bfor%252BCancer%252BTherapeutics%252Bby%252BSmall-Molecule%252BInhibitors%26aulast%3DLaPlante%26aufirst%3DGabriel%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D12%26spage%3D3079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana  Moreira</span>, <span class="hlFld-ContribAuthor ">Joana  Almeida</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Honorina  Cidade</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (12)
                                     , 3737. <a href="https://doi.org/10.3390/molecules26123737" title="DOI URL">https://doi.org/10.3390/molecules26123737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26123737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26123737%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DChalcones%252Bas%252BPromising%252BAntitumor%252BAgents%252Bby%252BTargeting%252Bthe%252Bp53%252BPathway%25253A%252BAn%252BOverview%252Band%252BNew%252BInsights%252Bin%252BDrug-Likeness%26aulast%3DMoreira%26aufirst%3DJoana%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D12%26spage%3D3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Ratni</span>, <span class="hlFld-ContribAuthor ">K.  Baumann</span>, <span class="hlFld-ContribAuthor ">P.  Bellotti</span>, <span class="hlFld-ContribAuthor ">X. A.  Cook</span>, <span class="hlFld-ContribAuthor ">L. G.  Green</span>, <span class="hlFld-ContribAuthor ">T.  Luebbers</span>, <span class="hlFld-ContribAuthor ">M.  Reutlinger</span>, <span class="hlFld-ContribAuthor ">A. F.  Stepan</span>, <span class="hlFld-ContribAuthor ">W.  Vifian</span>. </span><span class="cited-content_cbyCitation_article-title">Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 758-766. <a href="https://doi.org/10.1039/D1MD00043H" title="DOI URL">https://doi.org/10.1039/D1MD00043H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00043H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00043H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPhenyl%252Bbioisosteres%252Bin%252Bmedicinal%252Bchemistry%25253A%252Bdiscovery%252Bof%252Bnovel%252B%2525CE%2525B3-secretase%252Bmodulators%252Bas%252Ba%252Bpotential%252Btreatment%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DRatni%26aufirst%3DH.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D758%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liu-Na  Pan</span>, <span class="hlFld-ContribAuthor ">Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Quan-Shun  Sun</span>, <span class="hlFld-ContribAuthor ">Chao-Guo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular diversity of the acid promoted domino reaction of 3-hydroxy-3-(indol-3-yl)indolin-2-ones and cyclic mercapto-substituted β-enamino esters. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (18)
                                     , 8314-8320. <a href="https://doi.org/10.1039/D1NJ00947H" title="DOI URL">https://doi.org/10.1039/D1NJ00947H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ00947H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ00947H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DMolecular%252Bdiversity%252Bof%252Bthe%252Bacid%252Bpromoted%252Bdomino%252Breaction%252Bof%252B3-hydroxy-3-%252528indol-3-yl%252529indolin-2-ones%252Band%252Bcyclic%252Bmercapto-substituted%252B%2525CE%2525B2-enamino%252Besters%26aulast%3DPan%26aufirst%3DLiu-Na%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D18%26spage%3D8314%26epage%3D8320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai-Jiang  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Qing  Mao</span>, <span class="hlFld-ContribAuthor ">Fengbo  Wu</span>, <span class="hlFld-ContribAuthor ">Feng-Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan-Sheng  Feng</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113359. <a href="https://doi.org/10.1016/j.ejmech.2021.113359" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113359%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnitroisoxazole-containing%252Bspiro%25255Bpyrrolidin-oxindole%25255D%252Bderivatives%252Bas%252Bnovel%252Bglutathione%252Bperoxidase%252B4%25252Fmouse%252Bdouble%252Bminute%252B2%252Bdual%252Binhibitors%252Bthat%252Binhibit%252Bbreast%252Badenocarcinoma%252Bcell%252Bproliferation%26aulast%3DLiu%26aufirst%3DShuai-Jiang%26date%3D2021%26volume%3D217%26spage%3D113359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Zhou</span>, <span class="hlFld-ContribAuthor ">Ilona  Kryczek</span>, <span class="hlFld-ContribAuthor ">Shasha  Li</span>, <span class="hlFld-ContribAuthor ">Xiong  Li</span>, <span class="hlFld-ContribAuthor ">Angelo  Aguilar</span>, <span class="hlFld-ContribAuthor ">Shuang  Wei</span>, <span class="hlFld-ContribAuthor ">Sara  Grove</span>, <span class="hlFld-ContribAuthor ">Linda  Vatan</span>, <span class="hlFld-ContribAuthor ">Jiali  Yu</span>, <span class="hlFld-ContribAuthor ">Yijian  Yan</span>, <span class="hlFld-ContribAuthor ">Peng  Liao</span>, <span class="hlFld-ContribAuthor ">Heng  Lin</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Gaopeng  Li</span>, <span class="hlFld-ContribAuthor ">Wan  Du</span>, <span class="hlFld-ContribAuthor ">Weichao  Wang</span>, <span class="hlFld-ContribAuthor ">Xueting  Lang</span>, <span class="hlFld-ContribAuthor ">Weimin  Wang</span>, <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>, <span class="hlFld-ContribAuthor ">Weiping  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. </span><span class="cited-content_cbyCitation_journal-name">Nature Immunology</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 460-470. <a href="https://doi.org/10.1038/s41590-021-00888-3" title="DOI URL">https://doi.org/10.1038/s41590-021-00888-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41590-021-00888-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41590-021-00888-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Immunology%26atitle%3DThe%252Bubiquitin%252Bligase%252BMDM2%252Bsustains%252BSTAT5%252Bstability%252Bto%252Bcontrol%252BT%252Bcell-mediated%252Bantitumor%252Bimmunity%26aulast%3DZhou%26aufirst%3DJiajia%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D4%26spage%3D460%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander J.  Boddy</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis and applications of spirocyclic oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (5)
                                     , 1026-1084. <a href="https://doi.org/10.1039/D0QO01085E" title="DOI URL">https://doi.org/10.1039/D0QO01085E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01085E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01085E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DStereoselective%252Bsynthesis%252Band%252Bapplications%252Bof%252Bspirocyclic%252Boxindoles%26aulast%3DBoddy%26aufirst%3DAlexander%2BJ.%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D5%26spage%3D1026%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Algar</span>, <span class="hlFld-ContribAuthor ">Mercedes  Martín-Martínez</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113015. <a href="https://doi.org/10.1016/j.ejmech.2020.113015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvolution%252Bin%252Bnon-peptide%252B%2525CE%2525B1-helix%252Bmimetics%252Bon%252Bthe%252Broad%252Bto%252Beffective%252Bprotein-protein%252Binteraction%252Bmodulators%26aulast%3DAlgar%26aufirst%3DSergio%26date%3D2021%26volume%3D211%26spage%3D113015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai-Jiang  Liu</span>, <span class="hlFld-ContribAuthor ">Qing  Mao</span>, <span class="hlFld-ContribAuthor ">Ya-Jun  Zhong</span>, <span class="hlFld-ContribAuthor ">Jing  Xue</span>, <span class="hlFld-ContribAuthor ">Ben-Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly diastereoselective assembly of isoxazole and trifluoromethyl containing spiro[pyrrolidin-oxindoles] from N-2,2,2-trifluoroethyl-substituted isatin imines and styrylisoxazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>62 </em>, 152687. <a href="https://doi.org/10.1016/j.tetlet.2020.152687" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152687%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DHighly%252Bdiastereoselective%252Bassembly%252Bof%252Bisoxazole%252Band%252Btrifluoromethyl%252Bcontaining%252Bspiro%25255Bpyrrolidin-oxindoles%25255D%252Bfrom%252BN-2%25252C2%25252C2-trifluoroethyl-substituted%252Bisatin%252Bimines%252Band%252Bstyrylisoxazoles%26aulast%3DLiu%26aufirst%3DShuai-Jiang%26date%3D2021%26volume%3D62%26spage%3D152687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kerry Silva  McPherson</span>, <span class="hlFld-ContribAuthor ">Dmitry M.  Korzhnev</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2021,</strong> <em>461 </em><a href="https://doi.org/10.1039/D1CB00101A" title="DOI URL">https://doi.org/10.1039/D1CB00101A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CB00101A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CB00101A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DTargeting%252Bprotein%2525E2%252580%252593protein%252Binteractions%252Bin%252Bthe%252BDNA%252Bdamage%252Bresponse%252Bpathways%252Bfor%252Bcancer%252Bchemotherapy%26aulast%3DMcPherson%26aufirst%3DKerry%2BSilva%26date%3D2021%26date%3D2021%26volume%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mai F.  Tolba</span>. </span><span class="cited-content_cbyCitation_article-title">Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2020,</strong> <em>147 </em>
                                    (11)
                                     , 2996-3006. <a href="https://doi.org/10.1002/ijc.33056" title="DOI URL">https://doi.org/10.1002/ijc.33056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.33056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.33056%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DRevolutionizing%252Bthe%252Blandscape%252Bof%252Bcolorectal%252Bcancer%252Btreatment%25253A%252BThe%252Bpotential%252Brole%252Bof%252Bimmune%252Bcheckpoint%252Binhibitors%26aulast%3DTolba%26aufirst%3DMai%2BF.%26date%3D2020%26date%3D2020%26volume%3D147%26issue%3D11%26spage%3D2996%26epage%3D3006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqiao  Han</span>, <span class="hlFld-ContribAuthor ">Ziwei  Ren</span>, <span class="hlFld-ContribAuthor ">Yixin  Wu</span>, <span class="hlFld-ContribAuthor ">Yunzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenmei  Cui</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Mingliang  Ma</span>, <span class="hlFld-ContribAuthor ">Yijie  Du</span>, <span class="hlFld-ContribAuthor ">Suzhen  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological activation of the p53 pathway by a new compound CYZ2017 exerts anti-tumor effects. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2020,</strong> <em>533 </em>
                                    (4)
                                     , 1069-1075. <a href="https://doi.org/10.1016/j.bbrc.2020.09.122" title="DOI URL">https://doi.org/10.1016/j.bbrc.2020.09.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2020.09.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2020.09.122%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DPharmacological%252Bactivation%252Bof%252Bthe%252Bp53%252Bpathway%252Bby%252Ba%252Bnew%252Bcompound%252BCYZ2017%252Bexerts%252Banti-tumor%252Beffects%26aulast%3DHan%26aufirst%3DYuqiao%26date%3D2020%26volume%3D533%26issue%3D4%26spage%3D1069%26epage%3D1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Konopleva</span>, <span class="hlFld-ContribAuthor ">Giovanni  Martinelli</span>, <span class="hlFld-ContribAuthor ">Naval  Daver</span>, <span class="hlFld-ContribAuthor ">Cristina  Papayannidis</span>, <span class="hlFld-ContribAuthor ">Andrew  Wei</span>, <span class="hlFld-ContribAuthor ">Brian  Higgins</span>, <span class="hlFld-ContribAuthor ">Marion  Ott</span>, <span class="hlFld-ContribAuthor ">John  Mascarenhas</span>, <span class="hlFld-ContribAuthor ">Michael  Andreeff</span>. </span><span class="cited-content_cbyCitation_article-title">MDM2 inhibition: an important step forward in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2020,</strong> <em>34 </em>
                                    (11)
                                     , 2858-2874. <a href="https://doi.org/10.1038/s41375-020-0949-z" title="DOI URL">https://doi.org/10.1038/s41375-020-0949-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-020-0949-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-020-0949-z%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DMDM2%252Binhibition%25253A%252Ban%252Bimportant%252Bstep%252Bforward%252Bin%252Bcancer%252Btherapy%26aulast%3DKonopleva%26aufirst%3DMarina%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D11%26spage%3D2858%26epage%3D2874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liu-Na  Pan</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Rong-Guo  Shi</span>, <span class="hlFld-ContribAuthor ">Chao-Guo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective synthesis of dispiro[indoline-3,3′-furan-2′,3′′-pyrrolidine]
              via
              [3 + 2]cycloaddition reaction of MBH maleimides of isatins and 1,3-dicarbonyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (20)
                                     , 3202-3208. <a href="https://doi.org/10.1039/D0QO00845A" title="DOI URL">https://doi.org/10.1039/D0QO00845A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00845A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00845A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DDiastereoselective%252Bsynthesis%252Bof%252Bdispiro%25255Bindoline-3%25252C3%2525E2%252580%2525B2-furan-2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%2525E2%252580%2525B2-pyrrolidine%25255D%252Bvia%252B%25255B3%252B%25252B%252B2%25255Dcycloaddition%252Breaction%252Bof%252BMBH%252Bmaleimides%252Bof%252Bisatins%252Band%252B1%25252C3-dicarbonyl%252Bcompounds%26aulast%3DPan%26aufirst%3DLiu-Na%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D20%26spage%3D3202%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiaomei  Jin</span>, <span class="hlFld-ContribAuthor ">Dongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A [3 + 2] cycloaddition/C-arylation of isatin
              N
              ,
              N
              ′-cyclic azomethine imine 1,3-dipole with arynes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (51)
                                     , 30620-30623. <a href="https://doi.org/10.1039/D0RA06404A" title="DOI URL">https://doi.org/10.1039/D0RA06404A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA06404A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA06404A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252B%25255B3%252B%25252B%252B2%25255D%252Bcycloaddition%25252FC-arylation%252Bof%252Bisatin%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-cyclic%252Bazomethine%252Bimine%252B1%25252C3-dipole%252Bwith%252Barynes%26aulast%3DJin%26aufirst%3DQiaomei%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D51%26spage%3D30620%26epage%3D30623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ave  Kuusk</span>, <span class="hlFld-ContribAuthor ">Helen  Boyd</span>, <span class="hlFld-ContribAuthor ">Hongming  Chen</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule modulation of p53 protein-protein interactions. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2020,</strong> <em>401 </em>
                                    (8)
                                     , 921-931. <a href="https://doi.org/10.1515/hsz-2019-0405" title="DOI URL">https://doi.org/10.1515/hsz-2019-0405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2019-0405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2019-0405%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DSmall-molecule%252Bmodulation%252Bof%252Bp53%252Bprotein-protein%252Binteractions%26aulast%3DKuusk%26aufirst%3DAve%26date%3D2020%26volume%3D401%26issue%3D8%26spage%3D921%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benedito A.  Carneiro</span>, <span class="hlFld-ContribAuthor ">Wafik S.  El-Deiry</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting apoptosis in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Clinical Oncology</span><span> <strong>2020,</strong> <em>17 </em>
                                    (7)
                                     , 395-417. <a href="https://doi.org/10.1038/s41571-020-0341-y" title="DOI URL">https://doi.org/10.1038/s41571-020-0341-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41571-020-0341-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41571-020-0341-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Clinical%2520Oncology%26atitle%3DTargeting%252Bapoptosis%252Bin%252Bcancer%252Btherapy%26aulast%3DCarneiro%26aufirst%3DBenedito%2BA.%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D7%26spage%3D395%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  Di Costanzo</span>, <span class="hlFld-ContribAuthor ">Nunzio  Del Gaudio</span>, <span class="hlFld-ContribAuthor ">Lidio  Conte</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>. </span><span class="cited-content_cbyCitation_article-title">The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1898. <a href="https://doi.org/10.3390/cancers12071898" title="DOI URL">https://doi.org/10.3390/cancers12071898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071898%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BUbiquitin%252BProteasome%252BSystem%252Bin%252BHematological%252BMalignancies%25253A%252BNew%252BInsight%252Binto%252BIts%252BFunctional%252BRole%252Band%252BTherapeutic%252BOptions%26aulast%3DDi%2BCostanzo%26aufirst%3DAntonella%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takumi  Abe</span>, <span class="hlFld-ContribAuthor ">Seiya  Hirao</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid access to indole-fused bicyclo[2.2.2]octanones by merging the umpolung strategy and molecular iodine as a green catalyst. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (22)
                                     , 4193-4197. <a href="https://doi.org/10.1039/D0OB01038C" title="DOI URL">https://doi.org/10.1039/D0OB01038C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01038C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01038C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRapid%252Baccess%252Bto%252Bindole-fused%252Bbicyclo%25255B2.2.2%25255Doctanones%252Bby%252Bmerging%252Bthe%252Bumpolung%252Bstrategy%252Band%252Bmolecular%252Biodine%252Bas%252Ba%252Bgreen%252Bcatalyst%26aulast%3DAbe%26aufirst%3DTakumi%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D22%26spage%3D4193%26epage%3D4197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankur  Vaidya</span>, <span class="hlFld-ContribAuthor ">Shweta  Jain</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Sahu</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Jain</span>, <span class="hlFld-ContribAuthor ">Kamla  Pathak</span>, <span class="hlFld-ContribAuthor ">Devender  Pathak</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Sanjay Kumar  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Agents Based on Vulnerable Components in a Signalling Pathway. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (10)
                                     , 886-907. <a href="https://doi.org/10.2174/1389557520666200212105417" title="DOI URL">https://doi.org/10.2174/1389557520666200212105417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557520666200212105417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557520666200212105417%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252BAgents%252BBased%252Bon%252BVulnerable%252BComponents%252Bin%252Ba%252BSignalling%252BPathway%26aulast%3DVaidya%26aufirst%3DAnkur%26date%3D2020%26volume%3D20%26issue%3D10%26spage%3D886%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Cui</span>, <span class="hlFld-ContribAuthor ">Ke  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Manman  Song</span>, <span class="hlFld-ContribAuthor ">Congcong  Wang</span>, <span class="hlFld-ContribAuthor ">Donghui  Wei</span>, <span class="hlFld-ContribAuthor ">Er-Qing  Li</span>, <span class="hlFld-ContribAuthor ">Zheng  Duan</span>, <span class="hlFld-ContribAuthor ">François  Mathey</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(
              i
              )/Ganphos catalysis: enantioselective synthesis of diverse spirooxindoles using iminoesters and alkyl substituted methyleneindolinones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (19)
                                     , 3740-3746. <a href="https://doi.org/10.1039/D0OB00546K" title="DOI URL">https://doi.org/10.1039/D0OB00546K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00546K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00546K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper%252528%252Bi%252B%252529%25252FGanphos%252Bcatalysis%25253A%252Benantioselective%252Bsynthesis%252Bof%252Bdiverse%252Bspirooxindoles%252Busing%252Biminoesters%252Band%252Balkyl%252Bsubstituted%252Bmethyleneindolinones%26aulast%3DCui%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D19%26spage%3D3740%26epage%3D3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Li</span>, <span class="hlFld-ContribAuthor ">Xinhao  Peng</span>, <span class="hlFld-ContribAuthor ">Jinyi  Lang</span>, <span class="hlFld-ContribAuthor ">Chuan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00631" title="DOI URL">https://doi.org/10.3389/fphar.2020.00631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00631%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DTargeting%252BMouse%252BDouble%252BMinute%252B2%25253A%252BCurrent%252BConcepts%252Bin%252BDNA%252BDamage%252BRepair%252Band%252BTherapeutic%252BApproaches%252Bin%252BCancer%26aulast%3DLi%26aufirst%3DWen%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang‐Jiang  Qin</span>, <span class="hlFld-ContribAuthor ">Mehrdad  Rajaei</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Yu</span>, <span class="hlFld-ContribAuthor ">Courtney  Hunt</span>, <span class="hlFld-ContribAuthor ">Ruiwen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MDM2 for novel molecular therapy: Beyond oncology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (3)
                                     , 856-880. <a href="https://doi.org/10.1002/med.21637" title="DOI URL">https://doi.org/10.1002/med.21637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21637%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252BMDM2%252Bfor%252Bnovel%252Bmolecular%252Btherapy%25253A%252BBeyond%252Boncology%26aulast%3DWang%26aufirst%3DWei%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D3%26spage%3D856%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyun  Jiang</span>, <span class="hlFld-ContribAuthor ">Fubing  Li</span>, <span class="hlFld-ContribAuthor ">Zhuo  Cheng</span>, <span class="hlFld-ContribAuthor ">Yanjie  Kong</span>, <span class="hlFld-ContribAuthor ">Ceshi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The role of E3 ubiquitin ligase HECTD3 in cancer and beyond. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2020,</strong> <em>77 </em>
                                    (8)
                                     , 1483-1495. <a href="https://doi.org/10.1007/s00018-019-03339-3" title="DOI URL">https://doi.org/10.1007/s00018-019-03339-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-019-03339-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-019-03339-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DThe%252Brole%252Bof%252BE3%252Bubiquitin%252Bligase%252BHECTD3%252Bin%252Bcancer%252Band%252Bbeyond%26aulast%3DJiang%26aufirst%3DQiuyun%26date%3D2020%26date%3D2019%26volume%3D77%26issue%3D8%26spage%3D1483%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarra  Boudriga</span>, <span class="hlFld-ContribAuthor ">Saoussen  Haddad</span>, <span class="hlFld-ContribAuthor ">Vikneswaran  Murugaiyah</span>, <span class="hlFld-ContribAuthor ">Moheddine  Askri</span>, <span class="hlFld-ContribAuthor ">Michael  Knorr</span>, <span class="hlFld-ContribAuthor ">Carsten  Strohmann</span>, <span class="hlFld-ContribAuthor ">Christopher  Golz</span>. </span><span class="cited-content_cbyCitation_article-title">Three-Component Access to Functionalized Spiropyrrolidine Heterocyclic Scaffolds and Their Cholinesterase Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (8)
                                     , 1963. <a href="https://doi.org/10.3390/molecules25081963" title="DOI URL">https://doi.org/10.3390/molecules25081963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25081963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25081963%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThree-Component%252BAccess%252Bto%252BFunctionalized%252BSpiropyrrolidine%252BHeterocyclic%252BScaffolds%252Band%252BTheir%252BCholinesterase%252BInhibitory%252BActivity%26aulast%3DBoudriga%26aufirst%3DSarra%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D8%26spage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarida  Espadinha</span>, <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>, <span class="hlFld-ContribAuthor ">Maria M.M.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">PPIs as therapeutic targets for anticancer drug discovery: the case study of MDM2 and BET bromodomain inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 267-288. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00010-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00010-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00010-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00010-8%26sid%3Dliteratum%253Aachs%26atitle%3DPPIs%252Bas%252Btherapeutic%252Btargets%252Bfor%252Banticancer%252Bdrug%252Bdiscovery%25253A%252Bthe%252Bcase%252Bstudy%252Bof%252BMDM2%252Band%252BBET%252Bbromodomain%252Binhibitors%26aulast%3DEspadinha%26aufirst%3DMargarida%26date%3D2020%26spage%3D267%26epage%3D288%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Idham Darussalam  Mardjan</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 0:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00032-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00032-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00032-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00032-9%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BOne%252BExtra%252BHeteroatom%252B0%25253A1%26aulast%3DMardjan%26aufirst%3DMuhammad%2BIdham%2BDarussalam%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D.  Harper</span>, <span class="hlFld-ContribAuthor ">R. Alan  Aitken</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry of thieno[b]pyrrolones, dihydrothieno[b]pyrrolones, and their fused derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 165-283. <a href="https://doi.org/10.1016/bs.aihch.2019.11.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.11.001%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bchemistry%252Bof%252Bthieno%25255Bb%25255Dpyrrolones%25252C%252Bdihydrothieno%25255Bb%25255Dpyrrolones%25252C%252Band%252Btheir%252Bfused%252Bderivatives%26aulast%3DHarper%26aufirst%3DAndrew%2BD.%26date%3D2020%26spage%3D165%26epage%3D283%26pub%3DElsevier%26date%3D2020%26volume%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amandeep  Thakur</span>, <span class="hlFld-ContribAuthor ">Arshdeep  Singh</span>, <span class="hlFld-ContribAuthor ">Navdeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Ritu  Ojha</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>. </span><span class="cited-content_cbyCitation_article-title">Steering the antitumor drug discovery campaign towards structurally diverse indolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103436. <a href="https://doi.org/10.1016/j.bioorg.2019.103436" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103436%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSteering%252Bthe%252Bantitumor%252Bdrug%252Bdiscovery%252Bcampaign%252Btowards%252Bstructurally%252Bdiverse%252Bindolines%26aulast%3DThakur%26aufirst%3DAmandeep%26date%3D2020%26volume%3D94%26spage%3D103436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahendra B.  Bodake</span>, <span class="hlFld-ContribAuthor ">Ghanshyam R.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Vijay J.  Medhane</span>, <span class="hlFld-ContribAuthor ">Avinash D.  Bholay</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Novel Thiazole Substituted Pyrrolidine
Derivatives and their Antimicrobial Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2020,</strong> <em>32 </em>
                                    (8)
                                     , 2007-2012. <a href="https://doi.org/10.14233/ajchem.2020.22772" title="DOI URL">https://doi.org/10.14233/ajchem.2020.22772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2020.22772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2020.22772%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DEfficient%252BSynthesis%252Bof%252BNovel%252BThiazole%252BSubstituted%252BPyrrolidine%252BDerivatives%252Band%252Btheir%252BAntimicrobial%252BEvaluation%26aulast%3DBodake%26aufirst%3DMahendra%2BB.%26date%3D2020%26date%3D2020%26volume%3D32%26issue%3D8%26spage%3D2007%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas D.  Fang</span>, <span class="hlFld-ContribAuthor ">Qiuqiong  Tang</span>, <span class="hlFld-ContribAuthor ">Yanhui  Kong</span>, <span class="hlFld-ContribAuthor ">Qixin  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaxing  Gu</span>, <span class="hlFld-ContribAuthor ">Xu  Fang</span>, <span class="hlFld-ContribAuthor ">Peng  Zou</span>, <span class="hlFld-ContribAuthor ">Tao  Rong</span>, <span class="hlFld-ContribAuthor ">Jingwen  Wang</span>, <span class="hlFld-ContribAuthor ">Dajun  Yang</span>, <span class="hlFld-ContribAuthor ">Yifan  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Journal for ImmunoTherapy of Cancer</span><span> <strong>2019,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40425-019-0750-6" title="DOI URL">https://doi.org/10.1186/s40425-019-0750-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40425-019-0750-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40425-019-0750-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520for%2520ImmunoTherapy%2520of%2520Cancer%26atitle%3DMDM2%252Binhibitor%252BAPG-115%252Bsynergizes%252Bwith%252BPD-1%252Bblockade%252Bthrough%252Benhancing%252Bantitumor%252Bimmunity%252Bin%252Bthe%252Btumor%252Bmicroenvironment%26aulast%3DFang%26aufirst%3DDouglas%2BD.%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Fanghui  Ma</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of spiro[imidazolidine-4,3′-indolin]-2′-imines
              via
              copper(
              i
              )-catalyzed formal [2 + 2 + 1] cycloaddition of 3-diazoindolin-2-imines and triazines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (39)
                                     , 8849-8852. <a href="https://doi.org/10.1039/C9OB01767D" title="DOI URL">https://doi.org/10.1039/C9OB01767D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01767D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01767D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPreparation%252Bof%252Bspiro%25255Bimidazolidine-4%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-imines%252Bvia%252Bcopper%252528%252Bi%252B%252529-catalyzed%252Bformal%252B%25255B2%252B%25252B%252B2%252B%25252B%252B1%25255D%252Bcycloaddition%252Bof%252B3-diazoindolin-2-imines%252Band%252Btriazines%26aulast%3DZhou%26aufirst%3DYuxuan%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D39%26spage%3D8849%26epage%3D8852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jindong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Fang</span>, <span class="hlFld-ContribAuthor ">Shiyi  Jin</span>, <span class="hlFld-ContribAuthor ">Rui  Ma</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Ding  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Application of isatin-derived saturated esters in the synthesis of 3,3′-spirooxindole γ-butyrolactams. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (38)
                                     , 8745-8748. <a href="https://doi.org/10.1039/C9OB01347D" title="DOI URL">https://doi.org/10.1039/C9OB01347D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01347D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01347D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DApplication%252Bof%252Bisatin-derived%252Bsaturated%252Besters%252Bin%252Bthe%252Bsynthesis%252Bof%252B3%25252C3%2525E2%252580%2525B2-spirooxindole%252B%2525CE%2525B3-butyrolactams%26aulast%3DZhu%26aufirst%3DJindong%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D38%26spage%3D8745%26epage%3D8748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Ping  Zhu</span>, <span class="hlFld-ContribAuthor ">Ke  Xie</span>, <span class="hlFld-ContribAuthor ">Xiang-Hong  He</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Rong  Zeng</span>, <span class="hlFld-ContribAuthor ">Yang  Fan</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic diastereoselective [3+2] cyclization of MBH carbonates with dinucleophiles: synthesis of bicyclic imidazoline derivatives that inhibit MDM2–p53 interaction. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (76)
                                     , 11374-11377. <a href="https://doi.org/10.1039/C9CC05916D" title="DOI URL">https://doi.org/10.1039/C9CC05916D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC05916D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC05916D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DOrganocatalytic%252Bdiastereoselective%252B%25255B3%25252B2%25255D%252Bcyclization%252Bof%252BMBH%252Bcarbonates%252Bwith%252Bdinucleophiles%25253A%252Bsynthesis%252Bof%252Bbicyclic%252Bimidazoline%252Bderivatives%252Bthat%252Binhibit%252BMDM2%2525E2%252580%252593p53%252Binteraction%26aulast%3DZhu%26aufirst%3DHong-Ping%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D76%26spage%3D11374%26epage%3D11377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Xia  Lin</span>, <span class="hlFld-ContribAuthor ">Hui‐Xiong  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Spirooxindole Pyrrolones by a Rhodium(III)‐Catalyzed C−H Activation/Carbene Insertion/Lossen Rearrangement Sequence. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (38)
                                     , 13469-13473. <a href="https://doi.org/10.1002/ange.201906589" title="DOI URL">https://doi.org/10.1002/ange.201906589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201906589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201906589%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEfficient%252BSynthesis%252Bof%252BSpirooxindole%252BPyrrolones%252Bby%252Ba%252BRhodium%252528III%252529%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BActivation%25252FCarbene%252BInsertion%25252FLossen%252BRearrangement%252BSequence%26aulast%3DMa%26aufirst%3DBiao%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D38%26spage%3D13469%26epage%3D13473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Xia  Lin</span>, <span class="hlFld-ContribAuthor ">Hui‐Xiong  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Spirooxindole Pyrrolones by a Rhodium(III)‐Catalyzed C−H Activation/Carbene Insertion/Lossen Rearrangement Sequence. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (38)
                                     , 13335-13339. <a href="https://doi.org/10.1002/anie.201906589" title="DOI URL">https://doi.org/10.1002/anie.201906589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201906589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201906589%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEfficient%252BSynthesis%252Bof%252BSpirooxindole%252BPyrrolones%252Bby%252Ba%252BRhodium%252528III%252529%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BActivation%25252FCarbene%252BInsertion%25252FLossen%252BRearrangement%252BSequence%26aulast%3DMa%26aufirst%3DBiao%26date%3D2019%26volume%3D58%26issue%3D38%26spage%3D13335%26epage%3D13339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Kostiantyn P.  Melnykov</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated spirocyclic nitrogen-containing heterocycles with gem-difluorocycloalkane moieties (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2019,</strong> <em>55 </em>
                                    (8)
                                     , 692-694. <a href="https://doi.org/10.1007/s10593-019-02521-6" title="DOI URL">https://doi.org/10.1007/s10593-019-02521-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02521-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02521-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSaturated%252Bspirocyclic%252Bnitrogen-containing%252Bheterocycles%252Bwith%252Bgem-difluorocycloalkane%252Bmoieties%252B%252528microreview%252529%26aulast%3DGrygorenko%26aufirst%3DOleksandr%2BO.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D8%26spage%3D692%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Wang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Yushang  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  Yuan</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 92-104. <a href="https://doi.org/10.1016/j.ejmech.2019.05.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bpast%25252C%252Bpresent%252Band%252Bfuture%252Bof%252Bpotential%252Bsmall-molecule%252Bdrugs%252Btargeting%252Bp53-MDM2%25252FMDMX%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiu%26aufirst%3DYao%26date%3D2019%26volume%3D176%26spage%3D92%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiantian  Cong</span>, <span class="hlFld-ContribAuthor ">Huamin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuzheng  Li</span>, <span class="hlFld-ContribAuthor ">Hai-Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Junliang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral bifunctional bisphosphine enabled enantioselective tandem Michael addition of tryptamine-derived oxindoles to ynones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (62)
                                     , 9176-9179. <a href="https://doi.org/10.1039/C9CC04357H" title="DOI URL">https://doi.org/10.1039/C9CC04357H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC04357H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC04357H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DChiral%252Bbifunctional%252Bbisphosphine%252Benabled%252Benantioselective%252Btandem%252BMichael%252Baddition%252Bof%252Btryptamine-derived%252Boxindoles%252Bto%252Bynones%26aulast%3DCong%26aufirst%3DTiantian%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D62%26spage%3D9176%26epage%3D9179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiraborrirak  Charoenpattarapreeda</span>, <span class="hlFld-ContribAuthor ">Yaw Sing  Tan</span>, <span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Walsh</span>, <span class="hlFld-ContribAuthor ">Elaine  Fowler</span>, <span class="hlFld-ContribAuthor ">Rohan S.  Eapen</span>, <span class="hlFld-ContribAuthor ">Yuteng  Wu</span>, <span class="hlFld-ContribAuthor ">Hannah F.  Sore</span>, <span class="hlFld-ContribAuthor ">Chandra S.  Verma</span>, <span class="hlFld-ContribAuthor ">Laura  Itzhaki</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (55)
                                     , 7914-7917. <a href="https://doi.org/10.1039/C9CC04022F" title="DOI URL">https://doi.org/10.1039/C9CC04022F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC04022F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC04022F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTargeted%252Bcovalent%252Binhibitors%252Bof%252BMDM2%252Busing%252Belectrophile-bearing%252Bstapled%252Bpeptides%26aulast%3DCharoenpattarapreeda%26aufirst%3DJiraborrirak%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D55%26spage%3D7914%26epage%3D7917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justyna  Kocik</span>, <span class="hlFld-ContribAuthor ">Monika  Machula</span>, <span class="hlFld-ContribAuthor ">Aneta  Wisniewska</span>, <span class="hlFld-ContribAuthor ">Ewa  Surmiak</span>, <span class="hlFld-ContribAuthor ">Tad A.  Holak</span>, <span class="hlFld-ContribAuthor ">Lukasz  Skalniak</span>. </span><span class="cited-content_cbyCitation_article-title">Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (7)
                                     , 1014. <a href="https://doi.org/10.3390/cancers11071014" title="DOI URL">https://doi.org/10.3390/cancers11071014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11071014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11071014%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DHelping%252Bthe%252BReleased%252BGuardian%25253A%252BDrug%252BCombinations%252Bfor%252BSupporting%252Bthe%252BAnticancer%252BActivity%252Bof%252BHDM2%252B%252528MDM2%252529%252BAntagonists%26aulast%3DKocik%26aufirst%3DJustyna%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D7%26spage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Chao-Guo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">A [3+2] cycloaddition reaction for the synthesis of spiro[indoline-3,3′-pyrrolidines] and evaluation of cytotoxicity towards cancer cells. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (23)
                                     , 8903-8910. <a href="https://doi.org/10.1039/C9NJ00994A" title="DOI URL">https://doi.org/10.1039/C9NJ00994A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ00994A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ00994A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DA%252B%25255B3%25252B2%25255D%252Bcycloaddition%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bspiro%25255Bindoline-3%25252C3%2525E2%252580%2525B2-pyrrolidines%25255D%252Band%252Bevaluation%252Bof%252Bcytotoxicity%252Btowards%252Bcancer%252Bcells%26aulast%3DHuang%26aufirst%3DYing%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D23%26spage%3D8903%26epage%3D8910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukasz  Skalniak</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Twarda‐Clapa</span>, <span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Ewa  Surmiak</span>, <span class="hlFld-ContribAuthor ">Monika  Machula</span>, <span class="hlFld-ContribAuthor ">Aneta  Wisniewska</span>, <span class="hlFld-ContribAuthor ">Beata  Labuzek</span>, <span class="hlFld-ContribAuthor ">Ameena M.  Ali</span>, <span class="hlFld-ContribAuthor ">Sylwia  Krzanik</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Dubin</span>, <span class="hlFld-ContribAuthor ">Matthew  Groves</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>, <span class="hlFld-ContribAuthor ">Tad A.  Holak</span>. </span><span class="cited-content_cbyCitation_article-title">A fluorinated indole‐based
              MDM
              2 antagonist selectively inhibits the growth of p53
              wt
              osteosarcoma cells. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2019,</strong> <em>286 </em>
                                    (7)
                                     , 1360-1374. <a href="https://doi.org/10.1111/febs.14774" title="DOI URL">https://doi.org/10.1111/febs.14774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.14774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.14774%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DA%252Bfluorinated%252Bindole%2525E2%252580%252590based%252BMDM%252B2%252Bantagonist%252Bselectively%252Binhibits%252Bthe%252Bgrowth%252Bof%252Bp53%252Bwt%252Bosteosarcoma%252Bcells%26aulast%3DSkalniak%26aufirst%3DLukasz%26date%3D2019%26date%3D2019%26volume%3D286%26issue%3D7%26spage%3D1360%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated bioisosteres of benzene: where to go next?. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (11)
                                     , 2839-2849. <a href="https://doi.org/10.1039/C8OB02812E" title="DOI URL">https://doi.org/10.1039/C8OB02812E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02812E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02812E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSaturated%252Bbioisosteres%252Bof%252Bbenzene%25253A%252Bwhere%252Bto%252Bgo%252Bnext%25253F%26aulast%3DMykhailiuk%26aufirst%3DPavel%2BK.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D11%26spage%3D2839%26epage%3D2849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenqiang  Yang</span>, <span class="hlFld-ContribAuthor ">Xingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao  Jin</span>, <span class="hlFld-ContribAuthor ">Han  Sun</span>, <span class="hlFld-ContribAuthor ">Runan  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Qian  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Copper‐Catalysed Double
              O
              ‐Arylation for Enantioselective Synthesis of
              oxa
              ‐Spirocycles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (3)
                                     , 562-568. <a href="https://doi.org/10.1002/adsc.201801395" title="DOI URL">https://doi.org/10.1002/adsc.201801395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201801395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201801395%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper%2525E2%252580%252590Catalysed%252BDouble%252BO%252B%2525E2%252580%252590Arylation%252Bfor%252BEnantioselective%252BSynthesis%252Bof%252Boxa%252B%2525E2%252580%252590Spirocycles%26aulast%3DYang%26aufirst%3DWenqiang%26date%3D2019%26date%3D2018%26volume%3D361%26issue%3D3%26spage%3D562%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrid E.  Wertz</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Bedside: Targeting the Ubiquitin System. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (2)
                                     , 156-177. <a href="https://doi.org/10.1016/j.chembiol.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DFrom%252BDiscovery%252Bto%252BBedside%25253A%252BTargeting%252Bthe%252BUbiquitin%252BSystem%26aulast%3DWertz%26aufirst%3DIngrid%2BE.%26date%3D2019%26volume%3D26%26issue%3D2%26spage%3D156%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana D.  Amaral</span>, <span class="hlFld-ContribAuthor ">Dário  Silva</span>, <span class="hlFld-ContribAuthor ">Cecília M. P.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Susana  Solá</span>, <span class="hlFld-ContribAuthor ">Maria M. M.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00015" title="DOI URL">https://doi.org/10.3389/fchem.2019.00015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00015%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DA%252BNovel%252BSmall%252BMolecule%252Bp53%252BStabilizer%252Bfor%252BBrain%252BCell%252BDifferentiation%26aulast%3DAmaral%26aufirst%3DJoana%2BD.%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Gollner</span>, <span class="hlFld-ContribAuthor ">Harald  Weinstabl</span>, <span class="hlFld-ContribAuthor ">Julian E.  Fuchs</span>, <span class="hlFld-ContribAuthor ">Dorothea  Rudolph</span>, <span class="hlFld-ContribAuthor ">Geraldine  Garavel</span>, <span class="hlFld-ContribAuthor ">Karin S.  Hofbauer</span>, <span class="hlFld-ContribAuthor ">Jale  Karolyi‐Oezguer</span>, <span class="hlFld-ContribAuthor ">Gerhard  Gmaschitz</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Hela</span>, <span class="hlFld-ContribAuthor ">Nina  Kerres</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Grondal</span>, <span class="hlFld-ContribAuthor ">Patrick  Werni</span>, <span class="hlFld-ContribAuthor ">Juergen  Ramharter</span>, <span class="hlFld-ContribAuthor ">Joachim  Broeker</span>, <span class="hlFld-ContribAuthor ">Darryl B.  McConnell</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Synthesis of Complex Spiro[3
              H
              ‐indole‐3,2′‐pyrrolidin]‐2(1
              H
              )‐ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2–p53 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (1)
                                     , 88-93. <a href="https://doi.org/10.1002/cmdc.201800617" title="DOI URL">https://doi.org/10.1002/cmdc.201800617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800617%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeted%252BSynthesis%252Bof%252BComplex%252BSpiro%25255B3%252BH%252B%2525E2%252580%252590indole%2525E2%252580%2525903%25252C2%2525E2%252580%2525B2%2525E2%252580%252590pyrrolidin%25255D%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590ones%252Bby%252BIntramolecular%252BCyclization%252Bof%252BAzomethine%252BYlides%25253A%252BHighly%252BPotent%252BMDM2%2525E2%252580%252593p53%252BInhibitors%26aulast%3DGollner%26aufirst%3DAndreas%26date%3D2019%26date%3D2018%26volume%3D14%26issue%3D1%26spage%3D88%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Shidong  Chu</span>, <span class="hlFld-ContribAuthor ">Ariana  Nemati</span>, <span class="hlFld-ContribAuthor ">Chunsheng  Huang</span>, <span class="hlFld-ContribAuthor ">Beth A.  Snyder</span>, <span class="hlFld-ContribAuthor ">Roger G.  Ptak</span>, <span class="hlFld-ContribAuthor ">Miriam  Gochin</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 533-542. <a href="https://doi.org/10.1016/j.ejmech.2018.10.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthe%252Bmolecular%252Bcharacteristics%252Bof%252Bbisindole%252Binhibitors%252Bas%252BHIV-1%252Bglycoprotein-41%252Bfusion%252Binhibitors%26aulast%3DZhou%26aufirst%3DGuangyan%26date%3D2019%26volume%3D161%26spage%3D533%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Xuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuefeng  He</span>, <span class="hlFld-ContribAuthor ">Zhen-Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Liang</span>, <span class="hlFld-ContribAuthor ">Wenhuan  He</span>, <span class="hlFld-ContribAuthor ">Xiaoding  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiangmeng  Chen</span>, <span class="hlFld-ContribAuthor ">Liqin  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of six-membered spirooxindoles
              via
              a chiral Brønsted acid-catalyzed asymmetric intramolecular Friedel–Crafts reaction. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (65)
                                     , 37035-37039. <a href="https://doi.org/10.1039/C8RA06710D" title="DOI URL">https://doi.org/10.1039/C8RA06710D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA06710D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA06710D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252Bsix-membered%252Bspirooxindoles%252Bvia%252Ba%252Bchiral%252BBr%2525C3%2525B8nsted%252Bacid-catalyzed%252Basymmetric%252Bintramolecular%252BFriedel%2525E2%252580%252593Crafts%252Breaction%26aulast%3DChen%26aufirst%3DHui-Xuan%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D65%26spage%3D37035%26epage%3D37039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahya  Nural</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antimycobacterial activity, and acid dissociation constants of polyfunctionalized 3-[2-(pyrrolidin-1-yl)thiazole-5-carbonyl]-2H-chromen-2-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2018,</strong> <em>149 </em>
                                    (10)
                                     , 1905-1918. <a href="https://doi.org/10.1007/s00706-018-2250-7" title="DOI URL">https://doi.org/10.1007/s00706-018-2250-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-018-2250-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-018-2250-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%25252C%252Bantimycobacterial%252Bactivity%25252C%252Band%252Bacid%252Bdissociation%252Bconstants%252Bof%252Bpolyfunctionalized%252B3-%25255B2-%252528pyrrolidin-1-yl%252529thiazole-5-carbonyl%25255D-2H-chromen-2-one%252Bderivatives%26aulast%3DNural%26aufirst%3DYahya%26date%3D2018%26date%3D2018%26volume%3D149%26issue%3D10%26spage%3D1905%26epage%3D1918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Yuan</span>, <span class="hlFld-ContribAuthor ">Jiean  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Yong  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Hydroamidation of Enals by Trapping of a Transient Acyl Species. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (28)
                                     , 8639-8643. <a href="https://doi.org/10.1002/ange.201803556" title="DOI URL">https://doi.org/10.1002/ange.201803556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201803556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201803556%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252BHydroamidation%252Bof%252BEnals%252Bby%252BTrapping%252Bof%252Ba%252BTransient%252BAcyl%252BSpecies%26aulast%3DYuan%26aufirst%3DPengfei%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D28%26spage%3D8639%26epage%3D8643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Yuan</span>, <span class="hlFld-ContribAuthor ">Jiean  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Yong  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Hydroamidation of Enals by Trapping of a Transient Acyl Species. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (28)
                                     , 8503-8507. <a href="https://doi.org/10.1002/anie.201803556" title="DOI URL">https://doi.org/10.1002/anie.201803556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201803556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201803556%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252BHydroamidation%252Bof%252BEnals%252Bby%252BTrapping%252Bof%252Ba%252BTransient%252BAcyl%252BSpecies%26aulast%3DYuan%26aufirst%3DPengfei%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D28%26spage%3D8503%26epage%3D8507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahya  Nural</span>, <span class="hlFld-ContribAuthor ">Muge  Gemili</span>, <span class="hlFld-ContribAuthor ">Mahmut  Ulger</span>, <span class="hlFld-ContribAuthor ">Hayati  Sari</span>, <span class="hlFld-ContribAuthor ">Laurens M.  De Coen</span>, <span class="hlFld-ContribAuthor ">Ertan  Sahin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (5)
                                     , 942-946. <a href="https://doi.org/10.1016/j.bmcl.2018.01.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.01.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.01.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.01.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bantimicrobial%252Bactivity%252Band%252Bacid%252Bdissociation%252Bconstants%252Bof%252Bmethyl%252B5%25252C5-diphenyl-1-%252528thiazol-2-yl%252529pyrrolidine-2-carboxylate%252Bderivatives%26aulast%3DNural%26aufirst%3DYahya%26date%3D2018%26volume%3D28%26issue%3D5%26spage%3D942%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of New Spirooxindoles Targeting the p53–MDM2 Protein-Protein Interactions for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 213-237. <a href="https://doi.org/10.1007/978-981-13-0773-7_8" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_8%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDevelopment%252Bof%252BNew%252BSpirooxindoles%252BTargeting%252Bthe%252Bp53%2525E2%252580%252593MDM2%252BProtein-Protein%252BInteractions%252Bfor%252BCancer%252BTherapy%26aulast%3DYu%26aufirst%3DBin%26date%3D2018%26date%3D2018%26spage%3D213%26epage%3D237%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  Min</span>, <span class="hlFld-ContribAuthor ">Qiu-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Da-Hua  Shi</span>, <span class="hlFld-ContribAuthor ">Chao-Guo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Facile one-pot synthesis of spirooxindole-pyrrolidine derivatives and their antimicrobial and acetylcholinesterase inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (19)
                                     , 16211-16216. <a href="https://doi.org/10.1039/C8NJ03813A" title="DOI URL">https://doi.org/10.1039/C8NJ03813A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ03813A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ03813A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DFacile%252Bone-pot%252Bsynthesis%252Bof%252Bspirooxindole-pyrrolidine%252Bderivatives%252Band%252Btheir%252Bantimicrobial%252Band%252Bacetylcholinesterase%252Binhibitory%252Bactivities%26aulast%3DHuang%26aufirst%3DYing%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D19%26spage%3D16211%26epage%3D16216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibo  Chen</span>, <span class="hlFld-ContribAuthor ">Dingyuan  Luo</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Lin</span>, <span class="hlFld-ContribAuthor ">Qiuyun  Luo</span>, <span class="hlFld-ContribAuthor ">Hanjie  Yi</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Xianglei  Yan</span>, <span class="hlFld-ContribAuthor ">Baoxia  Li</span>, <span class="hlFld-ContribAuthor ">Yuelei  Chen</span>, <span class="hlFld-ContribAuthor ">Xingguang  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng  Liu</span>, <span class="hlFld-ContribAuthor ">Miaozhen  Qiu</span>, <span class="hlFld-ContribAuthor ">Dajun  Yang</span>, <span class="hlFld-ContribAuthor ">Ningyi  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (26)
                                     , 43008-43022. <a href="https://doi.org/10.18632/oncotarget.17398" title="DOI URL">https://doi.org/10.18632/oncotarget.17398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.17398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.17398%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRestoration%252Bof%252Bp53%252Busing%252Bthe%252Bnovel%252BMDM2-p53%252Bantagonist%252BAPG115%252Bsuppresses%252Bdedifferentiated%252Bpapillary%252Bthyroid%252Bcancer%252Bcells%26aulast%3DChen%26aufirst%3DHaibo%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D26%26spage%3D43008%26epage%3D43022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian Robert  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–Protein Interaction Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 399-399. <a href="https://doi.org/10.1007/7355_2017_27" title="DOI URL">https://doi.org/10.1007/7355_2017_27</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_27%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%26aulast%3DHardcastle%26aufirst%3DIan%2BRobert%26date%3D2017%26spage%3D399%26epage%3D399%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Yong  Han</span>, <span class="hlFld-ContribAuthor ">Jia  Zhao</span>, <span class="hlFld-ContribAuthor ">Jian-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Guang-Yan  Xiang</span>, <span class="hlFld-ContribAuthor ">Ding-Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei  Bai</span>, <span class="hlFld-ContribAuthor ">Bao-Dong  Cui</span>, <span class="hlFld-ContribAuthor ">Nan-Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Yong-Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective [3 + 2] cycloaddition of 3-ylideneoxindoles with in situ generated CF
              2
              HCHN
              2
              : syntheses of CF
              2
              H-containing spirooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (26)
                                     , 5571-5578. <a href="https://doi.org/10.1039/C7OB01266G" title="DOI URL">https://doi.org/10.1039/C7OB01266G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01266G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01266G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDiastereoselective%252B%25255B3%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252B3-ylideneoxindoles%252Bwith%252Bin%252Bsitu%252Bgenerated%252BCF%252B2%252BHCHN%252B2%252B%25253A%252Bsyntheses%252Bof%252BCF%252B2%252BH-containing%252Bspirooxindoles%26aulast%3DHan%26aufirst%3DWen-Yong%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D26%26spage%3D5571%26epage%3D5578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative MDM2 inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Chemical structure of compound <b>6</b> and five regions (A–E) where chemical modifications were made. (B) Cocrystal structure of <b>2</b> (light blue spheres, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TRF">5TRF</a>) and model of the binding mode of <b>6</b> (green sticks) in complex with MDM2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pharmacodynamics (PD) effect of <b>33</b> in SJSA-1 tumors in mice. Mice were given a single, oral dose of the vehicle, or <b>33</b> at 100 mg/kg and sacrificed at indicated time points. West blotting was performed on harvested tumor tissue to probe MDM2, p53, p21, PAPR, cleaved PARP (cl-PAPR) proteins. (B) Antitumor activity of <b>33</b> in the SJSA-1 osteosarcoma tumor xenograft model in mice. Compound <b>33</b> was administered via oral gavage at 100 mg/kg daily for 14 days. (C) Body weight change of mice during administration of <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Proposed Mechanism of Decomposition for <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(A) Stability of compound <b>33</b> in various solutions. Compound <b>33</b> was incubated in CH<sub>3</sub>CN/H<sub>2</sub>O, MeOH/H<sub>2</sub>O, or cell culture media, and the % composition of <b>33</b> in the solutions was determined daily for 2 days by UPLC (ultraperformance liquid chromatography) and plotted. (B, C, D) UPLC/MS spectrum of <b>33</b>, <b>6</b>, and <b>31</b>, respectively, after incubation for 2 days in cell culture media. Peaks are labeled with retention time followed by molecular weight.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design of Compound <b>54</b> by Combining the Optimal Substituents of Sites A and D</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reference <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Antitumor activity of compound <b>54</b>, in comparison to compound <b>2</b> in the SJSA-1 osteosarcoma tumor xenograft model in mice. Compound <b>54</b> was administered via oral gavage at 50 or 100 mg/kg daily for 14 days and compound <b>2</b> was administered via oral gavage at 100 mg/kg daily for 14 days. (B) Changes in body weight of mice during animal dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Replacement of the Benzoic Acid in Compound <b>39</b> with Nonclassical Benzoic Acid Bioisosteres</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Antitumor activity of compounds <b>39</b> and <b>56</b> in the SJSA-1 osteosarcoma xenograft model in mice. (B) Body weight change of mice during administration period.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic (PD) analysis of the effect of MDM2 inhibitors in SJSA-1 tumors. Mice bearing SJSA-1 tumors were dosed with a single oral dose of <b>56</b>, <b>57</b>, <b>58</b>, <b>59</b>, <b>60</b> and <b>2</b> at 100 mg/kg and the tumors were harvested at 6 and 24 hours for western blot analysis. (A, B) PD of <b>56</b>, <b>57</b> and <b>58</b> show modest activation of p53 as seen with the low levels of p53, MDM2, and p21; (C) Compounds <b>59</b>, <b>60</b> and <b>2</b> show robust activation of p53 as seen with increased levels of p53, MDM2, ubiquitinated MDM2 (ub-MMD2) and p21, and induce strong apoptosis as seen with increased levels of cleaved PARP (cl-PAPR) and cleaved caspase-3 (cl-Casp3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0007.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Antitumor activity of compound <b>59</b>, <b>60</b> in comparison to <b>56</b> in the SJSA-1 osteosarcoma xenograft model in mice. Compound <b>59</b> and <b>60</b> were administered at 30 mg/kg or 100 mg/kg daily for 14 days and <b>56</b> at 100 mg/kg daily for 14 days. (B) Animal weight changes of mice during the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0008.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Antitumor activity of compound <b>60</b> in the RS4; 11 acute lymphoblastic leukemia xenograft model in mice. Compound <b>60</b> was administered at 50 mg/kg, 75 mg/kg, or 100 mg/kg daily for 14 days and 200 mg/kg weekly for 3 weeks. (B) Animal body weight of mice during administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0009.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Stability comparison of compounds <b>2</b> and <b>60</b> in (A) 1:1 CH<sub>3</sub>CN to H<sub>2</sub>O; (B) 1:1 MeOH to H<sub>2</sub>O; (C) cell culture media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>6</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, reflux, 2 h; (b) R<sub>1</sub>NH<sub>2</sub>, THF, reflux overnight; (c) CH<sub>3</sub>CN/H<sub>2</sub>O (1:1), CAN, 15 min; (d) CH<sub>3</sub>CN/H<sub>2</sub>O, overnight.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>16</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, piperidine, reflux.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>21</b>, <b>27</b>, and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM/AcOH (1:1), paraformaldehyde, NaBH(OAc)<sub>3</sub>; (b) THF/MeOH/H<sub>2</sub>O, LiOH·H<sub>2</sub>O; (c) DCE, CDI, DIEA, 50 °C 30 min, then NH<sub>4</sub>OH; (d) DCM, Lawesson’s reagent, reflux overnight; (e) (1) THF, BrCH<sub>2</sub>COR, Et<sub>3</sub>N, reflux overnight, (2) DME, TFAA, pyridine, −20 °C to rt, 30 min; (f) THF/MeOH/H<sub>2</sub>O (1:1:1), NaOH, rt, prep-HPLC.</p></p></figure><figure data-id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>22</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCE, CDI, DIEA, DMAP, 50 °C for 30 min, then <b>71</b>, <b>74</b>, <b>76</b>, <b>78</b>, and reflux; (b) (1) THF, Deoxo-Fluor, −20 °C for 30 min, (2) BrCCl<sub>3</sub>, DBU at rt overnight; (c) THF/H<sub>2</sub>O (2:1), LiOH·H<sub>2</sub>O, rt for 30 min, then preparative HPLC; (d) pyridine, 100 °C for 4 h; (e) DCM, PPh<sub>3</sub>, I<sub>2</sub>, Et<sub>3</sub>N, rt; (f) DCM, Lawesson’s reagent, reflux overnight.</p></p></figure><figure data-id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compounds in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM, HATU, DIEA, alkylamine; (b) THF/MeOH/H<sub>2</sub>O (1:1:1), LiOH·H<sub>2</sub>O for alkyl esters or NaOH for aryl esters; (c) DCM, Ph<sub>2</sub>POCl, DIEA 30 min, then arylamine and DMAP; (d) DCE, CDI, DIEA, DMAP, 50 °C for 30 min, then R<sub>2</sub>NH<sub>2</sub> and reflux.</p></p></figure><figure data-id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/medium/jm-2016-01665b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>59</b> and <b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01665/20170407/images/large/jm-2016-01665b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01665&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DCM/AcOH (1:1), paraformaldehyde or acetaldehyde, NaBH(OAc)<sub>3</sub>, rt overnight.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancer: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1016/S0065-230X(08)60785-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0065-230X%2808%2960785-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancer%3A+the+first+ten+thousand+mutations&doi=10.1016%2FS0065-230X%2808%2960785-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2808%2960785-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252808%252960785-X%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancer%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1999%26volume%3D77%26spage%3D81%26epage%3D137%26doi%3D10.1016%2FS0065-230X%2808%2960785-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vousden, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53 in health and disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1038/nrm2147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1038%2Fnrm2147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=17380161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=275-283&author=K.+H.+Vousdenauthor=D.+P.+Lane&title=p53+in+health+and+disease&doi=10.1038%2Fnrm2147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">p53 in health and disease</span></div><div class="casAuthors">Vousden, Karen H.; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-283</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As a component of the response to acute stress, p53 has a well established role in protecting against cancer development.  However, it is now becoming clear that p53 can have a much broader role and can contribute to the development, life expectancy and overall fitness of an organism.  Although the function of p53 as a tumor suppressor ensures that we can't live without it, an integrated view of p53 suggests that not all of its functions are conducive to a long and healthy life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoND8MaF-_GGbVg90H21EOLACvtfcHk0lgF9fsPntBKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlygsr0%253D&md5=c39c719e12d6cb436786acb162101b28</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2147%26sid%3Dliteratum%253Aachs%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D275%26epage%3D283%26doi%3D10.1038%2Fnrm2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Momand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambetti, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span><span class="refDoi"> DOI: 10.1016/0092-8674(92)90644-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2F0092-8674%2892%2990644-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1535557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Ogs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1992&pages=1237-1245&author=J.+Momandauthor=G.+P.+Zambettiauthor=D.+C.+Olsonauthor=D.+Georgeauthor=A.+J.+Levine&title=The+mdm-2+oncogene+product+forms+a+complex+with+the+p53+protein+and+inhibits+p53-mediated+transactivation&doi=10.1016%2F0092-8674%2892%2990644-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation</span></div><div class="casAuthors">Momand, Jamil; Zambetti, Gerard P.; Olson, David C.; George, Donna; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1237-45</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A cellular phosphoprotein with an apparent mol. mass of 90 kd (p90) that forms a complex with both mutant and wild-type p53 protein has been characterized, purified, and identified.  The protein was identified as a product of the murine double minute 2 gene (mdm-2).  The mdm-2 gene enhances the tumorigenic potential of cells when it is overexpressed and encodes a putative transcription factor.  To det. if mdm-2 could modulate p53 transactivation, a p53-responsive element from the muscle creatine kinase gene was employed.  A wild-type p53-expressing plasmid enhanced the expression of the p53-responsive element when cotransfected into cells that contain no endogenous p53.  When a cosmid expressing mdm-2 was transfected with this p53-expressing plasmid, the transactivation of the p53-responsive element was inhibited.  Thus, a product of the mdm-2 oncogene forms a tight complex with the p53 protein, and the mdm-2 oncogene can inhibit p53-mediated transactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UJbHLRWEsLVg90H21EOLACvtfcHk0lgF9fsPntBKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Ogs7o%253D&md5=448d8b28555303773d76084e2d8b32ee</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990644-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990644-R%26sid%3Dliteratum%253Aachs%26aulast%3DMomand%26aufirst%3DJ.%26aulast%3DZambetti%26aufirst%3DG.%2BP.%26aulast%3DOlson%26aufirst%3DD.%2BC.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520mdm-2%2520oncogene%2520product%2520forms%2520a%2520complex%2520with%2520the%2520p53%2520protein%2520and%2520inhibits%2520p53-mediated%2520transactivation%26jtitle%3DCell%26date%3D1992%26volume%3D69%26spage%3D1237%26epage%3D1245%26doi%3D10.1016%2F0092-8674%2892%2990644-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Freedman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Functions of the MDM2 oncoprotein</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1007/s000180050273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1007%2Fs000180050273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10065155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=96-107&author=D.+A.+Freedmanauthor=L.+Wuauthor=A.+J.+Levine&title=Functions+of+the+MDM2+oncoprotein&doi=10.1007%2Fs000180050273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Functions of the MDM2 oncoprotein</span></div><div class="casAuthors">Freedman, D. A.; Wu, L.; Levine, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review is given with 79 refs.  The p53 protein is activated in response to physiol. stress resulting in either a G 1 arrest of cells or apoptosis.  As such, p53 must be tightly regulated, and the MDM2 oncoprotein plays a central role in that regulatory process.  The transcription of the Mdm2 oncogene is induced by the p53 protein after DNA damage, and the MDM2 protein then binds to p53 and blocks its activities as a tumor suppressor and promotes its degrdn.  These 2 proteins thus form an autoregulatory feedback loop in which p53 pos. regulates MDM2 levels and MDM2 neg. regulates p53 levels and activity.  Immediately after UV irradn. MDM2 mRNA and protein levels fall in a p53-independent fashion, resulting in increased p53 levels.  The p53 protein is then activated as a transcription factor by posttranslational modification permitting p53 to initiate its cell-cycle arrest or apoptotic (programmed cell death) functions.  At later times, after the repair of DNA, MDM2 levels increase in a p53-dependent fashion.  This induction of MDM2 results in the inhibition of p53 transcriptional activity and the degrdn. of p53 protein.  MDM2-p53 complexes in the nucleus are transported to the cytoplasm via signals present in the MDM2 protein, where p53 is degraded in the proteasome.  Thus MDM2 acts as a nuclear-cytoplasmic shuttle for the p53 protein.  There are many levels at which this process is regulated, and as such there are many places for chemotherapeutic interventions.  The amino-terminal domain of the MDM2 protein is all that is required to bind the p53 protein.  The MDM2 protein has addnl. domains and therefore may have addnl. functions.  Any of these MDM2 domains may contribute to MDM2's activities as an oncogene independent of its inhibition of the tumor suppressor functions of p53.  Thus MDM2 itself could be a target for cancer therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRcPEDlOyBLVg90H21EOLACvtfcHk0livNU32_69Y5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2lsLY%253D&md5=634456f449df4433ccf8ba9d7e23808b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs000180050273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050273%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DFunctions%2520of%2520the%2520MDM2%2520oncoprotein%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D1999%26volume%3D55%26spage%3D96%26epage%3D107%26doi%3D10.1007%2Fs000180050273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bond, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">MDM2 is a central node in the p53 pathway: 12 years and counting</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.2174/1568009053332627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.2174%2F1568009053332627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=15720184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVeqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=3-8&author=G.+L.+Bondauthor=W.+W.+Huauthor=A.+J.+Levine&title=MDM2+is+a+central+node+in+the+p53+pathway%3A+12+years+and+counting&doi=10.2174%2F1568009053332627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MDM2 is a central node in the p53 pathway: 12 years and counting</span></div><div class="casAuthors">Bond, Gareth L.; Hu, Wenwei; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Twelve years ago, the Mdm2 oncogene was shown to bind to and inhibit the tumor suppressor protein, p53.  During the past 12 years, both genetic and biochem. studies have demonstrated that Mdm2 is a key neg. regulator of the tumor suppressor p53.  Mdm2 and p53 form an oscillating auto-regulatory feedback loop, which is tightly controlled to allow the appropriate response to environmental stresses to suppress tumor formation.  When Mdm2 activity is inappropriately heightened, as it is in many human tumors, p53 activity is attenuated and tumor susceptibility arises.  The p53 gene is mutated in 50% of all human tumors, but in those tumors that retain wild type p53, inhibiting Mdm2 activity could activate p53 tumor suppression and therefore provide a therapeutic strategy for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe_fHLgXrKRrVg90H21EOLACvtfcHk0livNU32_69Y5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVeqt7w%253D&md5=a2c578da4c2d390cd893ec240b6bd9e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568009053332627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009053332627%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DG.%2BL.%26aulast%3DHu%26aufirst%3DW.%2BW.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DMDM2%2520is%2520a%2520central%2520node%2520in%2520the%2520p53%2520pathway%253A%252012%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2005%26volume%3D5%26spage%3D3%26epage%3D8%26doi%3D10.2174%2F1568009053332627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">The p53-mdm-2 autoregulatory feedback loop</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1101/gad.7.7a.1126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1101%2Fgad.7.7a.1126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=8319905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK3sXlslGhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=1126-1132&author=X.+Wuauthor=J.+H.+Bayleauthor=D.+Olsonauthor=A.+J.+Levine&title=The+p53-mdm-2+autoregulatory+feedback+loop&doi=10.1101%2Fgad.7.7a.1126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The p53-mdm-2 autoregulatory feedback loop</span></div><div class="casAuthors">Wu, Xiangwei; Bayle, J. Henri; Olson, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7A</span>),
    <span class="NLM_cas:pages">1126-31</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    </div><div class="casAbstract">The p53 protein can bind to a set of specific DNA sequences, and this may activate the transcription of genes adjacent to these DNA elements.  The mdm-2 gene is shown here to contain a p53 DNA-binding site and a genetically responsive element such that expression of the mdm-2 gene can be regulated by the level of wild-type p53 protein.  The mdm-2 protein, in turn, can complex with p53 and decrease its ability to act as a pos. transcription factor at the mdm-2 gene-responsive element.  In this way, the mdm-2 gene is autoregulated.  The p53 protein regulates the mdm-2 gene at the level of transcription, and the mdm-2 protein regulates the p53 protein at the level of its activity.  This creates a feedback loop that regulates both the activity of the p53 protein and the expression of the mdm-2 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyvx38hSAdLbVg90H21EOLACvtfcHk0lhwvyGp09hsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlslGhtLo%253D&md5=ee1ae7f78e5c76e94507718527504079</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1101%2Fgad.7.7a.1126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.7.7a.1126%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBayle%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520p53-mdm-2%2520autoregulatory%2520feedback%2520loop%26jtitle%3DGenes%2520Dev.%26date%3D1993%26volume%3D7%26spage%3D1126%26epage%3D1132%26doi%3D10.1101%2Fgad.7.7a.1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Juven-Gershon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oren, M.</span><span> </span><span class="NLM_article-title">Mdm2: the ups and downs</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10203572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK1MXjsF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=71-83&author=T.+Juven-Gershonauthor=M.+Oren&title=Mdm2%3A+the+ups+and+downs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mdm2: the ups and downs</span></div><div class="casAuthors">Juven-Gershon, Tamar; Oren, Moshe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review with 110 refs., including sections entitled introduction; Mdm2: the cancer connection; the Mdm2 protein; the mdm2-p53 autoregulatory loop; post-translational regulation of Mdm2; Mdm2-p53 interactions: potential target for therapeutic intervention; protein partners of Mdm2: who else besides p53; p53-independent activities of Mdm2; effects of Mdm2 on development, differentiation, and cell cycle regulation; family connections; and conclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojR2A0M5ypIrVg90H21EOLACvtfcHk0lhwvyGp09hsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsF2mtb4%253D&md5=37dab158ebc840fcc56a182bdd68d3a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuven-Gershon%26aufirst%3DT.%26aulast%3DOren%26aufirst%3DM.%26atitle%3DMdm2%253A%2520the%2520ups%2520and%2520downs%26jtitle%3DMol.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Momand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, G.</span><span> </span><span class="NLM_article-title">MDM2--master regulator of the p53 tumor suppressor protein</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/S0378-1119(99)00487-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0378-1119%2899%2900487-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2000&pages=15-29&author=J.+Momandauthor=H.+H.+Wuauthor=G.+Dasgupta&title=MDM2%2D%2Dmaster+regulator+of+the+p53+tumor+suppressor+protein&doi=10.1016%2FS0378-1119%2899%2900487-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2899%2900487-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252899%252900487-4%26sid%3Dliteratum%253Aachs%26aulast%3DMomand%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%2BH.%26aulast%3DDasgupta%26aufirst%3DG.%26atitle%3DMDM2--master%2520regulator%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DGene%26date%3D2000%26volume%3D242%26spage%3D15%26epage%3D29%26doi%3D10.1016%2FS0378-1119%2899%2900487-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small-molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1126/science.1092472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small-molecule+antagonists+of+MDM2&doi=10.1126%2Fscience.1092472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0lgIBcP1n68ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small-molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848%26doi%3D10.1126%2Fscience.1092472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">p53 Activation by small molecules: application in oncology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4491</span><span class="NLM_x">–</span> <span class="NLM_lpage">4499</span><span class="refDoi"> DOI: 10.1021/jm058174k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058174k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlarsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4491-4499&author=L.+T.+Vassilev&title=p53+Activation+by+small+molecules%3A+application+in+oncology&doi=10.1021%2Fjm058174k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">p53 Activation by Small Molecules: Application in Oncology</span></div><div class="casAuthors">Vassilev, Lyubomir T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4491-4499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  P53 activation by small mols. and their application in chemoprevention are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8McGVTfuxrVg90H21EOLACvtfcHk0lgIBcP1n68ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlarsLc%253D&md5=44ee6a039c0c5ad69e218de742de0d53</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm058174k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058174k%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3Dp53%2520Activation%2520by%2520small%2520molecules%253A%2520application%2520in%2520oncology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4491%26epage%3D4499%26doi%3D10.1021%2Fjm058174k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Targeting the MDM2-p53 interaction for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5318</span><span class="NLM_x">–</span> <span class="NLM_lpage">5324</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-5136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1158%2F1078-0432.CCR-07-5136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=18765522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5318-5324&author=S.+Shangaryauthor=S.+Wang&title=Targeting+the+MDM2-p53+interaction+for+cancer+therapy&doi=10.1158%2F1078-0432.CCR-07-5136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MDM2-p53 Interaction for Cancer Therapy</span></div><div class="casAuthors">Shangary, Sanjeev; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5318-5324</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  P53 is a powerful tumor suppressor and is an attractive cancer therapeutic target because it can be functionally activated to eradicate tumors.  The gene encoding p53 protein is mutated or deleted in half of human cancers, which inactivates its tumor suppressor activity.  In the remaining cancers with wild-type p53 status, its function is effectively inhibited through direct interaction with the human murine double minute 2 (MDM2) oncoprotein.  Blocking the MDM2-p53 interaction to reactivate the p53 function is a promising cancer therapeutic strategy.  This review will highlight the advances in the design and development of small-mol. inhibitors of the MDM2-p53 interaction as a cancer therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtwmcFovaS7Vg90H21EOLACvtfcHk0lgp9UyG8W41JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbzK&md5=830e9b394b8d99261d3681ad8d450612</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-5136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-5136%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520MDM2-p53%2520interaction%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5318%26epage%3D5324%26doi%3D10.1158%2F1078-0432.CCR-07-5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Targeting the MDM2-p53 protein-protein interaction for new cancer therapeutics</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1007/978-3-642-28965-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1007%2F978-3-642-28965-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=57-79&author=S.+M.+Wangauthor=Y.+J.+Zhaoauthor=D.+Bernardauthor=A.+Aguilarauthor=S.+Kumar&title=Targeting+the+MDM2-p53+protein-protein+interaction+for+new+cancer+therapeutics&doi=10.1007%2F978-3-642-28965-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MDM2-p53 protein-protein interaction for new cancer therapeutics</span></div><div class="casAuthors">Wang, Shaomeng; Zhao, Yujun; Bernard, Denzil; Aguilar, Angelo; Kumar, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Topics in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">57-80</span>CODEN:
                <span class="NLM_cas:coden">TMCOB8</span>;
        ISSN:<span class="NLM_cas:issn">1862-2461</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The p53 tumor suppressor protein is a transcriptional factor that plays a key role in regulation of several cellular processes including the cell cycle, apoptosis, DNA repair, and angiogenesis.  The murine double minute 2 (MDM2) protein is the primary cellular inhibitor of p53, functioning through direct interaction with p53.  Design of non-peptide, small-mol. inhibitors that block the MDM2-p53 interaction has been sought as an attractive strategy to activate p53 for the treatment of cancer and other human diseases.  Major advances have been made in the design of small-mol. inhibitors of the MDM2-p53 interaction in recent years, and several compds. have moved into advanced preclin. development or clin. trials.  In this chapter, we will highlight these advances in the design and development of MDM2 inhibitors, and discuss lessons learned from these efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz8RJm7ymBbbVg90H21EOLACvtfcHk0lgp9UyG8W41JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgsrfF&md5=1765c7b13fe3f7480cd9e8f6ead691ff</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-28965-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-28965-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DY.%2BJ.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520MDM2-p53%2520protein-protein%2520interaction%2520for%2520new%2520cancer%2520therapeutics%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D57%26epage%3D79%26doi%3D10.1007%2F978-3-642-28965-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Carry, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2Fj.bmcl.2013.03.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2480-2485&author=J.+C.+Carryauthor=C.+Garcia-Echeverria&title=Inhibitors+of+the+p53%2Fhdm2+protein-protein+interaction-path+to+the+clinic&doi=10.1016%2Fj.bmcl.2013.03.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DCarry%26aufirst%3DJ.%2BC.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520p53%252Fhdm2%2520protein-protein%2520interaction-path%2520to%2520the%2520clinic%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2480%26epage%3D2485%26doi%3D10.1016%2Fj.bmcl.2013.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ray-Coquard, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blay, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Cesne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span> </span><span class="NLM_article-title">Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span><span class="refDoi"> DOI: 10.1016/S1470-2045(12)70474-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS1470-2045%2812%2970474-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=23084521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wqur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1133-1140&author=I.+Ray-Coquardauthor=J.+Y.+Blayauthor=A.+Italianoauthor=A.+Le+Cesneauthor=N.+Penelauthor=J.+Zhiauthor=F.+Heilauthor=R.+Ruegerauthor=B.+Gravesauthor=M.+Dingauthor=D.+Gehoauthor=S.+A.+Middletonauthor=L.+T.+Vassilevauthor=G.+L.+Nicholsauthor=B.+N.+Bui&title=Effect+of+the+MDM2+antagonist+RG7112+on+the+P53+pathway+in+patients+with+MDM2-amplified%2C+well-differentiated+or+dedifferentiated+liposarcoma%3A+an+exploratory+proof-of-mechanism+study&doi=10.1016%2FS1470-2045%2812%2970474-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study</span></div><div class="casAuthors">Ray-Coquard, Isabelle; Blay, Jean-Yves; Italiano, Antoine; Le Cesne, Axel; Penel, Nicolas; Zhi, Jianguo; Heil, Florian; Rueger, Ruediger; Graves, Bradford; Ding, Meichun; Geho, David; Middleton, Steven A.; Vassilev, Lyubomir T.; Nichols, Gwen L.; Bui, Binh Nguyen</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1133-1140</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report a proof-of-mechanism study of RG7112, a small-mol. MDM2 antagonist, in patients with chemotherapy-naive primary or relapsed well-differentiated or dedifferentiated MDM2-amplified liposarcoma who were eligible for resection.  Patients with well-differentiated or dedifferentiated liposarcoma were enrolled at four centers in France.  Patients received up to three 28-day neoadjuvant treatment cycles of RG7112 1440 mg/m2 per day for 10 days.  If a patient progressed at any point after the first cycle, the lesion was resected or, if unresectable, an end-of-study biopsy was done.  The primary endpoint was to assess markers of RG7112-dependent MDM2 inhibition and P53 pathway activation (P53, P21, MDM2, Ki-67, macrophage inhibitory cytokine-1 [MIC-1], and apoptosis).  All analyses were per protocol.  This trial is registered with EudraCT, no. 2009-015522-10.  Between June 3, and Dec 14, 2010, 20 patients were enrolled and completed pretreatment and day 8 biopsies. 18 of 20 patients had TP53 wild-type tumors and two carried missense TP53 mutations. 14 of 17 assessed patients had MDM2 gene amplification.  Compared with baseline, P53 and P21 concns., assessed by immunohistochem., had increased by a median of 4·86 times (IQR 4·38-7·97; p=0·0001) and 3·48 times (2·05-4·09; p=0·0001), resp., at day 8 (give or take 2 days).  At the same timepoint, relative MDM2 mRNA expression had increased by a median of 3·03 times (1·23-4·93; p=0·003) that at baseline.  The median change from baseline for Ki-67-pos. tumor cells was -5·05% (IQR -12·55 to 0·05; p=0·01).  Drug exposure correlated with blood concns. of MIC-1 (p<0·0001) and haematol. toxicity.  One patient had a confirmed partial response and 14 had stable disease.  All patients experienced at least one adverse event, mostly nausea (14 patients), vomiting (11 patients), asthenia (nine patients), diarrhoea (nine patients), and thrombocytopenia (eight patients).  There were 12 serious adverse events in eight patients, the most common of which were neutropenia (six patients) and thrombocytopenia (three patients).  MDM2 inhibition activates the P53 pathway and decreases cell proliferation in MDM2-amplified liposarcoma.  This study suggests that it is feasible to undertake neoadjuvant biopsy-driven biomarker studies in liposarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5gE_ssOHMbVg90H21EOLACvtfcHk0lgp9UyG8W41JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wqur3K&md5=ef950cefb26da53bc624fc45e8e006e9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2812%2970474-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252812%252970474-6%26sid%3Dliteratum%253Aachs%26aulast%3DRay-Coquard%26aufirst%3DI.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DLe%2BCesne%26aufirst%3DA.%26aulast%3DPenel%26aufirst%3DN.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DRueger%26aufirst%3DR.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DGeho%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DNichols%26aufirst%3DG.%2BL.%26aulast%3DBui%26aufirst%3DB.%2BN.%26atitle%3DEffect%2520of%2520the%2520MDM2%2520antagonist%2520RG7112%2520on%2520the%2520P53%2520pathway%2520in%2520patients%2520with%2520MDM2-amplified%252C%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%253A%2520an%2520exploratory%2520proof-of-mechanism%2520study%26jtitle%3DLancet%2520Oncol.%26date%3D2012%26volume%3D13%26spage%3D1133%26epage%3D1140%26doi%3D10.1016%2FS1470-2045%2812%2970474-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span><span class="refDoi"> DOI: 10.1021/jm501092z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501092z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1038-1052&author=Y.+Zhaoauthor=A.+Aguilarauthor=D.+Bernardauthor=S.+Wang&title=Small-molecule+inhibitors+of+the+MDM2-p53+protein-protein+interaction+%28MDM2+Inhibitors%29+in+clinical+trials+for+cancer+treatment&doi=10.1021%2Fjm501092z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment</span></div><div class="casAuthors">Zhao, Yujun; Aguilar, Angelo; Bernard, Denzil; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Design of small-mol. inhibitors (MDM2 inhibitors) to block the MDM2-p53 protein-protein interaction has been pursued as a new cancer therapeutic strategy.  In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compds. have been advanced into early phase clin. trials for the treatment of human cancers.  Here, we review the design, synthesis, properties, preclin., and clin. studies of these clin.-stage MDM2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNa9aW1Kz1Q7Vg90H21EOLACvtfcHk0liyULZDDPvC_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P&md5=2e58318782d7e0a04bf3398db8782984</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501092z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520protein-protein%2520interaction%2520%2528MDM2%2520Inhibitors%2529%2520in%2520clinical%2520trials%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1038%26epage%3D1052%26doi%3D10.1021%2Fjm501092z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7112: A small-molecule MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1021/ml4000657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wovkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.+J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+A+small-molecule+MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fml4000657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0liyULZDDPvC_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520A%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469%26doi%3D10.1021%2Fml4000657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span><span class="refDoi"> DOI: 10.1021/jm400487c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtValsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.+J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.+J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fjm400487c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Ding, Qingjie; Zhang, Zhuming; Liu, Jin-Jun; Jiang, Nan; Zhang, Jing; Ross, Tina M.; Chu, Xin-Jie; Bartkovitz, David; Podlaski, Frank; Janson, Cheryl; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir T.; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5979-5983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Restoration of p53 activity by inhibition of the p53-MDM2 interaction has been considered an attractive approach for cancer treatment.  However, the hydrophobic protein-protein interaction surface represents a significant challenge for the development of small-mol. inhibitors with desirable pharmacol. profiles.  RG7112 was the first small-mol. p53-MDM2 inhibitor in clin. development.  Here, the authors report the discovery and characterization of a second generation clin. MDM2 inhibitor, RG7388, with superior potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bhb1040eXrVg90H21EOLACvtfcHk0ljH9Lsgcopc6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtValsLzJ&md5=714bcfd797cf5850384239989c94a2c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983%26doi%3D10.1021%2Fjm400487c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaux, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barriere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman-Luca, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos-Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorge-Bernat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debussche, L.</span><span> </span><span class="NLM_article-title">SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5855</span><span class="NLM_x">–</span> <span class="NLM_lpage">5865</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1158%2F0008-5472.CAN-14-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=25145672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5855-5865&author=S.+Wangauthor=W.+Sunauthor=Y.+Zhaoauthor=D.+McEachernauthor=I.+Meauxauthor=C.+Barriereauthor=J.+A.+Stuckeyauthor=J.+L.+Meagherauthor=L.+Baiauthor=L.+Liuauthor=C.+G.+Hoffman-Lucaauthor=J.+Luauthor=S.+Shangaryauthor=S.+Yuauthor=D.+Bernardauthor=A.+Aguilarauthor=O.+Dos-Santosauthor=L.+Besretauthor=S.+Guerifauthor=P.+Pannierauthor=D.+Gorge-Bernatauthor=L.+Debussche&title=SAR405838%3A+an+optimized+inhibitor+of+MDM2-p53+interaction+that+induces+complete+and+durable+tumor+regression&doi=10.1158%2F0008-5472.CAN-14-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression</span></div><div class="casAuthors">Wang, Shaomeng; Sun, Wei; Zhao, Yujun; McEachern, Donna; Meaux, Isabelle; Barriere, Cedric; Stuckey, Jeanne A.; Meagher, Jennifer L.; Bai, Longchuan; Liu, Liu; Hoffman-Luca, Cassandra Gianna; Lu, Jianfeng; Shangary, Sanjeev; Yu, Shanghai; Bernard, Denzil; Aguilar, Angelo; Dos-Santos, Odette; Besret, Laurent; Guerif, Stephane; Pannier, Pascal; Gorge-Bernat, Dimitri; Debussche, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5855-5865</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite the risk of applying a selection for p53 mutations that escape MDM2 control, blocking MDM2-p53 protein-protein interaction has long been considered by many to offer an attractive cancer therapeutic strategy, a position strongly supported by the findings of this preclin. study.  Blocking the oncoprotein murine double minute 2 (MDM2)-p53 protein-protein interaction has long been considered to offer a broad cancer therapeutic strategy, despite the potential risks of selecting tumors harboring p53 mutations that escape MDM2 control.  In this study, we report a novel small-mol. inhibitor of the MDM2-p53 interaction, SAR405838 (MI-77301), that has been advanced into phase I clin. trials.  SAR405838 binds to MDM2 with Ki = 0.88 nmol/L and has high specificity over other proteins.  A cocrystal structure of the SAR405838:MDM2 complex shows that, in addn. to mimicking three key p53 amino acid residues, the inhibitor captures addnl. interactions not obsd. in the p53-MDM2 complex and induces refolding of the short, unstructured MDM2 N-terminal region to achieve its high affinity.  SAR405838 effectively activates wild-type p53 in vitro and in xenograft tumor tissue of leukemia and solid tumors, leading to p53-dependent cell-cycle arrest and/or apoptosis.  At well-tolerated dose schedules, SAR405838 achieves either durable tumor regression or complete tumor growth inhibition in mouse xenograft models of SJSA-1 osteosarcoma, RS4;11 acute leukemia, LNCaP prostate cancer, and HCT-116 colon cancer.  Remarkably, a single oral dose of SAR405838 is sufficient to achieve complete tumor regression in the SJSA-1 model.  Mechanistically, robust transcriptional upregulation of PUMA induced by SAR405838 results in strong apoptosis in tumor tissue, leading to complete tumor regression.  Our findings provide a preclin. basis upon which to evaluate SAR405838 as a therapeutic agent in patients whose tumors retain wild-type p53.  Cancer Res; 74(20); 5855-65. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptKSwfNhNzNLVg90H21EOLACvtfcHk0ljH9Lsgcopc6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjsr7M&md5=5b35759e14fe4c1ae4e734775c4334a0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0799%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DMeaux%26aufirst%3DI.%26aulast%3DBarriere%26aufirst%3DC.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHoffman-Luca%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DDos-Santos%26aufirst%3DO.%26aulast%3DBesret%26aufirst%3DL.%26aulast%3DGuerif%26aufirst%3DS.%26aulast%3DPannier%26aufirst%3DP.%26aulast%3DGorge-Bernat%26aufirst%3DD.%26aulast%3DDebussche%26aufirst%3DL.%26atitle%3DSAR405838%253A%2520an%2520optimized%2520inhibitor%2520of%2520MDM2-p53%2520interaction%2520that%2520induces%2520complete%2520and%2520durable%2520tumor%2520regression%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D5855%26epage%3D5865%26doi%3D10.1158%2F0008-5472.CAN-14-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1021/jm401753e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1454-1472&author=D.+Sunauthor=Z.+Liauthor=Y.+Rewauthor=M.+Gribbleauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=X.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+Fisherauthor=B.+M.+Foxauthor=J.+Fuauthor=A.+Z.+Gonzalezauthor=F.+Gonzalez-Lopez+De+Turisoauthor=J.+B.+Houzeauthor=X.+Huangauthor=M.+Jiangauthor=L.+Jinauthor=F.+Kayserauthor=J.+J.+Liuauthor=M.+C.+Loauthor=A.+M.+Longauthor=B.+Lucasauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+Mihalicauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+L.+Petersonauthor=P.+Rovetoauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=M.+Totevaauthor=Y.+Wangauthor=Y.+C.+Wangauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=M.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+Zhuauthor=S.+H.+Olsonauthor=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+MDM2-p53+inhibitor+in+clinical+development&doi=10.1021%2Fjm401753e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development</span></div><div class="casAuthors">Sun, Daqing; Li, Zhihong; Rew, Yosup; Gribble, Michael; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chen, Xiaoqi; Chow, David; Deignan, Jeffrey; Duquette, Jason; Eksterowicz, John; Fisher, Benjamin; Fox, Brian M.; Fu, Jiasheng; Gonzalez, Ana Z.; Gonzalez-Lopez De Turiso, Felix; Houze, Jonathan B.; Huang, Xin; Jiang, Min; Jin, Lixia; Kayser, Frank; Liu, Jiwen; Lo, Mei-Chu; Long, Alexander M.; Lucas, Brian; McGee, Lawrence R.; McIntosh, Joel; Mihalic, Jeff; Oliner, Jonathan D.; Osgood, Tao; Peterson, Matthew L.; Roveto, Philip; Saiki, Anne Y.; Shaffer, Paul; Toteva, Maria; Wang, Yingcai; Wang, Yu Chung; Wortman, Sarah; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Yu, Ming; Zhao, Xiaoning; Zhou, Jing; Zhu, Jiang; Olson, Steven H.; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1454-1472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the discovery of AM-8553 (1), a potent and selective piperidinone inhibitor of the MDM2-p53 interaction.  Continued research investigation of the N-alkyl substituent of this series, focused in particular on a previously underutilized interaction in a shallow cleft on the MDM2 surface, led to the discovery of a one-carbon tethered sulfone which gave rise to substantial improvements in biochem. and cellular potency.  Further investigation produced AMG 232 (2), which is currently being evaluated in human clin. trials for the treatment of cancer.  Compd. 2 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9.1 nM), with remarkable pharmacokinetic properties and in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft model (ED50 = 9.1 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjly0O6c42NbVg90H21EOLACvtfcHk0lh0xO3p-ic9og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitbY%253D&md5=91197d328d40f6fa2f6c37819149427f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DGribble%26aufirst%3DM.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DGonzalez-Lopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DMihalic%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520MDM2-p53%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1454%26epage%3D1472%26doi%3D10.1021%2Fjm401753e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Holzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valat-Stachyra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouisset-Leonard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissot-Soldermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruetz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessier, F.</span><span> </span><span class="NLM_article-title">Discovery of a dihydroisoquinolinone derivative (NVP-CGM097): a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6348</span><span class="NLM_x">–</span> <span class="NLM_lpage">6358</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00810</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00810" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyrurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6348-6358&author=P.+Holzerauthor=K.+Masuyaauthor=P.+Furetauthor=J.+Kallenauthor=T.+Valat-Stachyraauthor=S.+Ferrettiauthor=J.+Berghausenauthor=M.+Bouisset-Leonardauthor=N.+Buschmannauthor=C.+Pissot-Soldermannauthor=C.+Rynnauthor=S.+Ruetzauthor=S.+Stutzauthor=P.+Cheneauthor=S.+Jeayauthor=F.+Gessier&title=Discovery+of+a+dihydroisoquinolinone+derivative+%28NVP-CGM097%29%3A+a+highly+potent+and+selective+MDM2+inhibitor+undergoing+phase+1+clinical+trials+in+p53wt+tumors&doi=10.1021%2Facs.jmedchem.5b00810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors</span></div><div class="casAuthors">Holzer, Philipp; Masuya, Keiichi; Furet, Pascal; Kallen, Joerg; Valat-Stachyra, Therese; Ferretti, Stephane; Berghausen, Joerg; Bouisset-Leonard, Michele; Buschmann, Nicole; Pissot-Soldermann, Carole; Rynn, Caroline; Ruetz, Stephan; Stutz, Stefan; Chene, Patrick; Jeay, Sebastien; Gessier, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6348-6358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a result of our efforts to discover novel p53:MDM2 protein-protein interaction inhibitors useful for treating cancer, the potent and selective MDM2 inhibitor NVP-CGM097 (I) with an excellent in vivo profile was selected as a clin. candidate and is currently in phase 1 clin. development.  This article provides an overview of the discovery of this new clin. p53:MDM2 inhibitor.  The following aspects are addressed: mechanism of action, scientific rationale, binding mode, medicinal chem., pharmacokinetic and pharmacodynamic properties, and in vivo pharmacol./toxicol. in preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5qgUnQrBbkLVg90H21EOLACvtfcHk0lh0xO3p-ic9og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyrurvI&md5=bf887aa5428654a86fd89a482a07e226</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00810%26sid%3Dliteratum%253Aachs%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DValat-Stachyra%26aufirst%3DT.%26aulast%3DFerretti%26aufirst%3DS.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DBouisset-Leonard%26aufirst%3DM.%26aulast%3DBuschmann%26aufirst%3DN.%26aulast%3DPissot-Soldermann%26aufirst%3DC.%26aulast%3DRynn%26aufirst%3DC.%26aulast%3DRuetz%26aufirst%3DS.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DGessier%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520a%2520dihydroisoquinolinone%2520derivative%2520%2528NVP-CGM097%2529%253A%2520a%2520highly%2520potent%2520and%2520selective%2520MDM2%2520inhibitor%2520undergoing%2520phase%25201%2520clinical%2520trials%2520in%2520p53wt%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6348%26epage%3D6358%26doi%3D10.1021%2Facs.jmedchem.5b00810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Aguilar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10486</span><span class="NLM_x">–</span> <span class="NLM_lpage">10498</span><span class="refDoi"> DOI: 10.1021/jm501541j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501541j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10486-10498&author=A.+Aguilarauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=D.+Bernardauthor=J.+R.+Deschampsauthor=S.+Wang&title=Design+of+chemically+stable%2C+potent%2C+and+efficacious+MDM2+inhibitors+that+exploit+the+retro-mannich+ring-opening-cyclization+reaction+mechanism+in+spiro-oxindoles&doi=10.1021%2Fjm501541j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles</span></div><div class="casAuthors">Aguilar, Angelo; Sun, Wei; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Bernard, Denzil; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10486-10498</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spiropyrrolidineoxindoles such as I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were prepd. as inhibitors of the interaction between the proteins MDM2 and p53 for use as antitumor agents; the second-generation inhibitors incorporate sym. disubstitution in the pyrrolidine ring next to the spiro junction in order to facilitate isomerization via retro-Mannich/Mannich reactions to the more active stereoisomers (in which the aryl rings attached to the pyrrolidine are trans) as well as to improve stability in vitro and in vivo.  In particular, I (R = 4-HO2CC6H4) (MI-1061), which bound to MDM2 with a Ki value of 0.16 nM, showed excellent chem. stability and caused regression of human SJSA-1 xenograft tumors in mice.  The structures of diphenylhydroxyethyl spiropyrrolidineoxindole and spiropyrrolidineoxindolecarboxylate intermediates in the prepn. of I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_es94k2y2-rVg90H21EOLACvtfcHk0ljnBMwp8wNnHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O&md5=6399fb5e19fc8d69e40e6fd19721e270</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501541j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501541j%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520chemically%2520stable%252C%2520potent%252C%2520and%2520efficacious%2520MDM2%2520inhibitors%2520that%2520exploit%2520the%2520retro-mannich%2520ring-opening-cyclization%2520reaction%2520mechanism%2520in%2520spiro-oxindoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10486%26epage%3D10498%26doi%3D10.1021%2Fjm501541j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carry, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7234</span><span class="refDoi"> DOI: 10.1021/ja3125417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3125417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=7223-7234&author=Y.+Zhaoauthor=L.+Liuauthor=W.+Sunauthor=J.+Luauthor=D.+McEachernauthor=X.+Liauthor=S.+Yuauthor=D.+Bernardauthor=P.+Ochsenbeinauthor=V.+Fereyauthor=J.+C.+Carryauthor=J.+R.+Deschampsauthor=D.+Sunauthor=S.+Wang&title=Diastereomeric+spirooxindoles+as+highly+potent+and+efficacious+MDM2+inhibitors&doi=10.1021%2Fja3125417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors</span></div><div class="casAuthors">Zhao, Yujun; Liu, Liu; Sun, Wei; Lu, Jianfeng; McEachern, Donna; Li, Xiaoqin; Yu, Shanghai; Bernard, Denzil; Ochsenbein, Philippe; Ferey, Vincent; Carry, Jean-Christophe; Deschamps, Jeffrey R.; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7223-7234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the MDM2-p53 protein-protein interaction (MDM2 inhibitors) are being intensely pursued as a new therapeutic strategy for cancer treatment.  We previously published a series of spirooxindole-contg. compds. as a new class of MDM2 small-mol. inhibitors.  We report herein a reversible ring-opening-cyclization reaction for some of these spirooxindoles, which affords four diastereomers from a single compd.  Our biochem. binding data showed that the stereochem. in this class of compds. has a major effect on their binding affinities to MDM2, with >100-fold difference between the most potent and the least potent stereoisomers.  Our study has led to the identification of a set of highly potent MDM2 inhibitors with a stereochem. that is different from that of our previously reported compds.  The most potent compd. (MI-888) binds to MDM2 with a Ki value of 0.44 nM and achieves complete and long-lasting tumor regression in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEWm0CbFl2rVg90H21EOLACvtfcHk0ljnBMwp8wNnHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D&md5=5c05b0adc0d14506602d0884b64411b0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja3125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3125417%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DOchsenbein%26aufirst%3DP.%26aulast%3DFerey%26aufirst%3DV.%26aulast%3DCarry%26aufirst%3DJ.%2BC.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiastereomeric%2520spirooxindoles%2520as%2520highly%2520potent%2520and%2520efficacious%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D7223%26epage%3D7234%26doi%3D10.1021%2Fja3125417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active p53-MDM2 inhibitors RO5353 and RO2468 for potential clinical development</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1021/ml400359z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400359z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=124-127&author=Z.+Zhangauthor=X.+J.+Chuauthor=J.+J.+Liuauthor=Q.+Dingauthor=J.+Zhangauthor=D.+Bartkovitzauthor=N.+Jiangauthor=P.+Karnachiauthor=S.+S.+Soauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+potent+and+orally+active+p53-MDM2+inhibitors+RO5353+and+RO2468+for+potential+clinical+development&doi=10.1021%2Fml400359z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development</span></div><div class="casAuthors">Zhang, Zhuming; Chu, Xin-Jie; Liu, Jin-Jun; Ding, Qingjie; Zhang, Jing; Bartkovitz, David; Jiang, Nan; Karnachi, Prabha; So, Sung-Sau; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small-mol. MDM2 inhibitors to restore dysfunctional p53 activities represents a novel approach for cancer treatment.  In a previous communication, the efforts leading to the identification of a non-imidazoline MDM2 inhibitor, RG7388, were disclosed and revealed the desirable in vitro and in vivo pharmacol. properties that this class of pyrrolidine-based inhibitors possesses.  Given this richness and the crit. need for a wide variety of chem. structures to ensure success in the clinic, research was expanded to evaluate addnl. derivs.  Here we report two new potent, selective, and orally active p53-MDM2 antagonists, RO5353 and RO2468 (I and II, resp.), as follow-ups with promising potential for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhz706p6MGerVg90H21EOLACvtfcHk0lht4TX_9dv2ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVal&md5=30b9dff342ff18ce8dafe7f564d4a771</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml400359z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400359z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520p53-MDM2%2520inhibitors%2520RO5353%2520and%2520RO2468%2520for%2520potential%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D124%26epage%3D127%26doi%3D10.1021%2Fml400359z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active gamma-secretase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3414</span><span class="NLM_x">–</span> <span class="NLM_lpage">3424</span><span class="refDoi"> DOI: 10.1021/jm300094u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300094u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3414-3424&author=A.+F.+Stepanauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=J.+K.+Dutraauthor=T.+J.+O%E2%80%99Sullivanauthor=K.+J.+DiRicoauthor=W.+S.+McDonaldauthor=A.+Wonauthor=P.+H.+Dorffauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=D.+R.+Riddellauthor=G.+W.+Kauffmanauthor=B.+L.+Kormosauthor=L.+Zhangauthor=Y.+Luauthor=S.+H.+Capettaauthor=M.+E.+Greenauthor=K.+Karkiauthor=E.+Sibleyauthor=K.+P.+Atchisonauthor=A.+J.+Hallgrenauthor=C.+E.+Oborskiauthor=A.+E.+Robshawauthor=B.+Sneedauthor=C.+J.+O%E2%80%99Donnell&title=Application+of+the+bicyclo%5B1.1.1%5Dpentane+motif+as+a+nonclassical+phenyl+ring+bioisostere+in+the+design+of+a+potent+and+orally+active+gamma-secretase+inhibitor&doi=10.1021%2Fjm300094u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300094u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300094u%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCapetta%26aufirst%3DS.%2BH.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DAtchison%26aufirst%3DK.%2BP.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DApplication%2520of%2520the%2520bicyclo%255B1.1.1%255Dpentane%2520motif%2520as%2520a%2520nonclassical%2520phenyl%2520ring%2520bioisostere%2520in%2520the%2520design%2520of%2520a%2520potent%2520and%2520orally%2520active%2520gamma-secretase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3414%26epage%3D3424%26doi%3D10.1021%2Fjm300094u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span><span> </span><span class="NLM_article-title">Plasma Protein Binding</span>. In  <span class="citation_source-book">Drug-like Properties: Concepts, Structure Design and Methods</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Chapter 14, pp  <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FB978-012369520-8.50015-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=187-196&author=E.+H.+Kerns&author=L.+Di&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FB978-012369520-8.50015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369520-8.50015-2%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DPlasma%2520Protein%2520Binding%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2008%26spage%3D187%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lifjOm07wZGmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Smart, B. E.</span><span> </span><span class="NLM_article-title">Fluorine substituent effects (on bioactivity)</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/S0022-1139(01)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2FS0022-1139%2801%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=3-11&author=B.+E.+Smart&title=Fluorine+substituent+effects+%28on+bioactivity%29&doi=10.1016%2FS0022-1139%2801%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine substituent effects (on bioactivity)</span></div><div class="casAuthors">Smart, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review, with 32 refs.,.  The characteristic effects of F and fluoroalkyl substituents on the physicochem. properties of mols. that are important to biol. activity of fluorinated compds. are highlighted.  The influence of fluorination on acidity, H-bonding, and lipophilicity that affect compd. absorption and distribution is described.  The current perspectives on F steric interactions and the controversial role of H-bonding involving the C-F bond are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6E1WbRFxuJ7Vg90H21EOLACvtfcHk0lifjOm07wZGmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D&md5=bd8cda675e305cd19c4a4eb8db59e107</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2801%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252801%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DB.%2BE.%26atitle%3DFluorine%2520substituent%2520effects%2520%2528on%2520bioactivity%2529%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2001%26volume%3D109%26spage%3D3%26epage%3D11%26doi%3D10.1016%2FS0022-1139%2801%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Huchet, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">On the polarity of partially fluorinated methyl groups</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.jfluchem.2013.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1016%2Fj.jfluchem.2013.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=119-128&author=Q.+A.+Huchetauthor=B.+Kuhnauthor=B.+Wagnerauthor=H.+Fischerauthor=M.+Kansyauthor=D.+Zimmerliauthor=E.+M.+Carreiraauthor=K.+Muller&title=On+the+polarity+of+partially+fluorinated+methyl+groups&doi=10.1016%2Fj.jfluchem.2013.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">On the polarity of partially fluorinated methyl groups</span></div><div class="casAuthors">Huchet, Quentin A.; Kuhn, Bernd; Wagner, Bjorn; Fischer, Holger; Kansy, Manfred; Zimmerli, Daniel; Carreira, Erick M.; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Indole and 5-methoxyindole derivs., substituted at C3 with Pr or 4-methylcyclohexyl scaffolds bearing varying degrees of fluorination of the terminal Me group, were prepd. and studied.  These compds. exhibit characteristic polarity patterns, measured either by log P or chromatog. capacity factors, which are consistent with the partially known lipophilicity pattern for the corresponding n-propylbenzene series.  Based on a simple CF bond vector anal., the polarity increase upon exchange of a terminal Me by a trifluoromethyl group in an aliph. substituent should be comparable to that arising from a single H/F exchange at the terminal Me group, while the vol. increase in the former case is three times larger than that in the latter.  This may explain the observation that replacement of a Me by a fluoromethyl group results in a more pronounced lowering of mol. lipophilicity than its replacement by a trifluoromethyl group.  The same anal. predicts a difluoromethyl group to exhibit a lipophilicity redn. similar to that of a fluoromethyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYIHkZh7XzVrVg90H21EOLACvtfcHk0lifjOm07wZGmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFegs7c%253D&md5=83c0ebac3835db0f547d8235ffebcd14</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2013.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2013.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DHuchet%26aufirst%3DQ.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOn%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520methyl%2520groups%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2013%26volume%3D152%26spage%3D119%26epage%3D128%26doi%3D10.1016%2Fj.jfluchem.2013.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Moody, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span> </span><span class="NLM_article-title">Total synthesis of (+)-nostocyclamide</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1039/a704094f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1039%2Fa704094f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=601-607&author=C.+J.+Moodyauthor=M.+C.+Bagley&title=Total+synthesis+of+%28%2B%29-nostocyclamide&doi=10.1039%2Fa704094f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fa704094f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa704094f%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%252B%2529-nostocyclamide%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1998%26spage%3D601%26epage%3D607%26doi%3D10.1039%2Fa704094f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Phillips, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. R.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span><span class="refDoi"> DOI: 10.1021/ol005777b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol005777b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFKntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=1165-1168&author=A.+J.+Phillipsauthor=Y.+Utoauthor=P.+Wipfauthor=M.+J.+Renoauthor=D.+R.+Williams&title=Synthesis+of+functionalized+oxazolines+and+oxazoles+with+DAST+and+Deoxo-Fluor&doi=10.1021%2Fol005777b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor</span></div><div class="casAuthors">Phillips, Andrew J.; Uto, Yoshikazu; Wipf, Peter; Reno, Michael J.; Williams, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1168</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild and highly efficient cyclization of β-hydroxy amides, e.g., I, to oxazolines, e.g., II, is described using DAST and Deoxo-Fluor [(MeOCH2CH2)2NSF3] reagents.  E.g., Diethylaminosulfur trifluoride is added to a soln. of I in CH2Cl2 at -78° and stirred for 1 h; addn. of potassium carbonate to the soln. and warming to room temp. gives II in 86% yield.  DAST gives slightly higher yields for the cyclization of serine-contg. substrates while (MeOCH2CH2)2NSF3 gives higher yields with threonine-derived β-hydroxy amides.  A one-pot protocol for the synthesis of oxazoles from β-hydroxy amides is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX6dr0Wb8zCrVg90H21EOLACvtfcHk0liIloVCu7WaNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFKntLk%253D&md5=f3431b30d0f3bd7f9a7591ae35a88edc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol005777b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol005777b%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DUto%26aufirst%3DY.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DReno%26aufirst%3DM.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26atitle%3DSynthesis%2520of%2520functionalized%2520oxazolines%2520and%2520oxazoles%2520with%2520DAST%2520and%2520Deoxo-Fluor%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D1165%26epage%3D1168%26doi%3D10.1021%2Fol005777b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Borg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estennebouhtou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csoregh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselink, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span> </span><span class="NLM_article-title">Synthesis of 1,2,4-oxadiazole-derived, 1,3,4-oxadiazole-derived, and 1,2,4-triazole-derived dipeptidomimetics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3112</span><span class="NLM_x">–</span> <span class="NLM_lpage">3120</span><span class="refDoi"> DOI: 10.1021/jo00115a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00115a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=3112-3120&author=S.+Borgauthor=G.+Estennebouhtouauthor=K.+Luthmanauthor=I.+Csoreghauthor=W.+Hesselinkauthor=U.+Hacksell&title=Synthesis+of+1%2C2%2C4-oxadiazole-derived%2C+1%2C3%2C4-oxadiazole-derived%2C+and+1%2C2%2C4-triazole-derived+dipeptidomimetics&doi=10.1021%2Fjo00115a029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00115a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00115a029%26sid%3Dliteratum%253Aachs%26aulast%3DBorg%26aufirst%3DS.%26aulast%3DEstennebouhtou%26aufirst%3DG.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DCsoregh%26aufirst%3DI.%26aulast%3DHesselink%26aufirst%3DW.%26aulast%3DHacksell%26aufirst%3DU.%26atitle%3DSynthesis%2520of%25201%252C2%252C4-oxadiazole-derived%252C%25201%252C3%252C4-oxadiazole-derived%252C%2520and%25201%252C2%252C4-triazole-derived%2520dipeptidomimetics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3112%26epage%3D3120%26doi%3D10.1021%2Fjo00115a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span> </span><span class="NLM_article-title">Total synthesis of (−)-muscoride A</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6522</span><span class="refDoi"> DOI: 10.1021/jo960891m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960891m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=6517-6522&author=P.+Wipfauthor=S.+Venkatraman&title=Total+synthesis+of+%28%E2%88%92%29-muscoride+A&doi=10.1021%2Fjo960891m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo960891m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960891m%26sid%3Dliteratum%253Aachs%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DVenkatraman%26aufirst%3DS.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-muscoride%2520A%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D6517%26epage%3D6522%26doi%3D10.1021%2Fjo960891m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0liIloVCu7WaNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lhX0QQIB1QyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Eldridge, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, R. P.</span><span> </span><span class="NLM_article-title">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1023/A:1007996124545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=10.1023%2FA%3A1007996124545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=9385547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=425-445&author=M.+D.+Eldridgeauthor=C.+W.+Murrayauthor=T.+R.+Autonauthor=G.+V.+Paoliniauthor=R.+P.+Mee&title=Empirical+scoring+functions%3A+I.+The+development+of+a+fast+empirical+scoring+function+to+estimate+the+binding+affinity+of+ligands+in+receptor+complexes&doi=10.1023%2FA%3A1007996124545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span></div><div class="casAuthors">Eldridge, Matthew D.; Murray, Christopher W.; Auton, Timothy R.; Paolini, Gaia V.; Mee, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-445</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">This paper describes the development of a simple empirical scoring function designed to est. the free energy of binding for a protein-ligand complex when the 3D structure of the complex is known or can be approximated.  The function uses simple contact terms to est. lipophilic and metal-ligand binding contributions, a simple explicit form for hydrogen bonds and a term which penalizes flexibility.  The coeffs. of each term are obtained using a regression based on 82 ligand-receptor complexes for which the binding affinity is known.  The function reproduces the binding affinity of the complexes with a cross-validated error of 8.68 kJ/mol.  Tests on internal consistency indicate that the coeffs. obtained are stable to changes in the compn. of the training set.  The function is also tested on two test sets contg. a further 20 and 10 complexes, resp.  The deficiencies of this type of function are discussed and it is compared to approaches by other workers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJZ-k95NG1LVg90H21EOLACvtfcHk0lhX0QQIB1QyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D&md5=ece4b881e181f3d5c1287af55efaf6b4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007996124545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007996124545%26sid%3Dliteratum%253Aachs%26aulast%3DEldridge%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DAuton%26aufirst%3DT.%2BR.%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DMee%26aufirst%3DR.%2BP.%26atitle%3DEmpirical%2520scoring%2520functions%253A%2520I.%2520The%2520development%2520of%2520a%2520fast%2520empirical%2520scoring%2520function%2520to%2520estimate%2520the%2520binding%2520affinity%2520of%2520ligands%2520in%2520receptor%2520complexes%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D425%26epage%3D445%26doi%3D10.1023%2FA%3A1007996124545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TRF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TRF','PDB','5TRF'); return false;">PDB: 5TRF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i84"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01665">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50577"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01665">10.1021/acs.jmedchem.6b01665</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_001.csv">CSV</a>)</p></li><li><p class="inline">Structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_002.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_001.csv">jm6b01665_si_001.csv (6.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01665/suppl_file/jm6b01665_si_002.pdb">jm6b01665_si_002.pdb (67.37 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01665%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01665" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799532f9c33d96e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
